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Summary
Probiotics (live microbes) and prebiotics (non-digestible food-ingredients) are rapidly gaining interest
worldwide as supplements and functional food ingredients but little South African information in this
regard is available. Furthermore, the availability of South African produced probiotic concentrates for
commercial use is also very limited. The aims of this study therefore were to complete a market and
product assessment of probiotic and prebiotic containing products in South Africa and to evaluate
probiotic strains for commercial use in South Africa.
For the purposes of market and product assessment probiotic and/or prebiotic containing products
manufactured in South Africa were identified. The scientific and legal correctness of health and
content claims made on the labels of the products were assessed. An exploratory survey was
conducted to determine the awareness of South African consumers of probiotics and prebiotics. For
the evaluation of probiotic strains for potential commercial use in South Africa, a panel of twelve
lactic acid bacteria (LAB) were screened for inhibitory activity against two porcine pathogens and
indicator strains from the LMG-panel isolated from the faeces of patients diagnosed with AIDS. The
five LAB with the best inhibitory activity were tested for growth in soymilk-base and for the effect of
lyophilization on the inhibitory activity thereof. The effect of prebiotics on the growth and inhibitory
activity of the strains was tested in vitro.
A range of products containing probiotics and prebiotics available on the South African market was
identified. Irregulatories concerning health claims on the labels were found, but content claims
seemed to be less of a problem. The results also indicate that the proposed South African regulations
for the labelling of probiotic and prebiotic containing products need to be revised to include the
probiotic and prebiotic related health claims for which sufficient scientific evidence is available. The
probiotic strains with potential for commercial use in South Africa that were identified, include
Lactobacillus plantarum 423, Lactobacillus casei LHS, Lactobacillus salivarius 241, Lactobacillus
curvatus DF38 and Pediococcus pentosaceus 34. These strains were grown successfully in soymilk-
base and lyophilization did not have a negative effective on the inhibitory activity thereof. The growth
and inhibitory activity of the five LAB were promoted when combined with 1% (w/v)
Raftilose'f'Synergyl .
It is concluded that although a variety of probiotic and prebiotic containing products are available on
the South African market, the scientific and legislative correctness of especially health related claims
is not satisfactory and that South African consumer awareness of these products is low. It is also
concluded that a combination of at least three of the five identified LAB and 1% (w/v)
Raftilosef'xynergyl can be used by South African manufacturers for the production of probiotic and
prebiotic containing supplements.
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vOpsomming
Die belangstelling 111 probiotika (lewendige mikrobe) en prebiotika (onverteerbare
voedselbestanddele) as supplemente en funksionele voedselbestanddele is besig om wêreldwyd toe te
neem, alhoewel weinig Suid-Arikaanse inligting in hierdie verband beskikbaar is. Die beskikbaarheid
van Suid-Afrikaans geproduseerde probiotika konsentrate vir kommersïele gebruik is ook baie beperk.
Die doelwitte van hierdie studie was dus om 'n mark- en produkevaluering van probiotika- en
prebiotika-bevattende produkte in Suid-Afrika uit te voer en om probiotiese stamme te evalueer vir
uiteindelike kommersiële gebruik in Suid-Afrika.
Vir die doel van die mark- en produkevaluering is probiotika- en prebiotika-bevattende produkte wat
in Suid-Afrika vervaardig word geïdentifiseer. Die wetenskaplike en wetlike korrektheid van die
gesondheids- en inhoudsaansprake op die etikette van die produkte is evalueer. 'n Markopname is
uitgevoer om die bewustheid van Suid-Afrikaanse verbruikers van probiotika en prebiotika vas te stel.
Vir die evaluering van probiotiese stamme vir potensïele kommersiële gebruik in Suid-Afrika is 'n
paneel van twaalf melksuurbakteriëe getoets vir inhibitoriese aktiwiteit teen twee patogene geïsoleer
uit varke asook teen indikator stamme van die LMG-paneel. Die vyf melksuurbakteriëe met die beste
inhibitoriese aktiwiteit is getoets vir groei in sojamelk-basis en ook vir die effek van vriesdroging op
die groei en inhibitoriese aktiwiteit van die stamme daarvan. Die effek van prebiotika op die groei en
inhibitoriese aktiwiteit van die stamme is in vitro getoets.
'u Reeks van probiotika- en prebiotika-bevattende produkte wat beskikbaar is op die Suid-Afrikaanse
mark, is geidentifiseer. Ongeruimdhede met die gesondheidsaansprake op die etikette is gevind, maar
inhoudsaansprake was minder problematies. Die resultate dui ook daarop dat die voorgestelde Suid-
Afrikaanse regulasies vir die etikettering van probiotika- en prebiotika-bevattende produkte hersien
moet word om al die probiotika- en prebiotika-verwante gesondheidsaansprake waarvoor voldoende
wetenskaplike bewyse beskikbaar is in te sluit. Die probiotiese stamme met potensiaal vir
kommersiële gebruik in Suid-Afrika sluit die volgende in: Lactobacillus plantarum 423, Lactobacillus
casei LHS, Lactobacillus salivarius 241, Lactobacillus curvatus OF 38 en Pediococcus pentosaceus
34. Hierdie stamme is suksesvol gekweek in sojamelk-basis en vriesdroging het nie' n negatiewe
effek op die groei en inhibitoriese aktiwiteit daarvan gehad me. Die kombinasie van die vyf
melksuurbakteriëe met 1% Raftilose'ÏSynergy het die groei en inhibitoriese aktiwiteit daarvan
bevorder.
Die gevolgtrekking wat gemaak word is dat alhoewel 'n varrasie van probiotika- en prebiotika-
bevattende produkte beskikbaar is op die Suid-Afrikaanse mark, die wetenskaplike en wetlike
korrektheid van spesifiek die gesondheids-verwante aansprake op die etikette daarvan nie bevredigend
is nie en dat die bewustheid van die Suid-Afrikaanse verbruikers van hierdie produkte laag is. Die
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gevolgtrekking kan ook gemaak word dat 'n kombinasie van ten minste drie van die vyf
geïdentifiseerde melksuurbakteriëe en 1% Raftilose'ÏSynergy deur Suid-Afrikaanse vervaardigers
gebruik kan word vir die vervaardiging van produkte wat probiotika en prebiotika bevat.
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CHAPTER 1
INTRODUCTION
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Introduction
1. Introduction and problem identification
There is an increasing awareness that the health of any individual is linked to the activity of bacteria
resident in the gastrointestinal tract (Buddington et al., 2002). Gut microflora consist of a complex
collection of micro-organisms that form an integral and biologically important component of the body.
These microflora interact with one another and their host and are largely involved in the breakdown of
substrates (Cummings & Macfarlane, 1991).
The mature gastrointestinal ecosystem is resistant to colonization by invading species when in balance
with its host (Buddington et al., 2002). However, factors such as diet, medication, stress and
environmental factors could cause disturbances of the gastrointestinal tract bacteria (Fuller & Gibson,
1997), leading to a microbial imbalance.
The composition of the gut microflora can be manipulated through dietary supplementation of specific
compounds, known as probiotics (Collins & Gibson, 1999). In Greek the word probiotic means "for
life" and is defined by Fuller (1989) as "a live microbial food supplement that beneficially affects the
host by improving its intestinal microbial balance". Probiotic strains are found in various fermented
products and are commercially available in various forms including powders, tablets and suspensions.
These products may contain monocultures or mixed species (as many as nine), mostly members of the
genera Lactobacillus, Bifidobacterium and Enterococcus.
The potential effects of probiotics were first studied by Metchnikoff (1907) at the beginning of the
century. He concluded that the healthier condition of Bulgarian peasants was due to the consumption
of large quantities of fermented milk. Metchnikoff developed the theory that ingestion of sour milk
modifies the activity of colonic microflora. He isolated the bacteria and studied them in human
feeding trials. After his death his colleagues and many others continued with similar research and the
field has subsequently developed to the current knowledge and application of probiotics in improving
the health of individuals (Gibson & Fuller, 2000).
The potential health benefits of probiotics have been investigated in several studies. Results indicate
that probiotics could alleviate lactose intolerance, enhance immunity, reduce colon cancer, and reduce
gastrointestinal disorders such as diarrhea (Fuller & Gibson, 1995; Kopp-Hoolihan, 2001; Saavedra et
al., 1995; Salminen et al., 1998).
Mechanisms involved in the establishment of these beneficial effects include the following:
competition with pathogens for available nutrients and other growth factors (Rolfe, 2000),
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2antagonising pathogens directly through production of antimicrobial and antibacterial compounds such
as bacteriocins and butyric acid (De Vuyst & Vandamme, 1994; Dodd & Gasson, 1994; Kailasapathy
& Chin, 2000), reduction of gut pH by stimulating the growth of lactic acid bacteria (Langhendries el
al., 1995), competition for binding at receptor sites that pathogens may occupy (Fujiwara et al., 1997;
Kailasapathy & Chin, 2000), improvement of immune function and stimulation of immunomodulatory
cells (Isolauri et al., 1991; Isolauri et al., 1995; Rolfe, 2000), and production of lactase which aids
lactose digestion (Rolfe, 2000).
However, a probiotic is only effective if it does actually lead to one or more of the above mentioned
benefits, is safe, non-pathogenic, non-invasive, non-carcinogenic, contains more than 106viable cells,
survives in the gut, remains viable during storage as part of food-items or supplements and has good
sensory properties (Fooks et al., 1999; Fuller, 1989; Fuller & Gibson, 1997; Saavedra, 1995).
A number of factors influence the viability (growth and inhibitory activity) of beneficial gut
microflora, e.g. gastric acidity and the action of bile salts in the small intestine and the presence of
competing micro-organisms for nutrients (Bezkorovainy, 2001; Mattilla-Sandholm et al., 2002). One
very important factor is the availability of fermentable substrates in the gastrointestinal tract such as
ol igosaccharides and polisaccharides (Roberfroid, 2001). The supplementation of such substrates, also
known as prebiotics, to optimise the balance of gastrointestinal tract microflora, is under investigation
(Fooks et al., 1999). A prebiotic is defined as "a non-digestible food ingredient that beneficially
affects the host by selectively stimulating the growth, activity, or both of one or a limited number of
bacterial species already resident in the colon" (Gibson & Roberfroid, 1995). Prebiotics are found in
foods such as onion, garlic, banana, chicory, asparagus, leek and Jerusalem artichoke. Prebiotics can
also be synthesised from simple sugars such as sucrose or lactose, or may be formed by controlled
hydrolysis of starch or other polysaccharides (Gibson, 200 I; Van Loo el al., 1995).
A true prebiotic has to comply with the following criteria: it has to reach the colon without being
hydrolysed or absorbed in the upper part of the gastro-intestinal tract, be selectively fermented by
potentially beneficial microorganisms in the colon such as lactic acid bacteria, balance the gut
microflora by changing the composition of the colonic microflora towards a healthier composition,
and benefit host health (Fooks et al., 1999). Currently the only food-ingredients with convincing
prebiotic effects are non-digestible oligosaccharides which contain fructose, xylose, raffinose,
stachyose, galactose, glucose and mannose (Roberfroid, 2001). It is important to note that prebiotics
have also been found to have health benefits unrelated to the effect on the gut microflora. These
benefits include increased mineral absorption and improved bone health, a decrease in cholesterol and
constipation relief (Roberfroid, 2000).
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3The effect of a combination of probiotics and prebiotics, referred to as synbiotics, on the balance of
gastrointestinal tract microflora has also been investigated. A higher survival rate of the probiotic
strain was found than when the probiotic was supplemented on its own (Gibson & Roberfroid, 1995).
These findings indicate that combining probiotics with prebiotics should be seriously considered in the
case where probiotic supplements are recommended.
The perceived benefits of probiotic and prebiotic containing products have led to an expansion in the
probiotic and prebiotic market over the past five years (Daly & Davis, 1998; Temmerman et al.,
2002,). In Europe, consumer awareness with regard to probiotics is quite high and the probiotic
market, especially dairy products such as yoghurts and fermented milks, has experienced rapid growth.
France represents the largest market in Europe followed by Germany where the availability of
probiotic containing yoghurts has increased by 150% from 1996 to 1997. During the same time the
market in the United Kingdom grew only by 26%. In the United States probiotic containing products
are almost exclusively dairy products such as fluid milk, yoghurt and kefir (Heller & Weir, 2001).
However, consumer awareness of probiotic containing products in the United Stated is not that high as
probiotics ranked only in the s" or lowest level of marketing for the trimester ending July 200 I (STS,
2002). The Japanese also use probiotics as a significant and functional ingredient in many of their
fermented and/or functional drinks (Stanton, 200 I). In South Africa probiotic and prebiotic containing
products seem to be available, although no detailed information regarding these products or consumer
awareness thereof could be traced. Furthermore, imported probiotic strains are apparantly mostly used
in the production of probiotic containing products in South Africa (Personal communication, 2002,
Prof. L.M.T. Dicks, Department of Microbiology, University of Stellenbosch).
The growing use of probiotic and prebiotic containing products necessitates effective commercial
production and marketing. Prebiotics can easily be used in any matrix, in almost any food, whereas
the application of probiotics is much more complicated (Saavedra et al., 2002). When
commercialising probiotic cultures, factors such as the following should be considered: safe probiotic
strains, the functional and technological characteristics of the strains, as well as the use of growth
mediums and appropriate food vehicles that are safe for human consumption (Saarela et al., 2000;
Salminen et al., 1996a).
Safety aspects of probiotic bacteria involve GRAS I status, specifications such as ortgin (healthy
human gastrointestinal tract), non-pathogenicity and antibiotic resistance (Mattilla-Sandholm et al.,
2002). The functional characteristics that need to be considered are viability and persistence in the
gastrointestinal tract, immunomodulation, antagonistic and antimutagenic properties. Essential
technological characteristics include good sensory properties, viability during processing as well as
I GRAS = generally recognised as safe by the Food and Drug Administration of the USA
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4stability during manufacturing and storage (Mattilla-Sandholm et aI., 2002; Saarela et al., 2000). The
food vehicles appropriate for human consumption should ensure probiotic stability. Fermented dairy
products (e.g. yoghurt), soymilk and other food vehicles such as baby foods, cereals, drinks and
confectioneries have been found to be successful in this regard (Andersen, 1998; Kamaly, 1997;
Svensson, 1999). Yoghurt has a long history as an appropriate carrier for probiotic bacteria and in
recent years there has been a significant increase in the popularity of yoghurt (Lourens-Hattingh &
Viljoen,2001). Soymilk has also gained interest as a medium for growth and biochemical activities of
probiotic bacteria and has been known to be successfully in a number of studies (Kamaly, 1997).
Soymilk is more affordable than MRS2 medium (De Man et al., 1961), is safe for human and animal
consumption and can be used as an alternative to dairy products for lactose-intolerant people (Kamaly,
1997). The stability of probiotic bacteria in other food vehicles might be more challenging as the
probiotic bacteria do not multiply in the food matrix (Mattilla-Sandholm et al., 2002).
The packaging materials used and the conditions under which the products are stored are also
important for the quality of products containing probiotic bacteria. Probiotic cultures are freeze-dried
or spray-dried when used in special formulations such as capsules or tablets. These culture
concentrates are also supplied to manufactures for food fortification or the production of fermented
food products (Saarela et al., 2000). Freeze-drying is the most popular method as many probiotic
bacteria cannot tolerate the relatively high temperatures that are used in spray-drying (Mattilla-
Sandholm et al., 2002). Micro-encapsulation (protective coating of probiotic bacteria) and added
oligosaccharides in probiotic containing products have also been found successful in increasing the
survival of the probiotic bacteria (Kailasapathy & Rybka, 1997). Concentrated probiotic cultures
supplied to manufacturers should be filled in gas and light proof containers to protect the cultures
against light and humidity. Aluminium-foil coated cartons and humidity are most often used (Honer,
1995). The storage temperatures of probiotic containing products should be 3-4°C for fermented dairy
and soymilk products and room temperature for baby foods and cereals (Kailasapathy and Rybka,
1997).
The final step in commercialisation involves the labelling of products. The information printed on the
labels of probiotic and prebiotic containing products has to be correct regarding probiotic species-
identification, number of viable cells and prebiotic type and concentration (Temmerman et al., 2002).
In general, probiotic and prebiotic containing products only claim general health benefits and specific
content. In Europe no specific legislation regarding the labelling of probiotic and prebiotic containing
products exists (Richardson, 1996). However in the United States the FDA strictly regulates the
labelling and marketing of conventional foods containing probiotic bacteria and therefore no
statements regarding health benefits for probiotics can be stated on the labels of the products. In South
1
- MRS = De Mall, Rogosa and ~harpe growth medium for LAB which is used in the laboratory
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5Africa permissible information regarding labelling of health and content claims of probiotic and
prebiotic containing products are included in the proposed South African regulations governing the
labelling and advertising of Foodstuffs, Cosmetics and Disinfectants, Act, 1972 (Act no. 54 of 1972;
http://www.doh.gov.za. 2003/05/02 accessed). Permissible health claims include improvement of the
health and functioning of the digestive tract, manufacturing of B vitamins, inhibition of the growth of
harmful pathogens, and may, when ingested on a regular basis as part of a prudent, balanced diet,
assist in improving the immune status, the digestion of lactose and may help reduce the risk of colon
cancer. The content claims include permissible probiotic strains, viable cell numbers, prebiotic type
and concentration.
Most of the probiotics and prebiotics are available as over-the-counter products in outlets such as
pharmacies and food and health stores (Reid, 2001). Good marketing is essential to raise consumer
awareness and subsequently ensure continued growth of the probiotic and prebiotic market (Menrad,
2003). Marketing involves the identification of the target market i.e. health conscious consumers,
determining the communication strategy for example advertisements and brochures, price positioning
and distributing the products to the target market (Du Plessis, 1999).
Although a number of probiotic and prebiotic containing products seem to be available on the South
African market, very little scientific information has been published in this regard with specific
reference to the full range of products available on the market, the legal correctness of health and
content claims as well as consumer awareness of these products. Furthermore, a need seems to exist
for the identification of viable strains of probiotics that can be cultured in South Africa for use in the
manufacturing of probiotic containing products in the country.
2. Aims and objectives
The aims of this study were to complete a market and product assessment of probiotic and prebiotic
containing products in South Africa and to evaluate probiotic strains for commercial use in South
Africa.
The following objectives were formulated to attain these aims:
Market and product assessment:
• To identify probiotic and/or prebiotic containing supplements and food-items available on the
South African market
• To evaluate the health and cell count related claims stated on the labels of the identified products
• To investigate South African consumer awareness of probiotic/prebiotic containing supplements
and food-items
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6Evaluation of probiotic strains:
• To identify probiotic strains for potential commercial use in South Africa
• To determine the effectiveness of soymilk-base as a growth medium
• To determine the effect of lyophilization on the growth and inhibitory activity act of probiotics
grown in soymilk.
• To determine the effect of selected prebiotics on the inhibitory activity of selected probiotic strains
• To formulate recommendations regarding the composition of a probiotic and prebiotic containing
formula based on the identified probiotics.
3. Outline of the thesis
In Chapter 2 an overview of the relevant literature concerning probiotics, prebiotics as well as related
market and marketing aspects is presented. The market and product assessment of probiotic and
prebiotic containing products is presented in the first article in Chapter 3. The second article which
reports on the investigation of awareness of South African consumers of probiotic and prebiotic
containing products is presented in Chapter 4. The influence of prebiotics on the inhibitory activity of
lactic acid bacteria and their viability in soymilk-base for commercial production is presented in the
third article in Chapter 5. A general discussion of all three articles and final conclusions are presented
in Chapter 6. The journals to which the three manuscripts included in this thesis will be submitted
were not yet finally identified at the time of the finalization of the thesis. The referencing system
applied is therefore based on the system prescribed by the Department of Food Science, University of
Stellenbosch.
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Literature review
This chapter provides an overview of the literature on taxonomy, properties and health benefits and
culturing of probiotics as well as products containing probiotics. Compounds with convincing
prebiotic effects and the physiological and metabolic effects and manufacturing of prebiotics as well
as prebiotic containing products are also discussed. The concept of synbiotics is also alluded to.
Finally the market, consumer awareness, and marketing of probiotic/prebiotic containing products are
reviewed.
1. Probioties
1.1 Definition of probioties
Li lIy and Stillwell (1965) introduced the term probiotics as substances produced by one
microorganism that stimulates the growth of other microorganisms. Sperti (1971) extended this
definition to microorganisms or tissue extracts, which improves microbial growth. Parker (1974) first
used the word probiotic in the context of animal feed supplementation and defined it as, "organisms
and substances that contribute to intestinal microbial balance". The most common definition currently
used is that of Fuller (1989), i.e "Probiotics are live microbial feed supplements which beneficially
affect the host animal by improving its intestinal microbial balance." This definition was expanded by
Havenaar and Huis in't Veld (1992) to include food and non-food use and the use of 1110noand mixed
cultures.
1.2 Taxonomy of probiotic bacteria
In the past lactic acid bacteria were classified on the basis of phenotypic properties, e.g., morphology,
mode of glucose fermentation, growth at different temperatures, lactic acid configuration and
fermentation of different carbohydrates. However, studies based on comparative 16S ribosomal RNA
sequencing analysis showed that some taxa generated on the basis of phenotypic characteristics do not
correspond with the suggested phylogenetic groupings. Some species in the Lactobacillus
acidophilus, Lactobacillus casei and Lactobacillus paracasei groups, and certain bifidobacteria, are
not readily distinguishable. Modern molecular techniques, including polymerase chain reaction,
combined with other genotyping methods, are therefore important for species identification. The
classification and identification of a probiotic strain may give a good indication of its typical habitat
and origin. The species and genus name may also indicate the strain's safety and technical
applicability for use in probiotic products (Holzapfel et al., 1998).
1.2.1 Overview
Lactic acid bacteria (LAB) is a diverse group that consists of Gram-positive, non-spore-forming
bacteria that occur as cocci or rods. They grow in complex media, with fermentable carbohydrates as
energy source (Axelsson, 1998). Food sources of LAB include dairy products, fermented meat,
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sourdough, fermented vegetables, silage and beverages. They are also found on plants, sewage and the
genital, intestinal and respiratory tracts of man and animals (Wood & Holzapfel, 1995). These bacteria
are non-motile, do not form spores and are not capsulated.
On the basis of hexose catabolism, LAB can be divided into two groups, namely homofermentative
bacteria that use the Embden-Meyerhof-Parnas pathway and heterofermentative bacteria that use the
6-phosphogluconate pathway (Orla-Jensen, 1919). The Embden-Meyerhof pathway involves the
degradation of glucose to pyruvate in the presence or absence of oxygen. The 6-phosphogluconate
pathway operates aerobically and anaerobically and is important in biosynthesis and catabolism
(Prescott et al., 1999). Homofermentative bacteria, such as the genera Lactococcus, Pediococcus,
Streptococcus, and Lactobacillus spp. degrade hexoses to lactate or to lactate and additional products
such as acetate, ethanol, CO2 and formate. Heterofermentatives, which include the bifidobacteria and
some Lactobacillus spp. produce acetate and lactate at a molar ratio of 3:2 (Kandler, 1983).
The phylogenetic relatedness of microorganisms is determined by comparing the sequences of
ribosomal RNA (rRNA). On the basis of the available information on 16S or 23S rONA sequences,
phylogenetic trees or dendograms are constructed. Gram-positive bacteria cluster in two of the
seventeen eubacterial phyla, which coincide with their DNA base composition (Schleifer & Ludwig,
1995a, 1995b). Lactic acid bacteria that can be used in probiotic foods or food supplements include
Lactobacillus acidophilus, Lactobacillus johnson ii, Lactobacillus casei, Lactobacillus gasseri,
Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium breve,
Bifidobacterium bifidum, Bifidobacterium infantis, Enterococcus faecalis and Enterococcus faecium
(Gibson & Fuller, 2000; German et al., 1999). Gram-positive bacteria with a DNA composition of 55
to 67mol% guanine plus cytosine (G+C), such as bifidobacteria, belong to the so-called Acttnomycetes
branch. The Clostridium branch comprises organisms of G+C content higher than 55%. The
phylogenetic relation of the different genera of the Clostridium branch is shown in Fig. 2.1 and is
based on the comparison of 16S rRNA sequences. Carnobacterium, Enterococcus, Vagococcus,
Aerococcus, Tetragenococcus and Lactosphaera are more closely related to each other than the other
LAB. Lactococcus and Streptococcus are relatively closely related, whereas the genus Lactobacillus is
phylogentically diverse (Schleifer & Ludwig, 1995a; 1995b). According to 16S rRNA sequencing
data, the genera Lactobacillus and Pediococcus are phylogenetically intermixed as five species of a
Pediococcus cluster with 32 homo- and heterofermentative Lactobacillus spp. in the Casei and
Pediococcus group (Collins et al., 1991). Only LAB from the genera Lactobacillus, Enterococcus and
Pediococcus were used in this study and will therefore be described in more detail.
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FIGURE 2.1 Consensus tree, based on comparative sequence analysis of 16S rRNA, showing major
phylogenetic groups of lactic acid bacteria with low mol% guanine plus cytosine in the DNA and the
nonrelated Gram-positive genera Bifidobacterium and Propionibacterium (Scheifer & Ludwig, 1995a;
1995b).
1.2.1.1 Genus Lactobacillus
Members of the genus Lactobacillus are found in a variety of habitats with rich, carbohydrate-
containing substrates, such as mucosal membranes of vertebrates (oral cavity, intestine and vagina), on
plants or material of plant origin, in manure and man-made habitats such as sewage and fermented or
spoiled food (Kandler & Weiss, 1986). Lactobacilli are non-spare-forming rods or coccibacilli with a
G + C content of DNA usually between 33 and 55 mol%. Lactobacilli are aero-tolerant or anaerobic,
acidophilic and have complex nutritional requirements regarding needs for carbohydrates, amino
acids, peptides, fatty acids esters, salts, nucleic acid derivatives and vitamins (Kandler & Weiss,
1986). Lactobacilli may metabolise various compounds, e.g. citrate, malate, tartrate, quinolate, nitrate
and nitrite and use these as an energy source (e.g. via building a proton motive force) or electron
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acceptors (Kandler & Weiss, 1986). The major divisions of lactobacilli are based on their
fermentative characteristics. The divisions include obligately homofermentative, facultative
heterofermentive and obligately heterofermentative (Stiles & Holzhapfel, 1997). Obligately
homofermentative lactobacilli ferment glucose exclusively to lactic acid and do not ferment pentoses
or gluconate (Stiles & Holzhapfel, 1997). It represents Orla-Jensen's thermobacteria and the
important food-associated species include L. acidophilus, L. delbrueckii, L. helveticus, L. farciminis
and L. kefiranofaciens (Hammes & Vogel, 1995; Pot et al., 1994; Vandamme et al., 1996).
Facultative heterofermentive lactobacilli ferment hexoses to lactic acid and may produce gas from
gluconate but not from glucose. They also ferment pentoses by an inducible phosphoketolase to
produce lactic and acetic acids (Stiles & Holzhapfel, 1997). Important food-associated species include
L. casei, L. plantarum, L. pentosus, L. curvatus and L. sakei (Hammes & Vogel, 1995; Pot et al., 1994;
Vandamme et al., 1996). Obligately heterofermentative lactobacilli ferment hexoses to lactic acid,
acetic acid and/or ethanol and carbon dioxide. The production of gas from glucose is a characteristic
feature of these bacteria. The most important food-associated species is L. sanjrancisco which
converts maltose to lactic acid and acetic acids and various flavour compounds in sourdough bread
(Sti les & Holzhapfel, 1997). Other species include L. fermentum, L. kefir, L. reuteri, L. bifermentans,
L. fructivorans, L. brevis, L. buchneri and L. viridescens (now Weissella viridescens) (Hammes &
Vogel, 1995; Pot et al., 1994; Vandamme et al., 1996). The heterofermentative lactobacilli that lack
aspartic acid or diaminopimelic acid in their peptidoglycan appear phylogenetically different from
other lactobacilli and were grouped with Leuconostoc paramesenteroides into a new genus Weissella
(Collins et al., 1993).
1.2.1.2 Genus Pediococcus
Members of the genus Pediococcus are most often found in low numbers, together with leuconostocs
and lactobacilli, on plant materials including barley, malt, hops, dried leaves, hay, citrus fruits, apples
and strawberries, in various foods and as spoilage agents in alcoholic beverages such as beer (Wood &
Holzapfel, 1995).
Pediococci are the only lactic acid bacteria that divide alternately in two perpendicular directions to
form tetrads although pairs of cells may also occur (Gunther, 1959). The colonies are typically 1-3
mm in diameter, generally smooth-edged and invariably not pigmented when grown in a rich medium,
such as De Man, Rogosa and Sharpe (MRS) agar (Garvie, 1986). Pediococci contain between 35 and
39 mol% G + C, is facultatively anaerobic and the growth temperature is between 39 and 45°C
(Garvie, 1968). Lactose in milk is not a readily available carbohydrate, which makes milk a poor
growth medium (Garvie, 1968). Fermentation of glucose follows the Embden Meyerhof pathway with
DL. or L. (+) - lactate as the major end product under optimal conditions. Pyrovate can be diverted to
other end products and diacetyl acetoin is often produced by P. damnosus, while P. pentosaceus
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produces equimolar amounts of lactate and acetate from pentoses (Fukui et al., 1957). Amino acid
requirements are not known and vitamin requirements are similar for most species (Jensen and Seeley,
1954). Species of Pediococcus and related tetrad-forming bacteria include P. damnosus, P.
dextrinicus, P. parvulus, P. inopinatus, P. pentosaceus, P. acidilactici, Aerococcus urinae-equi
(previously P. urinae-equii and Tetragenococcus halophilus (previously P. halophilus) (Sneath el al.,
1986).
1.2.1.3 Genus Enterococcus
The Genus Enterococcus is associated with the gastro-intestinal tract of man and animals and serves as
indicators of faecal contamination of water and food. The taxonomy of Enterococci has been vague.
There are no phenotypic characteristics that separate the genus from the other genera of gram-positive,
catalase-negative cocci. The enterococci have been described by Sherman (1937) as those organisms
that grow between at 10 and 45°C, in 6.5% NaCI and at pH 9.6 and survive heating at 60°C for 30
minutes. Several species and strains of the genus Enterococcus do not meet all of these criteria (De
Vriese et al., 1993). Enterococci are ovoid and occur single, in pairs or in short chains and are non-
motile. They are facultatively anaerobic and cherno-organotrophs and their G + C content ranges from
37 to 40 mol%. They have a hornofermentative lactic acid fermentation and the predominant end
product of glucose fermentation is L (+)-Iactic acid. They have a PEP PTS system for uptake of
lactose and other carbohydrates, including gluconate (Bernsmann et al., 1982). Their nutritional
requirements include vitamins, biotin, pyridoxine, riboflavin, nicotinate and panthothenate and several
amino acids (DeVriese & Pot, 1995). The species included in the genus Enterococcus are E. faecalis,
E. faecium, E. avium, E. casseliflavus, E. cecorum, E. columbae, E. dispar, E. durans, E. fallox, E.
jlavescens, E. gallinarum, E. hirae, E. mundtii, E. malodoratus, E. pseudoarium, E. raffinosus, E.
saccharolyticus, E. sertolicida, E. solitarius and E. sultureus.
1.3. Properties and health benefits of probiotic bacteria
1.3.1 Overview
Probiotic bacteria have the ability to survive In the gastrointestinal tract and reach the colon to
colonize and consequently benefit the host (Roberfroid, 2000). This contributes to the production of
short-chain fatty acids and associated health benefits, including inhibition of pathogen colonization,
reduced colon cancer, cholesterol and constipation and an increased immune stimulation (Crittenden,
1999). The properties of probiotic bacteria that lead to these benefits include acid tolerance, tolerance
to human gastric juice and bile, adhesion to epithelial surfaces, increased immune stimulation,
antimutagenic and anticarcinogenic properties, antagonistic activity against pathogens and production
of the enzyme f)-galactosidase (lactase).
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1.3.2 Bile- and acid resistance
The bacterial numbers and populations in the gastrointestinal tract vary between the stomach, small
intestine and colon. The total bacterial count in gastric contents is usually below 103 per gram while it
ranges between 104 per ml in the small intestine to about 106 - 107 per ml in the terminal ileum
(Gorbach et al., 1967). The colon hosts a stable ecosystem that consists of io' - 10'2 different
microorganisms per gram contents (Cummings & Macfarlane, 1991).
The ecosystem of the small intestine is less stable and more susceptible to modifications than that of
the colon (Brassart & Schiffrin, 1997). It is therefore more difficult to modify the microflora in the
colon by administrated probiotic bacteria than in the small intestine. To be effective in this regard,
probiotic bacteria should survive passage through the stomach and the small intestine to reach the
colon in an active form so that it can influence the microbial ecosystem of the colon. The main
obstacles in this process are gastric acidity and the action of bile salts in the small intestine
(Bezkorovainy, 2001). The pH-value found in the stomach of humans after food consumption changes
from pH 5.0 at initiation of acid secretion to pH 1.8 after 80 minutes (Marteau et al., 1997). In the
small bowel the pH is 6.5 while the pH in the right or proximal colon ranges from 5.5 and 6.0 and
from 6.5 and 7.0 in the left or distal area of the colon (Fooks et al., 1999; Marteau et al., 1997). The
bile salt concentration in the duodenum is 15 mmol/L after a meal which progressively decreases to 5
mmol/L and eventually in the ileum the concentration is below 4 mmol/L (Marteau et al., 1997).
The effect of pH levels on the viability of probiotic bacteria is illustrated by the following in vitro
study: Six L. acidophilus and nine Bifidobacterium strains were maintained at a pH of 1.5 - 3.0 for up
to three hours. Probiotic viability depended on the species and strains used and the length of exposure
to acid and the pH. The best results were obtained with three L. acidophilus strains, B. lougum and B.
pseudolongum that survived a pH of 1.5 - 3.0 (Lankaputhra et al., 1995).
Bile salt hydrolases present in probiotic bacteria deconjugate bile salts and these acids are better
bacterial lysing agents of pathogenic bacteria than conjugated bile acids (Gopal et al., 1996). To
determine the effect of bile salts on the viability of probiotic bacteria, in vitro studies focus on the
assessment of the growth and survival of probiotic bacteria in the presence of bile acids. In a study
done by Lankaputhra et al. (1995), Lactobacillus and Bifidobacterium strains were maintained at bi Ie
concentrations of 0 - 1.5% for up to three hours. Colonies were counted after the bacterial
suspensions were plated. Results indicated that the survival of the strains varied and depended on bile
concentration and exposure times. Gopal et al. (1996) found that L. acidophilus, B. infantis and
Bifidobacterium adolescentis were the most resistant in the presence of 0.3% oxgall. These strains
deconjugated maximum concentration taurocholic acid (bile acid) after 12h of growth, but no
correlation between extent of deconjugation and growth inhibition was observed. Ibrahim and
Bezkorovainy (1993) grew several species from the American Type Culture Collection for 24h in the
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presence of 0.6 - 3.0g glycocholic acid/L. The cultures were transferred twice to fresh media
containing no bile salts. After the second transfer, the growth resumed to maximal extent and their
bile salt hydrolases were recovered.
The effect of acid and bile acid on the survival of probiotics was investigated using an artificial model
of the gastrointestinal tract. This model comprised four serial compartments simulating the stomach,
duodenum, jejenum and ileum, which were connected to computer-controlled valve pumps. The
organisms most resistant to stomach acid were B. bifidum and L. bulgaricus which survived for 140
minutes, whereas Streptococcus thermophilus and L. acidophilus only survived for 40 min. The
delivery of B. bifidum and L. acidophilus to the cecum in the presence of low bile salt concentrations
(2mmol/L) was significantly higher than in the presence of physiologic bile salt concentrations. These
values were comparable with those that have been observed in vivo (Marteau et al., 1997).
Results from these experiments indicate that variables which determine the degree of probiotic
survival through the gastrointestinal tract include the level of stomach acidity, length of exposure to
acid, concentration of and length of exposure to bile salts and the level of bile salt hydrolase activity.
Many probiotics do survive these conditions and enter the colon in viable state in sufficient amounts to
affect the microbial ecosystem in the colon (Bezkorovainy, 2001).
1.3.3 Adhesion properties and immune effects
Adhesion refers to the ability of a microbe to attach to intestinal mucosal cells, permanently establish
in the host's intestine and ensure beneficial effects. Adhesion processes involve the interaction
between receptor molecules on epithelial cells and adhesion molecules on the surfaces of adherent
bacteria (Salminen et al., 1996). Probiotic bacteria have definite adhesion properties (Salminen et al.,
1996a) which contribute to the ability to establish permenantly in the host's intestine. The adhesion
ability of these strains ensures that they persist longer than non-adhering strains and consequently
contribute to the following physiological effects: exclusion of pathogens on the intestinal epithelium
by competition from adherent probiotic bacteria (Salminen et al., 1996a) and mediation of local and
systemic immune effects through interaction with the mucosal surface that facilitates contact with gut
associated lymphoid tissue (Salminen et al., 1996a).
To illustrate the exclusion of pathogens by adherent probiotic bacteria, Hudault et al. (1997)
conducted an in vivo study using tissue samples from the colon of humans. The results indicated that
probiotic bacteria did interfere with the adherence of pathogens such as Salmonella typhimurium to
Caco-2 cells (Hudault et al., 1997). In a similar in vitro study, both living and heat-killed L.
acidophilus cells have been effective in adhering to the colon tissue and inhibition of pathogens
(Coconnier et al., I993a).
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The mediation of local and systemic immune effects by probiotic bacteria is illustrated by human
studies done on the antagonism between pathogens and probiotic bacteria adhered to the gut associated
lymphoid tissue. The results indicated that the antagonism enhances immune response by stimulating
nonspecific host resistance to microbial pathogens as well as modulating the host's immune responses
to potentially harmful antigens (Haschke et al., 2001; Isolauri, 1998; Isolauri et al., 2001).
Immune defences affected by probiotics can be specific- and non-specific. The most important
specific immune defence mechanism that is affected involves the production of IgA immunoglobulins
by B lymphocytes (Pfeifer & Rosat, 1999). The secretory IgA's play an important role in
agglutination and capture of intraluminal antigens, immunglobulin-dependent cytotoxity after
attachment of bacteria, inhibition of pathogen adhesion to the mucosa, antitoxin action and antiviral
activity (Pfeifer & Rosat, 1999). A number of studies have reported that supplementation with
probiotics increases IgA levels (Table 2.1).
TABLE 2.1: The effect of pro biotic supplementation on IgA levels
Study Effect on IgA levels Author(s)
Infants received supplements of a The concentrations of circulating IgA Kaila et al., 1992
strain of L. casei for 5 days were increased and rotavirus-induced
diarrhea was reduced.
Children with acute diarrhea An increase 111 specific antibody- Kaila et al., 1992
received supplements of L. secreting cells in the IgA class was
rhamnosus GG for 7 days. evident when compared to control
subjects.
Volunteers were immunized with The fermented milk and bifidobacteria Link-Arrister et at.,
attenuated Salmonella typhi Ty21 a to group showed 1994
determine if fermented milk a 4.08-fold increases In serum IgA
containing L. johnsonni LJ-I (5 x 109 antibody titers and the control group
CFU per day for 3 weeks) and only a 2.48-fold increase.
bifidobacteria could have
immunomodulatory effects.
Infants received a viable preparation A significant rotavirus specific IgA Salminen et al., 1996
of Lactobacillus GG for 7 days response during recovery was
during acute rotavirus gastroenteritis. indicated.
Subjects with milk-hypersensitive The milk-induced inflammatory Pelto et al., 1998
symptoms received a supplement of response was down-regulated. It had
L. rhamnosus GG for 7 days. an immunostimulatory effect 111
healthy subjects and promoted IgA
Immune response in Crohn's disease
patients.
Nonspecific immune defense systems affected by probiotic bacteria involve phagocytosis by cells of
myeloid origin such as monocytes, macrophages or polymorphonuclear cells (Pfeifer & Rosat, 1999).
Phagocytosis is responsible for early activation of the inflammatory response before antibody
production. When foreign bodies such as bacteria appear in the blood stream, phagocytes will be
activated to release toxic agents such as reactive oxygen intermediates and lytic enzymes that will
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destroy these foreign bodies (Isolauri et al., 2001; Pfeifer & Rosat, (999). The role of oral
introduction of probiotic bacteria in the enhancement of non-specific host defence against microbial
pathogens is illustrated by the work of Schiffrin et al. (1995) who found that the ingestion of L.
johnsonni LJ-I from fermented milk products for three weeks increased the blood phagocytic capacity
in humans. Similar results were found with the consumption of L. acidophilus Lal (Schiffrin et al.,
1995). Schiffrin et al. (1995) also reported that oral introduction of L. casei and L. bulgaricus
activated the production of macro phages and that the oral introduction of L. casei and L. acidophilus
activated phagocytosis in mice.
Research indicates that the effect of probiotic bacteria on the adhesion of pathogens to the intestinal
mucosal cells and immune response is specific relevant in the treatment of conditions such as acute
diarrhea, radiation enteritis and intestinal inflammatory conditions such as Crohn's disease and
ulcerative col itis (Salminen et al., 1988; Isolauri et al., 1991).
1.3.4 Antimutagenic/anticarcinogenic activity
The strongest link between cancer and probiotic intake has been found for colon cancer, although links
with bladder cancer are also evident (Gibson & Macfarlane, 1994; Morotomi et al., 1990).
Researchers believe that microflora in the colon play an important role in the development of colon
cancer (Rowland, 1988). Several species of bacteria found in the colon produce carcinogens and
tumour promoters from food components that reach the colon. Many of these microorganisms also
synthesise enzymes that generate toxic products (Table 2.2).
TABLE 2.2: Colonic bacteria that produce toxic products (compiled from Rastall & Gibson 2002)
Enzyme Substrate
~-glucosidase Plant glycosides, e.g. rutin, cycasin
Azoreductase Azo compoundes, e.g. benzidines
N itroreductase Nitro-compounds, e.g. nitrochrysene
~ -glucuronidase Bilary glucuronides, e.g. benzidine
IQ hydratse-dehydrogenase 2-am ino- 3-methyl- 3H- im idazo-4,5- f.q u ino Iinel Q
Nitrate/nitrite reductase Nitrate, nitrite
Antimutagenic mechanisms that have been proposed for probiotics include the following: binding and
degradation of micro-organisms that produce (pro) carcinogens, production of antimutagen ic
compounds by viable probiotic cells, modulation of procarcinogenic enzymes in the gut, alteration of
colonic transit time to remove faecal mutagens more effectively, reduction of the intestinal pH,
thereby altering microflora activity and bile solubility and suppression of tumours by enhancing
defence immune mechanism (Hirayama & Rafter, 1999; McIntosh, 1996).
Evidence for the possible role of probiotics in the prevention/treatment of colon cancer has come from
in vitro, animal and human studies. In vitro assessment of two LAB isolated from human faeces
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showed that the strains have an anti-proliferate effect on a tumour cell line (Zabala el ai., 200 I). The
parenteral and oral administration of L. casei strain Shirota, Lactobacillus GG and L. acidophilus to
rats resulted in immune stimulatory and antiturnour effects against experimentally implanted tumours
(Morotomi, 1996). L. rhamnosus GG and L. casei strain Shirota supplementation reduced fecal ~-
glucuronidase, nitroreductase and glycoeholic acid hydrolase activities in humans (Lid beck el al.,
1992). The dietary administration of lyophilized cultures of B. longum strongly suppressed colon and
mammary tumour development in humans (Reddy, 1999). This effect was associated with a decrease
in the colonic mucosal cell proliferation. The consumption of L. rhamnosus GG and L. gasseri strain
ADH also resulted in reduced fecal and urinary mutagenicity in humans (Lidbeck el al., 1992b; Aso
and Akazan, 1992). Two independent studies on the treatment of human urinary bladder cancer using
L. casei, indicated that probiotic bacteria could suppress urinary mutagenicity (Grill el al., 1995).
1.3.5 Antagonistic activity against pathogens
Antagonism by probiotic bacteria against pathogenic bacteria is important for the maintenance of a
normal intestinal balance. Antagonism is mediated by the production of antimicrobial substances such
as bacteriocins (proteins or protein complexes), organic acids (acetic and lactic acids) and low
molecular weight metabolites (diacetyl, CO2 and acetaldehyde) by probiotic strains (Saarela et al.,
2000).
The main fermentation products of LAB are organic acids (lactate and acetate) that lead to a lowering
of pH and inhibition of the growth of Gram-negative pathogens, moulds and yeasts (Gililand, 1989;
Silva et al., 1987). These acids are more effective in their undissociated form whereby they penetrate
the microbial cell, reduce the intercellular pH and interfere with essential cell functions (Silva et al.,
1987).
Bacteriocin production contributes to probiotic competitiveness, colonisation and growth in the
gastrointestinal tract and has been reported for most of the LAB group (De Vuyst & Vandamme,
1994). Bacteriocins are proteins or protein complexes with a bactericidal or bacteriostatic mode of
action affecting closely related species (Tagg et al., 1976). Four distinct classes of bacteriocins have
been identified on the basis of biochemical and genetic characterization including (I) antibiotics, (II)
small heat-stable, non-lanthionine peptides, (IIa) Listeria-active peptides, (lIb) poration complexes
consisting of two pepeides for activity, (IIc) thiol-activated peptides, (III) large heat-labile proteins,
and (IV) complex bacteriocins (Klaenhammer, 1993). An overview of bacteriocins produced by LAB
is presented in Table 2.3.
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TABLE 2.3: Bacteriocin (Like) substances produced by LAB
Producing microorganism Bacteriocin (like) compound Original reference
L. casei
LHS caseicin LHS Dicks et al. (1992)
L. curvatus
LTH1174 curvacin A Tichaczek et al. (1992)
L. plantarum
A2 lactolin Kodama (1952)
SIK-83 plantaricin SIK-83 Andersson (1986)
NCDO 1193 plantacin B West & Werner (1988)
C-11 plantaricin A Daeschel et al. (1990)
BN plantacin BN Lewus et al. (1991)
LPCO-IO plantaricin S Jimenez-Diaz et al. (1993)
MI406 plantaricin 406 Larsen et al. (1993)
423 plantaricin 423 Van Reenen et al. (1998)
P. pentosaceus
FBB-61, L-7230 pediocin A Etchells et al. (1964)
N5p pediocin N5p Strasser de Saad
& Manca de Nadra (1993)
E.faecalis
S-48 bacteriocin Bc-48 Lopez-Lara el al. (1991)
226 enterocin 226NWC Villiani etal. (1993)
Enterococcus spp. Enterococcins (I-V) Brock et al. (1963)
Diacetyl, CO2 and acetaldehyde, produced by probiotic bacteria are typical aroma compounds of
fermented food products and beverages and are only antagonistic when present at high concentrations.
The production of CO2 is inhibitory mainly against aerobic microorganisms (Bernet-Camard el al.,
1997; Silva et al., 1987). High concentrations of these low molecular weight metabolites are produced
by L. rhamnosus strain GG, L. acidophilus strain LB and L. johnsonni. Gram positive and -negative
pathogens and other microorganisms that seem to be inhibited by these metabolites include
Clostridium and Bacteriodes spp., Staphylococcus aureus, Listeria monocytogenes, S. typhhimurium,
Shigella flexneri, Escherichia coli, Klebsiella pneumoniae, Bacil/us cereus, Pseudomonas
aeruginosa, and Enterobacter spp. (Bernet-Camard el al., 1997; Coconnier et al., 1997; Silva el al.,
1987). Microorganisms that were not found to be inhibited by low molecular metabolites include
Lactobacillus or Bifidobacterium strains (Bernet-Camard et al., 1997). It is therefore evident that
supplementation with selected probiotic bacteria can inhibit the activity of a range of pathogen strains.
1.3.6 Production of ~-galactosidase (lactase)
The enzyme, beta-galactosidase (lactase), hydrolyses lactose to glucose and galactose (Savaiano and
Levitt, 1987). The enzyme is produced in the gastrointestinal tract for the first years of life. However,
in specific ethnic groups, including blacks, Asians and South Americans, the levels of this enzyme
decreases with age, resulting in lactose intolerance (inability to hydrolyse lactose) (Andersson et al.,
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200 I). Lactose intolerance can also develop secondary to an infection of the small intestine or
destruction of mucosal cells due to other causes or other infections or conditions, such as diarrhea,
AIDS or giardiasis, especially in children. Small bowel surgery or prolonged disuse of the
gastrointestinal tract may also affect lactase activity (Tyus, 1994).
The symptoms of lactose intolerance include abdominal pam, flatulence, or diarrhea because the
lactose behaves like an osmotic and non-digestible carbohydrate (Pfeifer and Rosat, 1999; Roberfroid,
2000). Probiotic bacteria used to produce fermented milk or yoghurt products, produce bacterial ~-
galactosidase in the intestine and stomach where lactose is degraded (Kopp-Hoolihan, 200 I).
Although lower concentrates are produced in the gastrointestinal tract than in the yoghurt starter
cultures, L. bulgaricus and S. thermophilus, the resulting ~-galactosidase levels are present in the
gastrointestinal tract for longer time periods, facilitating lactose hydrolysation (Sanders, 1993). The
role of probiotics in the improvement of lactose hydrolysation in those who are lactose intolerant, is
illustrated by research that indicates that lactose from yoghurt, or milk containing the probiotic L.
acidophilus is better absorbed by subjects with low ~-galactosidase activity than milk that does not
contain L. acidophilus. The symptoms of lactose intolerance in the subjects were fewer and bacterial
fermentation of undigested lactose was also evident in breath hydrogen concentrations (Montes et al.,
1995).
Dairy products or other products containing the mentioned probiotic bacteria can therefore be included
in the diet of people suffering from lactose intolerance to prevent/reduce the symptoms.
1.3.7 Summary of potential health effects of probiotics
The potential health effects of probiotics can be summarized as follows:
• Prevention/treatment of rotavirus diarrhea in children, traveler's diarrhea and inflammatory bowel
disease conditions by production of antimicrobial substances, attachment to intestinal mucosal
cells and stimulation of the immune response.
• Prevention of cancer by inactivation of dietary and intestinally generated mutagenic compounds
and reduction of fecal bacterial enzymes.
• Alleviation of lactose intolerance by elevating l3-galactosidase (lactase) levels for long time
periods.
1.4 Culturing of probiotics
For the commercialization of probiotics effective industrial production is essential, after which the
survival of the microorganisms and retention of functionality during storage must be ensured before
they can be delivered to manufacturers of products containing probiotic bacteria. Factors such as
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storage form, packaging materials used and storage conditions play an important role in the delivery of
a quality product (Saarela et al., 2000).
1.4.1 Growth needs of probiotic bacteria
The acidophilic nature, complex nutritional requirements and the typical habitats of probiotic bacteria
need to be taken into account in the development of specific growth media for these microorganisms
(McCann et al., 1996). The nutritional requirements of Lactobacillus species are met when the
medium contains fermentable carbohydrates, peptones and meat and yeast extracts. Supplementation
with tomato juice, magnesium, manganese, polysorbate, acetate and oleic acid esters, especially
Tween 80, have been found to promote the growth of probiotic bacteria and might even be essential
for most species. Mediums containing these supplements exhibit a low degree of selectively as
Pediococcus and Leuconostoc species and other secondary bacteria may grow on this medium (De
Man et al., 1960; Kandler & Weiss, 1986).
In in vitro laboratory studies the most commonly used growth medium(s) which contains all the
mentioned nutrients, are based on the MRS medium (De Man et al., 1960). For commercial
production, probiotic bacteria can also be grown in heat-treated milk and milk-based media. More
recently whey-base, a byproduct from cheese manufacture, has been used successfully (Gilliland,
1985; Svensson, 1999). Milk is nutritious and contains carbohydrates, fat, casein protein, vitamins
and minerals (Marshall & Tamime, 1997). To avoid too slow growth and the associated development
of off-flavours when a milk-base is used, casein and whey protein hydrolysates, yeast extract, glucose,
prebiotics, vitamins and minerals can be added to stimulate the growth and survival of the strains and
enhance the texture of the products (Hunger & Peitersen, 1992; Mizota, 1996). Furthermore, the
buffer capacity of fermented milk may be increased by the addition of protein. Probiotic strains will
then survive better as the pH of the medium is decreased and further pH changes during storage are
prevented (Kailasapathy & Supriadi, 1996). Lactobacilli can tolerate pH values in the range of 3.5 to
3.8, whereas the growth of bifidobacteria is retarded below pH 5.0 (Bergey's Manual, 1974). The
growth of probiotic bacteria may also be influenced by antimicrobial substances such as cleansing
agents, disinfectants and bacteriophages in milk (Svensson, 1999). Because the optimum growth
temperature for most probiotic bacteria is 37°C, production temperatures of 37°C will favour the
probiotic organism (Kneifel et al., 1993). As vegetarianism is increasing, appropriate vegetarian
probiotic products should also be developed (Beardsworth & Keil, 1991; 1992). For these purposes
the probiotic inoculum should therefore be cultured in a growth medium free of animal-derived
ingredients such as medium containing 25g/L soy peptone, glucose monohydrate and yeast extract
(Heenan et al., 2002).
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1.4.2 Production of commercially available probiotic preperations
Manufacturers of commercially available probiotic preperations are currently selecting lactic acid
bacteria with probiotic characteristics for these preparations (Mogensen & Friis, 1997). These
commercially available probiotic preperations may consist of a single strain or a mixture of several
strains (German et al., 1999).
The probiotic preparations for distribution should contain a large number of viable cells. In the past,
liquid and frozen preparations were used for distribution purposes. Currently freeze-drying and spray-
driying and micro-encapsulation are used for these purposes (Champagne et al., 1991; Gëlker, 1993).
Although spray-drying is more economical (Gëlker, 1993; Johnson & Etzel, 1993), freeze-drying is
the most popular method in the production of dried LAB preparations, as many LAB cannot tolerate
the relatively high temperatures that are used in spray-drying (Porubcan & Sellars, 1979). However,
protectants can be added to the cultures to be dried in order to prevent cell injury during drying and
subsequent storage (Champagne et al., 1991; Souzu, 1992). The most common protectants used at
industrial scale are lactose or sucrose, monosodium glutamate (MSG), and ascorbate in milk or in a
water base (Mayra-Makinen & Bigret, 1998). Micro-encapsulation (protective coating of probiotic
bacteria) and added oligosaccharides in probiotic containing products have also been found successful
in increasing the survival of the probiotic bacteria, although further research is needed to develop this
technique (Kailasapathy & Rybka, 1997).
The commercial probiotic preparations are mostly supplied to the manufacturers of probiotic
containing products in a highly concentrated form and constructed for OVS (direct vat set) application
(Honer, 1995). DVS cultures are highly concentrated cultures that are prepared as mixtures of defined
strains in predetermined proportions. They are supplied in frozen- or freeze-dried form and their high
concentration allows for their ability to be inoculated directly into the carrier food or capsules (Honer,
1995). Deep frozen cultures usually contain more than 1010cfu g-I, whereas freeze-dried cultures
contain more than 10" cfu g"1 (Oberman & Libudzisz, 1998). The cell concentration per gram of
product varies with the culture and the type of organism (Mattilla-Sandholm et al., 2002). Gas and
Iight proofed containers are used to package these probiotic preparations to protect them against light
and humidity. Aluminium-foil coated cartons and pouches are most often used (Honer, 1995).
1.5 Probiotic containing products
Probiotic bacteria may be incorporated in special formulations like capsules or tablets, or can be added
to food to contribute specific probiotic or functional properties (Mattilla-Sandholm el al., 2002). The
viability and stability of probiotic bacteria in these products has been a marketing and technological
challenge for industrial producers (Mattilla-Sandholm et al., 2002).
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1.5.1 Supplements
A dietary supplement is defined as a product intended for ingestion as a supplement to the diet.
Supplements may contain one or more of the following ingredients: vitamins, minerals, herbs,
botanicals, or other plant-derived substances; amino acids, enzymes, concentrates and extracts.
Dietary supplements can be manufactured as pills, tablets, capsules, gelcaps, liquids and powders
(Smolin & Grosvenor, 2000: 306). The production of supplements containing probiotic bacteria
involves the lyophilization (freeze/spray dried) and micro-encapsulation of probiotic bacteria for fully
protection in the gastrointestinal tract. Materials used for encapsulation include gelatin, shellac and
amylose (http://www.danoneinstitute.org/, 2003/08/09 accessed).
1.5.2 Functional foods containing probiotics
Food products fortified with probiotic bacteria form part of a class of food items referred to as
functional foods. Functional foods can be defined as physiologically active foods which provide
health benefits beyond basic nutrition by affecting one or a limited number of functions in the body in
a targeted way (Clydesdale, 1999; Roberfroid, 1999). "The component that makes the food
'functional' can be either an essential macronutrient with specific physiological effects such as
resistant starch or omega-3 fatty acids or an essential micronutrient in intakes over and above the daily
recommendations" (Roberfoid, 1999). It also includes food components that have some nutritive
value, but are not classified as 'essential', such as oligosaccharides or food components with no
nutritive value, such as live microorganisms (e.g. probiotics) or plant chemicals (Roberfoid, 1999).
Different types of products are proposed as vehicle foods for probiotic bacteria by which large
amounts of probiotic cells can be consumed for therapeutic effect. These include fermented diary,
soymilk products and non-dairy products such as cereals (Andersen, 1998; Honer, 1995; Lourens-
Hattingh & Viljoen, 2001).
1.5.2.1 Fermented dairy products
Probiotic strains used in the manufacturing of fermented dairy products are selected on the base of
rheological (flow and deformation) and organoleptic (appearance, taste and smell) and potential health
associated properties. The ability to grow and survive in milk and resulting shelf life also need to be
considered (Kailasapathy & Rybka, 1997). The most important species used in fermented dairy
products include Lactobacillus and Bifidobacterium species (Lourens-Hattingh & Viljoen, 2001).
Probiotic bacteria are often mixed with starter cultures to achieve the desired flavour and texture.
Products fermented with L. delbruekii for example might be too acidic with a too heavy acetaldehyde
flavour. Because of this, S. thermophilus and L. delbrueckii or ABT cultures of L. acidophilus,
Bifidobacterium and S. thermophilus are used as starter cultures to flavour the products in which they
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are used (Driessen & Loones, 1992). These cultures are also used in combination with other probiotic
bacteria to hasten the acidification process to minimise the risk of contamination by pathogens at 37°C
and ensure an acceptable production cost (Driessen & Loones, 1992).
The number of viable microbial cells that should be present in a fermented dairy product up to
expiration date is between 106 and 108 CFU/ml (Svensson, 1999). It is essential that products sold
with any health claims meet this criterion (Playne, 1994).
Factors that influence the viability of probiotics in dairy products include pH, storage temperature less
than 4°C, and presence of competing micro-organisms and inhibitors (e.g. NaCI) and oxygen tension
(Kneifel et al., 1993; Mattilla-Sandholm et al., 2002). The quantity of acid products, hydrogen
peroxide produced and oxygen used by the different strains may effect the growth and survival of each
strain, as the growth and survival properties differs between bacterial strains (Dave & Shah, 1997).
Therefore, the combination of probiotic strains is also important, and must be tested for compatibility
before being used in a product (Dave & Shah, 1997). The survival of probiotic bacteria can be
improved by de-aerating milk in the dairy plant and by packing strains in oxygen-impermeable
packages (Dave & Shah, 1997). The use of ascorbic acid as oxygen scavenger has also been
successful to improve the viability of probiotic bacteria (Dave & Shah, 1997).
1.5.2.2 Fermented soymilk products
Soymilk is a water extract of soybean that provides an adequate and inexpensive supply of protein and
energy for human consumption. Although it is a traditional oriental food beverage, the presence of the
indigestible oligosaccharides, stachyose and raffinose and the raw bean flavour limits the wider
consumption of soymilk and other soybean products (Wang et al., 2002). However, because of the
nutritional properties of soymilk it has been used successfully as a substrate for growth and
biochemical activities of LAB to produce stable fermented soy-milk products which contain more
readily digestible compounds (Kamaly, 1997), as is illustrated by the following examples:
• In a study done by Beasley et al. (2003) a monoculture of Lactococcus laetis LL3 strain isolated
from human milk was used to ferment soymilk into a sour milk-type product. Results indicated
that soymilk supported the growth of L. laetis and produced a microbiologically stable and
flavourable sour milk-like product (Beasley et al., 2003).
• Wang et al. (2002) described the behaviours of the bifidobacteria B. infantis and B. longum and of
the lactic acid bacteria L. acidophilus, L. bulgaricus and S. thermophilus during the fermentation
and storage of cultured soymilk drinks. Results indicated that soymilk supported the simultaneous
growth of bifidobacteria and L. acidophilus or S. thermophilus. However B. infantis and B.
longum had a deleterious effect on the growth of L. bulgaricus in soymilk. The numbers of
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bifidobacteria and lactic acid bacteria remained stable in drinks with or without sucrose during the
storage for 10 days at 5 "C.
• Wang et al. (2003) investigated the sugar and acid content of soymilk fermented with lactic acid
bacteria alone or in combination with bifidobacteria. Results indicated that L. acidophilus and S.
thermophilus metabolized the oligosaccharides, stachyose and raffinose present in the soymilk.
During the 24 - 32h fermentation the content of fructose, glucose and galactose in soymilk
increased and the pH decreased.
Probiotics can therefore be used in the manufacturing of acceptable soymilk fermented products.
However, the pH, storage temperature at 4°C, and presence of competing micro-organisms and
inhibitors (e.g. NaCI) and oxygen tension described in Section 1.6.1 should also be considered in the
manufacturing of these products.
1.5.2.3 Other food vehicles for pro biotic bacteria
Other possible food vehicles for the incorporation of probiotic bacteria include baby food, cereals and
confectionary. It is important that the activity and viability of the probiotic bacteria is maintained in
these products for extended periods of time as the probiotic bacteria are added as additives and do not
multiply. (Mattilla-Sandholm et al., 2002) Therefore the factors described in Section 1.5.2.1 regarding
the viability of probiotic bacteria should also be considered in the production of these products.
Storage at room temperature, which is common for many types of non-dairy products such as cereal
products, drinks and confectionery can create stability problems for probiotic bacteria (Kailasapathy &
Rybka, 1997). Recently, research on new probiotic formulations and micro-encapsulation
technologies exploiting biological carrier and barrier materials and systems for enteric release,
provided promising results in this regard. These technologies have been used to develop stable
probiotic-containing baby food formulations and confectioneries currently on the market
(Langhendries et al., 1995; Fukushima et al., 1997). The challenge for future probiotic processing and
formulation technologies is focussed on the maintenance of low production and thus product costs
(Mattilla-Sandholm et al., 2002).
1.5.3 Safety criteria
The use of probiotic bacteria has a long history and this provides evidence that these microbes are safe
for human consumption. LAB regarded as safe for human use need to comply with specifications
regarding origin (healthy human gastrointestinal tract), non-pathogenicity and antibiotic resistance
(Mattilla-Sandholm et al., 2002). Lactobacilli and lactococci are classified as "generally recognised as
safe" (GRAS) by the Food and Drug Administration of the USA.
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Safety criteria for successful probiotics have been defined in reviews by Lee and Salminen (1995);
Donohue and Salminen (1996) and Salminen etal. (1998) and include the following:
• Strains used for humans have to be preferably of human origin and isolated from healthy human
Gl-tract
• Strains should have no history of being pathogenic or associated with diseases such as infective
endocarditis of Gl-disorders
• They must not carry transmissible antibiotic resistance genes
2. Prebioties
2.1 Definition/description of prebiotics
Gibson and Roberfroid (1995) defined a prebiotic as "a non-digestible food ingredient that beneficially
affects the host by selectively stimulating the growth and/ or activity of one or a limited number of
bacteria in the colon that can improve host health". Prebiotics can either be found naturally in food
products such as onion, garlic, banana, chicory, asparagus, leek and Jerusalem artichoke or are
synthesised from simple sugars, such as sucrose or lactose, or can be produced by controlled
hydrolysis of starch or other polysaccharides (Gibson, 2001; Van Loo et al., 1995).
2.2 Compounds with convincing prebiotic effects
The nutritional properties of prebiotics classify them as functional food ingredients and they can also
play an important role in food product development due to their physiological properties (Roberfroid,
2000). The only food-ingredients that are currently known to have convincing prebiotic effects are
non-digestible oligosaccharides (NDO's). These oligosaccharides include those that contain fructose,
xylose, soya, galactose, glucose and mannose residues. Most research has been done on
oligosaccharides containing fructose e.g. inulin-fructans (Roberfroid, 2001). Oligosaccharides are
defined as glycosides that have between three and ten simple sugars linked together and contain low
levels of monosaccharides, di- or polysaccharides (Playne & Crittenden, 1996).
The properties of oligosaccharides depend on their chemical structure, molecular weight and levels of
mono- and disaccharides. These properties influence food-freezing temperature and mouthfeel
(Playne & Crittenden, 1996; Roberfroid, 1993).
However, the physiological properties of oligosaccharides such as reduced energy value, potential
hypocariogenic properties, dietary fibre like effects and improving growth of beneficial microflora are
the most important for the use of oligosaccharides to fortify food (Playne & Crittenden, 1996;
Roberfroid, 1993).
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2.2.1 Inulin
Inulin (Fig.2.2) contains 10% mono- and disaccharides (sucrose and fructose). Ninety percent of the
oligosaccharides found in chicory roots, the best natural source of inulin, is in the form of inulin
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FIGURE 2.2 Chemical structures of the prebiotics lactulose, inulin, and fructo-oligosaccharide
(Roberfroid, 1993).
The nutritional properties of inulin include the following:
• It is a non-digestible food ingredient and the energy value recommended for food labelling is
6.28kJ/g (Roberfroid, 1999a).
• It may be classed as a dietary fibre, because it is resistant to the digestive processes and
fermented by colonic bacteria, which increases the faecal biomass, produces short-chain fatty
acids and decreases the pH in the colon (Roberfroid, 1993).
• It stimulates the growth of bifidobacteria and inhibits the growth of bacteria, which IS less
beneficial (Roberfroid, 1999b)
Increased intakes will therefore result in increased dietary fibre content, increased bifidus-promoting
capacities and reduced total dietary energy content.
The following physical characteristics of inulin ensure that it can be used effectively to fortify food
products:
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• It has a neutral taste and is co[ourless, and therefore has minimal influence on the organoleptic
characteristics of the product. If necessary inulin can be combined with high intensity sweeteners
to give it a more sugar-like sweetness (Niness, 1999).
• lt is highly soluble in water and can be used to increase water viscosity at a concentration below
40% (Niness, 1999). At a concentration of 40-45% inulin forms a gel in water that is firm but
with a fatty mouthfeel. [n this form it is stable in acidic conditions and at high temperatures.
Therefore inulin can be used in fat-free products to give these products a smooth creamy texture
and taste (Wouters, 1998).
2.2.2 Other oligosaccharides
There are twelve classes of other food grade oligosaccharides, which have the same physiological
properties as inulin, including fructo-oligosaccharides, galacto- oligosaccharides, lactulose,
laktosucrose, palatinos- oligosaccharides, glycosyl sucrose, malto- oligosaccharides, isornalto-
oligosaccharides, cyclodextrins, gentio- oligosaccharides, soybean oligosaccharides and xylo-
oligosaccharides (Playne & Crittenden, 1996).
Oligosaccharides other than inulin that are frequently used as prebiotic food ingredients, include the
following:
• Fructo-oligosaccharides (FOS) (Fig. 2.2), which contain mostly glucose and fructose units modifiy
the nutritional and organoleptic (appearance, taste and smell) properties of foods, particularly low-
energy foods. For food labelling purposes the energy value of FOS is set at 6.28 kJ/g (Roberfroid,
1999a), although human studies suggest an energy value of 9.5kJ/g (Molis et al., 1996). FOS
provides 30 - 50% of the sweetness of table sugar and is more soluble than sucrose. Sucrose is
often replaced by a combination of FOS with high intensity sweeteners as it provides a balanced
sweetness profile and masks the aftertaste of sweetness such as aspartame or acesulfame K
(Wiedmann & Jagar, 1997).
• Galacto-oligosaccarides (GOS) which contain glucose and galactose units are found in human
milk but can be manufactured commercially. The natural occurring form in milk can stimulate the
growth of bifidus flora in breast-fed infants (Rubaltelli, 1998).
• Lactulose (Fig.2.2) which contains galactose and fructose units is a pharmaceutical preparation
that can be used to treat constipation and hepatic encephalopathy, as it is not absorbed in the upper
intestine. It can also be included in infant milk formulas for its bifidogenic effects (KontuIa et al.,
2000; Clausen & Mortensen, 1997; Baskaran et al., 1999).
• Lactosucrose contains galactose, fructose and glucose units and is also a pharmaceutical
preparation that has potential bifidogenic effects (Clausen & Mortensen, 1997; Baskaran et al.,
1999).
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2.2.3 Resistant starch
Resistant starch is also a carbohydrate, which is naturally found in raw potatoes and bananas and in
processed foods, such as pasta and bread (Wisker, 2000). Resistant starch is fermented by large bowel
microflora and not absorbed in the small intestine (Asp, 1997). It can therefore be seen as a dietary
fibre with prebiotic effect and has an estimated energy value of 11.7 kJ/g (Behall & Howe, 1996).
Resistant starch can be used as a fat mimetic or to increase dietary fibre content of food. It will not
alter the texture and appearance of food, because of its white colour, bland taste and micro-particulate
structure (Wiirsch, 1999).
2.3 Physiological and metabolic impact of prebioties and associated effects
Prebiotics have the potential to positively influence human health by escaping digestion in the small
bowel and by playing a role in the establishment of normal microflora in the large intestine
(Crittenden, 1999). The growth and activity of beneficial organisms (probiotic bacteria) in the
gastrointestinal tract are stimulated by prebiotics and therefore contribute to the health benefits of
probiotic bacteria as mentioned in Section 1.3.1. However, prebiotics also have health benefits not
directly related to the enhancement of the growth and inhibitory activity of probiotics. These benefits
include improvement of mineral uptake and reduction of plasma cholesterol levels and constipation
(Crittenden, 1999) which are largely brought about by the stool bulking effect of prebiotics as well as
the stimulating effect it has on the production of short-chain fatty acids.
2.3.1 Increased in biomass and stool bulking
Inulin-type fructans resist digestion in the upper part of the gastrointestinal tract because of their (3-
configuration of the enomeric C-2 in the fructose monomers. The non-digestible oligosaccharides
(NDO's) remain in solution in the chyme and contribute to osmotic pressure, resulting in increased
water flow. Colonic microflora ferment the NDO's and produce gases, short-chain fatty acids and
lactate. These processes also contribute to an increase in biomass and consequently to an increase in
faecal bulk and dry matter, which improves gastrointestinal motility (Van Loa et al., 1999). The latter
is illustrated by the work of Gibson et al. (1995) who studied the effect of oligofructose intake on
human biomass and stool bulking. Volunteers were given lSg oligofructose/d for a period of two
weeks. An increased stool weight corresponding to 1.5 - 2g increase in stool weight per gram
oligofructose ingested, was observed. However, the intestinal transit time was not effected (Van Lao
ef al., 1999: 123). In another controlled study done by Gibson et al. (1995), the subjects' stool output
was 92g/d before inulin intake and I23g/d after 15g/d inulin intake (Cummings et al., 2001). Van Loa
et al. (1999) reported that 1.5 - 2g NDO's/day resulted in faecal bulking and in a normalization of
stool frequency.
Stellenbosch University http://scholar.sun.ac.za
32
2.3.2 Production of short-chain fatty acids
In prebiotic metabolism, the anaerobic microflora in the colon convelt undigested carbohydrates to
SCFAs, including acetate, propionate and butyrate. The formation of different proportions of these
SCFA's is associated with fermentation by different populations of the colonic ecosystem, which are
stimulated by different carbohydrates. Research done on in vitro fermentations indicate that inulin-
type fructans typically increase production of acetate and butyrate, galacto-oligosaccharides increase
production of acetate and propionate, and xylo-oligosaccharides increases the production of acetate
only (Campbell et al., 1997). This is also illustrated by the work of Wang and Gibson (1993) who
compared the in vitro production and molar ratios of SCFA's from seventeen carbohydrate sources by
using fecal innocula from six healthy volunteers. The molar ratios of acetate: propionate: butyrate of
the two established prebiotics (FOS and inulin) were 78: 12:8 and 72: 18:8. In a similar in vitro study
the faeces of two subjects who had been eating 20g FOS daily for four weeks, were analysed. The
molar ratios of acetate: propionate: butyrate at 12h was found to be 63: 12:25 (Luo et al., 1996). The
production of SCFA's is associated a number of health benefits, including promotion of probiotic
bacterial growth, increased mineral absorption, improved lipid metabolism, suppression of
carcinogenesis and immunomodulation.
2.3.2.1 Promotion of pro biotic bacterial growth
The production ofSCFA's and lactic acid lead to a drop in the pH of the large intestine. This effect is
beneficial for the organism as it constitutes an ideal medium for the development of the hifidogenic
flora and, at the same time, limits the development of bacteria which are considered to be pathogens,
thus preventing or decreasing disease conditions associated with these organisms (Schley, 2002) (see
Section 1.3.1 for health benefits of probiotic bacteria).
2.3.2.2 Improved mineral absorption
Results of several studies done on mineral absorption indicate that NDO's improve the bioavailability
of minerals (Ohta et al., 1993; Delzenne et al., 1995; Scholz-Ahrens et al., 1998; Lemort and
Roberfroid, 1997). In different research studies all the results indicated that the increased absorption
originates mainly at the level of the large intestine and that it results in increased bone density (Baba et
al., 1996).
NDO's bind to minerals that are not absorbed in the small intestine. In the colon these minerals may
be released from the carbohydrate matrix and be absorbed. Colonic fermentation of NDO's results in
a high concentration of short-chain carboxylic acids, which facilitates the colonic absorption of
minerals, particularly calcium and magnesium. NDO's may also have an osmotic effect that transfers
water into the large bowel, thus increasing the volume of fluid in which these minerals can dissolve,
which in turn improves mineral absorption and balance (Roberfroid, 2000).
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The effect ofNDO's on mineral absorption is illustrated by human feeding studies where a significant
effect of inulin-type fructans on calcium absorption was found. In the first study nine men (mean age:
21.5 ± 2.5y) ingested 850mg Ca2+/day and a dietary supplement of 40glday of inulin. They
experienced a significant increase (± 12%) in the apparent absorption of calcium without any
significant change in urinary excretion. In the second study, twelve males between the ages of 15 and
18 years consumed 16.8 g of oligofructose/day. Their calcium balance, as measured by the double
stable isotope technique, increased II % with no significant effect on urinary excretion (Coudray el al.,
1997). Similar effects for magnesium and iron absorption have been reported for animals (Van Loo el
al., 1999).
A further mechanism through which NDO's might benefit the absorption of minerals, involves the
enhanced degradation of phytic acid (Lopez et al., 2000). The latter compound binds mineral cations,
rendering them unavailable for absorption. Results from studies done on phytic acid indicated that
fermentable carbohydrates in diets could enhance phytic acid breakdown and improve cation
absorption. The results of a recent study supports this possibility as improved mineral absorption
(calcium+20%, magnesium+50%, copper+45%) and mineral status (in blood, liver and bone) were
found in rats that ingested inul in (lOOg/kg diet) (Younes el al., 2001).
2.3.2.3 Improved lipid metabolism/profile
The mechanisms by which prebiotics influence blood lipids are not clearly understood at present
(Rastall & Gibson, 2002). Two hypothesis have been formulated to explain the possible mechanism
by which serurn cholesterol is lowered by prebiotics. The first hypothesis involves delayed gastric
emptying that slows down chyme entrance into small intestine. The rate of carbohydrate and lipid
absorption is decreased, with modulated (decreased) insulin secretion and lipoprotein formation
(Lupton, 2000). The second hypothesis refers to a two-fold increase in the portal concentration of
both acetate and propionate because of the production of short-chain fatty acids in the large intestine.
Acetate and propionate are absorbed by the portal vein and transported to the liver. Propionate inhibits
HMG CoA reductase (rate-limiting enzyme for cholesterol synthesis) activity in the liver with a
consequent decrease in cholesterol synthesis (Lupton, 2000). This hypothesis is supported by studies
done by Takase et al. (1994), Delzanne and Kok (1999) and Roberfroid (2000) who reported that
propionate inhibited fatty acid biosynthesis and the formation of serurn LOL cholesterol in individuals
consuming prebiotic supplements. Davidson et al. (1998) also reported that cholesterol concentrations
in rats are decreased by long-term administration of FOS. Preliminary data indicates that inulin
(18g/day for 3weeks) may also lower both total and LOL serum cholesterol in slightly
hypercholesterolemic subjects (Davidson et al., 1998).
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2.3.2.4 Suppression of carcinogenesis
As was mentioned in Section 1.3.4, it is believed that microflora playa role in the development of
bowel cancer. Short-chain fatty acids can potentially decrease the risk of colon cancer by the
following mechanisms:
• Butyrate stimulates apoptosis in colonic cancer cell lines and is the preferred fuel for healthy
colonocytes (Prasad, 1980; Kim et al., 1982). It is therefore desirable to increase the level of
butyrate formation in the large gut and prebiotics are known to have this effect (Olano-Martin et
al.,2000).
• The formation of phenol, indoles, amines and ammonia, which could promote the development of
colon cancer, is the result of protein and amino acid metabolism by certain microorganisms in the
colon. Prebiotics have been shown to effectively reduce the levels of these compounds by
inducing a shift in bacterial metabolism in the colon (Ballongue et aI., 1997; Rasrall & Gibson,
2002).
• The conversion of primary bile acids to secondary bile acids by microflora can increase the risk
for the development of colon cancer. Short-chain fatty acids produced after the ingestion of
prebiotics lowers the pH to lower than 6.5, which inhibits this conversion (Heijnen, 1998).
The colon cancer reducing properties of FOS, GOS and resistant starch have been investigated in
animal and human trials. FOS reduced toxic enzyme levels (Bouhnik et al., 1996) and resistant starch
reduced sterols, secondary bile acids and genotoxic enzyme levels (Hylla et al., 1998). However, a
recent study on GOS found no significant changes in markers for carcinogenesis (Alles et al., 1999).
Il is therefore clear that knowledge on the effects of prebiotics on colon cancer is still inadequate and
that more research in this regard needs to be conducted (Rastall & Gibson, 2002; Van Loo et al.,
1999).
2.3.2.5 Immunomodulation
Probiotics stimulate both non-specific host defense mechanisms and certain cell types involved in the
specific immune response (see Section 1.3.3). As prebiotics stimulate the growth and activity of
probiotics, the intake thereof may increase immune function, as is illustrated by the following studies.
• The growth and health status of children (4 -24 months) receiving a standard infant cereal
supplemented with FOS (0.55g/15g of cereal) or placebo was compared in a double blind,
randomized controlled study. One hundred and twenty-three children who attended a day care
center were enrolled and completed the study. The daily FOS intake of the group receiving
the fortified cereal was 1.2 g. Febrile events and any cold symptoms, runny nose, antibiotic
use and day care absenteeism were significantly reduced in the experimental group. Diarrhea-
associated symptoms such as fever, medical attention required, vomiting, discomfort and
regurgitation were also reduced. It was concluded that consumption of a cereal supplemented
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with FOS was associated with fewer infectious periods and less severe diarrheal disease
(Saavedra et al., 1999).
• Haschke et al. (2001) investigated the effects of a milk-containing infant cereal supplemented
with a prebiotic mixture of FOS and inulin Prebio 1 on the immune response of 8-months-old
infants after measles vaccination in a double randomized controlled study. The infants were
randomly assigned to receive cereal with (lg/25g cereal) or without prebio I during a lO-week
period. All infants were vaccinated with live attenuated measles vaccine after four weeks of
cereal feeding. Blood was collected before and 16 weeks after vaccination for IgG measles
antibody measurement. Post-vaccination IgG antibody titers were significanrly higher in the
group receiving Prebio 1 (Haschke et al., 2001).
2.4 Manufacturing of prebiotics
Oligosaccharides can be manufactured usmg a range of extraction and chemical and enzymatic
synthesis methods and cheap substrates (Roberfroid, 2001).
Extraction of oligosaccharides from biological material is the simplest approach to manufacture
prebiotics, e.g. inulin is extracted from chicory on a commercial basis (De Leenheer, 1994; Koga et
aI., 1993b). Chicory chips are extracted with hot water and the extracted chips are sold as animal feed.
Proteins, peptide, anions, colloids and phosphates are then removed from the chips by liming and
carbonation at alkaline pH. Anion and cation exchange chromatography is used to demineralise the
inulin and it is decolourised by chromatography on activated carbon. The final product is sterilised,
concentrated and spray-dried (De Leenheer, 1994).
The only prebiotic manufactured using a chemical approach is lactulose. Fructose is formed by a
base-catalysed Lobry de Bruyn-Alberda van Ekenstein isornerisation of the glucose moiety of lactose
as follows: Galf 1 -+ 4Glc -+ Gal]! 1-+ 4Fru. The reaction results in both the pyranose and furanose
forms of lactulose. The reaction is catalysed by either sodium hydroxide or borate (Timmerrnans,
1994) and degradative side reactions are minimised by carefully controlled reaction rates (Rastall &
Gibson, 2002).
The most common methods currently used to manufacture include polysaccharide hydrolysis and
enzymatic transfer reactions. Chemical methods of carbohydrate synthesis are generally inferior to
enzyme-mediated approaches for industrial production, as side reactions of the chemical method result
in unwanted colour and flavour compounds that must be removed in further refining steps. The field
of food-grade oligosaccharides production is proving to be an area for innovation in enzyme
technology and new processes are likely to be developed in the future (Rastall & Gibson, 2002).
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Polysaccharide hydrolysis is used to manufacture (FOS) from inulin and xylo-oligosaccharides (XOS)
from xylan. In Europe FOS are manufactured by partial enzyme hydrolysis of chicory inulin (De
Leenheer, 1994). Inulin contains chains terminating in either a reducing fructose residue or a non-
reducing glucose residue. FOS produced from inulin therefore have a degree of reducing activity (De
Leenheer, 1994). In Japan xylo-oligosaccharides are manufactured commercially by enzymatic
hydrolysis of xylan from corncobs (Koga et al., 1993a). The xylan is extensively hydrolysed to the
disaccharide xylobiose, its repeating unit. Smaller quantities of higher oligosaccharides are also
formed. Xylose and high molecular weight components are removed by membrane processes to
purify xylobiose (Rastall & Gibson, 2002).
Enzymatic transfer reactions are used to manufacture isomalto-ol igosaccharides, lactosucrose and
some FOS (Playne & Crittenden, 1996). Cheap sugars such as sucrose and lactose are utilised as
donors and acceptors in the following manufacturing procedures:
• FOS are build up by using fructosyltransferase from Aurea basidium pullulans or Aspergillus niger
or are used from a 60% (w/v) sucrose solution at 50-60°C in an immobilised cell-based reactor
(Yun, 1996). Glucose and sucrose can be removed by ion-change chromatography to ensure
product qualities.
• Galacto-oligosaccharides (GOS) are manufactured commercially from lactose usmg 13-
galactosidase (Matsumoto, 1993). l3-galactosidase is a hydrolase enzyme and works by
transferring galactose from lactose to water. GOS are formed under conditions of high lactose
concentration when lactose is utilised as an alternative acceptor to water (Tirnmerrnans, 1994).
• Lactosucrose is made by incubating a mixture of sucrose and lactose with l3-fructofuranosidase at
high concentrations (Kitahata & Fujita, 1993).
• lsornalto-oligosaccharides (IMO) are manufactured by a more complex process of enzymatic
synthesis (Yatake, 1993). Starch is hydrolyzed to malto-oligosaccharides and used as a substrate
in an enzymatic synthesis reaction. Glucose is removed from the mixture using chromatography
to give the final IMO products (Rastall & Gibson, 2002).
2.5 Dose of prebiotics required for health effects
The levels of prebiotic oligosaccharides in food such as onions, garlic, banana, asparagus, leek and
Jerusalem artischoke are too low to have any significant effects on health (Gibson, 200 I). Therefore
dietary fortification is important to ensure the different benefits of prebiotics (Gibson, 200 I). Dosages
of 8g to 40g prebiotics for one to three weeks have been assessed for their effect on lipid profile and
mineral absorption in humans (Table 2.4).
Stellenbosch University http://scholar.sun.ac.za
37
TABLE 2.4: The effect of the consumption of different types and doses of prebiotics on lipid
metabolism and mineral absorption
Study Effect on lipid metabolism and Author
mineral absorption
18 non-insulin-dependent No reduction of LOL-cholesterol and Yamashitaetal. (1984)
diabetic subjects were given 8 fasting blood glucose levels was
gram FOS for 14 days observed
Healthy adults were given 9g A reduction in serum triacylglycerol Canzi et al. (1995)
inulin/day for 2 weeks and cholesterol levels was found
Nine adult volunteers consumed A 58% increase (from 21.3 to 33.7%) Coudray et al. ( 1997)
40g inulin/day for 20 days in calcium absorption was observed
18 non-insulin-dependent No reduction of LOL-cholesterol and Alles et al. (1998)
diabetic subjects were given lSg fasting blood glucose levels was
FOS/day for 20 days observed
Healthy but slightly A regulating effect on total and LOL- Davidson et al. (1998)
hyperlipidaemic subjects were cholesterol levels was found
given 18g inulin/day for 3
weeks
54 healthy but slightly No effect on cholesterol was found. Williams (1998)
hyperlipidaemic volunteers However, a 19% decrease in fasting
consumed 109 inulin/day for IS serum triacylglycerol and a 10%
days decrease in insulin levels was observed
after eight weeks
Twelve volunteers consumed A significant increase of25% in Van den Heuvel el al.
lSg FOS/day for one week. calcium absorption was found ( 1999)
These results clearly indicate that the higher doses for longer periods were the most beneficial.
Generally, research indicates that prebiotic intake between 4-40gram/day is efficient to have a
significant effect on human health (Gibson, 2002).
2.6 Negative effects of increased pre biotic intake
Excessive intake of prebiotics may result in excessive gas production in the gastrointestinal tract
(Cummings et ai., 2001). Carbon dioxide and hydrogen are the main gases produced by gut
microorganisms as products of prebiotic fermentation (Cummings et ai., 2001). Gas production leads
to unwanted symptoms as reported in the following human trials with prebiotic feedings.
• In a study done by Stone-Oorshow and Levitt (1987), 112 subjects took lSg FOS daily for 12
days. Symptoms of abdominal pain, eructation, flatulence and bloating were significantly more
severe when compared with a group who only took sucrose.
• Two studies in which FOS was consumed at doses of 5 and 20g/day showed dose-related
increases in breath hydrogen and mild flatulence (Gibson et al., 1995; Luo et al., 1996).
• In a study concerning inulin intake, breath-hydrogen excretion increased and symptoms such as
flatulence, rumbling, stomach and gut cramps and bloating significantly increased in 64 women
consuming a dose of 14g1day. The symptoms were reported to be unacceptable in 12% of the
volunteers.
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Prebiotics with different chain lengths, degree of branching and degree of polymerization could be
developed to decrease the problem of gas formation and related symptoms (Cummings et al., 200 I).
2.7 Prebiotic containing products available on the market
Prebiotics can be used in the fortification of foods or be combined with probiotics in supplements
(Douglas, 2003: 2003/11/26 accessed). Prebiotics are usually encapsulated with probiotic bacteria in
capsule form to protect and increase the level of growth substrate for the probiotic in the
gastrointestinal tract.
A wide range of foods can be used as carriers of prebiotics because it is simple to use, less costly than
probiotics and easy to introduce in the food vehicle (Saavedra, 2002; Gibson, 2000). Examples of
foods that can be fortified with prebiotics include the following: beverages and fermented milks,
health drinks, bakery products, spreads, sauces, infant formulae and weaning foods, medical foods,
cereals, biscuits, confectionary, cakes, deserts, snack bar, soups and pet food (Gibson, 200 I).
In South Africa prebiotics, mainly FOS, are also manufactured and used in foodfortification. The only
prebiotic products available in South Africa include inulin and FOS manufactured by ORAFTI in
Belgium and distributed in South Africa by SAVANNAH Fine Chemicals. The range includes
Raftiline®GR (inulin), Raftilose®L95 (Oligofructose) and Raftilose®Synergy1 (combination of inulin
and oligofructose). No conclusive list of products containing prebiotics available in South Africa
could be found in the literature in South Africa.
2.8 Summary of key characteristics of probiotics and prebiotics
The key characteristics of true probiotics and prebiotics are summarized in Table 2.5.
TABLE 2.5: The key aspects of probiotics and prebiotics
Probiotics Prebiotics
• Should meet safety guidelines • Must not be hydrolysed or absorbed in the
• Should survive passage through the upper part of the gastrointestinal tract
gastrointestinal tract • Must be selectively fermented by potentially
• Should establish itself permanently in the beneficial bacteria in the colon
small intestine and colon • Should alter the composition of the colonic
• Should provide one or more specific health mierobiota towards a healthier composition
benefits • Should preferably induce additional effects
• Should selectively utilize a prebiotic as a which are beneficial to the host health
source of energy
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3. Synbiotics
Synbiotics refers to the combination of live microbial preparations (probiotics) with specific substrates
(prebiotics) (Fuller, 1989). This combination could improve the survival of the probiotic organism, as
its specific substrate is readily available for fermentation (Collins & Gibson, 1999). The health effects
of synbiotics would therefore include both the health effects of probiotics and prebiorics described in
this chapter. This possibility is supported by a number of studies, including the following:
• In a study done by Fooks and Gibson (200 I) a range of probiotics including L. plantarum 0407
and L. pentosus 905, L. reuteri, L. acidophilus and B. bifidum was tested for their ability to inhibit
the growth of some common enteropathogens including Escherichia coli, Campy/obaeter jejuni
and Salmonella enteritidis. The effect of prebiotics including FOS, inulin, XOS and mixtures of
inulin: FOS (80:20 w/w) and FOS: XOS (50:50 w/w) on probiotic antimicrobial activity against
pathogens was also determined. The impact of added prebiotics depended on the probiotic strain
involved as well as the type of prebiotic. Results indicate that L. plantarum 0407 and B. bifidum
Bb 12 tended to inhibit pathogen growth, particularly with E. coli. B. bifidum numbers were
enhanced by I-log cycle, in the presence of FOS and the FOS: XOS (50:50) mixture. Both L.
plantarum and B. bifidum numbers increased after 24-h fermentation when they were grown with
C. jejuni, regardless of the carbohydrate source used. In conclusion this study showed that
lactobacilli and bifidobacteria species can inhibit some important pathogenic species in vitro and
that this antagonism is influenced by the prebiotic provided (Fooks & Gibson, 2001).
• In a trial done by Ahmad et al. (2000) fifty-eight healthy children with acute gastroenteritis
received a low lactose formula with or without a combination of L. rhamnosus and FOS. The
duration of diarrhea was shortened by one day in the group that received the probiotic and
prebiotic supplement.
• Fisberg et al. (2000) completed a second study with 626 one to six year old children, with mild to
moderate malnutrition. The children received a nutritional supplement with or without asynbiotic
preparation containing L. acidophilus, B. infantis and FOS. The children were evaluated during a
monthly visit for a period of four months. The data recorded included supplement intake, height,
weight and stool pattern, incidence and duration of illness and episodes requiring antibiotics. The
number of 'sick days' recorded was significantly lower in the group receiving the synbiotic
supplement.
Synbiotics which promote host health can therefore be applied in the maintenance of the balance of the
gut flora in healthy individuals, as well as in restoring the equilibrium in individuals whose
gastrointestinal microflora have been altered as a result and/or disease, age, or diet (Fooks et al.,
1999).
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4. The market for functional and probiotic and prebiotic containing products
Probiotic containing functional foods are well established and are known to consumers (Stanton el al.,
200 I). However, the food manufacturer should satisfy the consumer demands to succeed in marketing
probiotic containing products. Probiotic drinks have been the key growth sector in Europe, U .S.A. and
Japan and the popularity of dose-delivery systems for probiotic containing drinks have also resulted in
research efforts targeted to develop probiotic foods outside the dairy sector (Stanton ef al., 200 I). The
market of probiotic and prebiotic containing products in Europe, United States, Japan and South
Africa is discussed with reference to products available, consumer awareness and legislative control.
4.1 European market
According to Hi lliam (1998), the key focus of the functional food market in Europe has been the
development of probiotic and prebiotic containing products. This has lead to a rapid growth in the
development of probiotics and prebiotics. To assess the functional food market, Leatherhead Food RA
undertook a study in nine countries, including the United Kingdom, France, Germany, Spain,
Belgium, Netherlands, Denmark, Finland and Sweden (Hilliarn, 1998). The probiotic market,
especially dairy products such as yoghurts and fermented milks, accounted for 65% of the European
functional food market in 1997, valued at 889 million US$ (Hilliam, 1998). In 1999, the sales of
probiotic dairy products increased to 1.35 billion US$ (Hilliam, 2000). The total European probiotic
market comprising the four main application areas including dairy, animal feed, supplements and
infant nutrition, was estimated at 4.3 billion US$ in 2003 and will grow to reach 13.79 billion US$ in
20 10 (Patton, 2003: 2003/11/26 accessed).
According to Hilliarn (2000) the probiotic yoghurt market in all the countries totalled more than 250
million kg in 1997. France represented the largest market with sales of 90 million kg, valued at
219US$ million in 1997 and 240US$ in 1999 (Hilliam, 1998; Hilliarn, 2000). Furthermore, it was
found that the German market for probiotic yoghurts is growing rapidly as the market volume
increased from 5 million US$ in 1995 to 419 million US$ in 2000, whereas the market in the United
Kingdom grew by 26% (Hilliam, 2000).
The leading brand in the yoghurt sector is LC 1 from Nestlé, with a 60% market share, followed by
Actimel from Danone with a 25% market share and Mueller's Procult brand (Mueller, Germany)
(Stanton et al., 2001). Nestle's LCI contains the L. acidophilus strain Lal and is available as a set
cultured milk or as a drinking yoghurt. Researchers from Nestlé conducted human studies on this
particular Lactobacillus strain and it was subsequently chosen for inclusion in milk products because
of its strong probiotics characteristics. Results of these studies indicated that the immune system of
the user is stimulated, leading to the product claim, "helps the body protect itself'. This product was
launched in France in 1994 and is currently available in most European countries (Young, 1996).
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Hilliam (1996) investigated consumer awareness of probiotic containing products in Europe and the
United Kingdom. He found that 80% of French respondents are aware of probiotics and 46% claimed
that they have bought products containing probiotics. Only 7% of Germans and 15% of respondents
in the United Kingdom claimed to have heard ofprobiotics. According to Cathro and Hilliam (1993),
only 16% of French respondents, 9% of German respondents and 3% of United Kingdom respondents
claimed that they have heard of prebiotics.
In Europe no specific legislation concerning the marketing and labelling of functional foods exists,
although laws on misleading health claims and food safety are being enforced. These laws affected
the Danish dairy company, MD Foods as they claimed cholesterol-reducing properties for Gaio
yoghurt, a cultured dairy product. The Advertising Standards Authority responded to the complaints
of a consumer organization and the product had to be withdrawn (Young, 1996).
4.2 Market in United States
In the United States the key area of functional food development is vitamin and mineral fortification of
foods. However, the market for probiotic and prebiotic containing foods is growing especially in the
form of diary products such as fluid milk, yoghurt and kefir. The yoghurt product sales increased with
12.8% and reached $2.39 billion in 2000. The sales of yoghurt shakes and drinks increased with 270%
and reached $75.7 million in mass-market sales (Heller & Weir, 2001). According to Patton (2003:
2003/11/26 accessed) the probiotic market including dairy products, animal feed, supplements and
infant food, in the United States is estimated at 14.39 billion US$ and will grow to reach 39.4 billion
US$ in 20 Io. Despite these changes/increases, it was found that for the trimester ending July 2001,
that probiotics ranked in the 5th or lowest level of marketing monitored in the United States (STS,
2002a). However, according to STS's TrendSense market-timing model, probiotics should show a
growing appeal in the natural and health food channel if research activity continues (STS, 2002a).
Little information regarding consumer awareness of probiotics and prebiotics in the United States is
available. According to Stanton et al. (200 I) and the Hartman Group (2002) consumer awareness is
low although it is still growing.
As far as legislation is concerned, companies in the U.S. are strictly prohibited from making claims on
foods and supplements that suggest the product can be involved in "diagnosis, cure, mitigation,
treatment, or prevention of disease, etc." with the exception, however, of health claims that are
approved by the Food and Drug Administration (FDA) for use on food labels (Hasler, 1996).
However, to date no claims regarding the potential health benefits of probiotics and prebiotics has
been approved by the FDA and thus no legislative recognition of probiotics and prebiotics exists
(Berner & O'Donnell, 1998).
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4.3 Japanese market
The original functional food market in Japan was dominated by soft drinks and dietary fibre, with
probiotics the significant functional ingredient in many of the dietary fibre products (Young, 1996). In
1993 a functional drink, containing bifidobacterial cultures, whey minerals, xylo-oligosaccharides and
dietary fibre, named Bikkie, was launched and achieved sales of 11 billion yen in the first year
(Young, 1996). Although the fermented milk, Yakult (Yakult, Japan) is classified as a functional food
in Europe, the presence of probiotics in isolation from other functional ingredients does not carry
functional food status in Japan (Young, 1996). It is expected that in the future the major functional
food ingredients in Japan will still be probiotics and prebiotics (Stanton, 200 I). Consumer awareness
in Japan of probiotics and prebiotics is very high (Young, 1996).
No information regarding awareness awareness of the Japanese consumer of probiotic-and prebiotic
containing products could be traced.
As far as Japanese legislative aspects are concerned, a program for the approval of functional foods
exists and is known as 'foods for specified use' (FOSHU) (Berner & O'Donnell, 1998). A FOSHU is
defined as a food that is expected to have certain health effects. The application of such a product is
evaluated by the Japan Association of Health and Nutritious Foods, by academic experts, and finally
by a committee appointed by the Ministry of Health and Welfare. The manufacturer is then licensed
to label the health benefits of the product (Shinohara, 1995). In 1995, seventy products were approved
by FOSHU and forty of these products contain oligosaccharides for improvement of intestinal
rnicroflora (Oku, 1996).
4.4 South African market
No statistics regarding the market share of functional foods containing probiotics and prebiotics in
South Africa are available. Probiotic products such as yoghurt made with AB cultures (L. acidophilus
and B. bifidum) and infant follow-up formulas, such as Nestlé NAN2 and NAN3, enriched with
Lactobacillus and Bifidobacterium, are currently found on the market. Only one reference could be
traced in the literature which reported on the availability of a few probiotic containing supplements
available in South African pharmacies (Table 2.6) (Du Toit, 2003). However, this is not an exhaustive
list of such products available in the country.
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TABLE 2.6: Probiotic supplements on the South African market
Manufacturer Product Probiotic cultures Cfu/g
Biopro Biopro Reuteri Lb. reuteri *N/a
Bioflora Infantiforte B. in/antis 1 x 10M
Bioflora Kiddieforte B. longum, B. bifidum, I x 10M
Lb. acidophilus
Bioflora Combiforte B.longum, B. bifidum, I x 10M
Lb. acidophilus
Cipla Medro Lactovita Lb. sporogenes 6 x 10M
Addock Ingram Ltd. Inteflora Saccharomyces 0.15g
boulardii
Phanna-Dynam ics Culturelle capsules/ B. longum, I x ro:
chew-tabs Lb. rhamnosus
Pharma- Dynarn ics Culturelle paediatric B. longum, I x lO'
sachets Lb. acidophilus,
Streptococcus
thermophilus
*N/a = Not available
No information regarding awareness of the South African consumer of probiotic-and prebiotic
containing products could be traced.
As far as legislative aspects are concerned, regulations are being finalised within the Foodstuffs,
Cosmetics and Disinfectants, Act, 1972 (Act no. 54 of 1972; http://www.doh.gov.za; 2003/05/02
accessed), which will regulate probiotic and prebiotic health claims for labelling purposes. The
permissible information to accompany a probiotic claim is the following: "Probiotics such as
bifidobacteria and the lactobacilli improve the intestinal microbial balance, and consequently the
health and functioning of the digestive tract. They manufacture B vitamins, inhibit the growth of
harmful pathogens and may, when ingested on a regular basis as part of a prudent, balanced diet, assist
in improving the immune status, the digestion of lactose, and may help reduce the risk of colon cancer.
The probiotic microbial count should exceed I x 106 colony forming units (cfu) per gram product for
foodstuffs. Permitted species are Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus
salivarius subsp. thermophilus, Lactobacillus delbrueckii subsp. bulgaricus." For foods and formulae
for infants younger than one year, the probiotic bacterial count should exceed 106 cfu per gram product
for foodstuffs and the only permitted organism is Bifidobacterium in/antis.
Prebiotics, mainly fructo-oligosaccharides, are also manufactured in South Afrcia and used in food
supplementation. No conclusive list of prebiotic containing products available in South Africa could
be found in the literature. Market analysis by the primary researcher indicated that the only prebiotic
products currently available in South Africa include inulin and fructo-oligosaccharides manufactured
by ORAFTI in Belgium and distributed in South Africa by SAVANNAH Fine Chemicals. The range
includes Raftiline®GR (inulin), Raftilose®L95 (Oligofructose) and Raftilosef'Synergyl (combination
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of inulin and oligofructose). According to the Foodstuffs, Cosmetics and Disinfectants, Act, 1972
(Act no. 54 of 1972; http://www.doh.gov.za; 2003/05/02 accessed), the proposed information to
accompany a prebiotic claim is the following: "Prebiotics are food components that escape digestion
by normal human digestive enzymes and reach the large intestine where they may create conditions
that will promote the growth of indigenous, colonic bacteria, also referred to as probiotics and are
considered to be beneficial. The product should contain at least 3 g "prebiotic" per daily serving. The
amount and sources of 'prebiotics' such as fructo-oligosaccharides, galactosylsucrose or galacto-
oligosaccharides from whey must be declared on the label. Fructo-oligosaccharides mainly from
chicory, onion, garlic, asparagus, Jerusalem artichoke and soya beans and galacto-oligosaccharides
from whey and galactosylsucrose must be stated on the label."
5. Marketing of functional foods
Kotler (1994) defines marketing as "a social and managerial process by which individuals and groups
obtain what they need and want through creating, offering and exchanging products of value with
others". Marketing is also concerned with the orientation of products or services to the market. An
important component of this decision-making process is associated with consumer awareness and
buying behaviour of consumers in the target market (Du Plessis, 1999). It is important to know how
consumers perceive a product, what their values, needs and expectations are and how consumer
attitudes are formed and how learning takes place. For example, the influence of advertising on
buying behaviour, where target consumers buy their products, how they decide on a specific product
and how much they are willing to pay for such a product influence the decision-making processes of
marketers. Therefore, the process a marketer should follow in the marketing of a product include
market segmentation, the selection of target markets and positioning the product in terms of desired
attributes to meet these needs, development of appropriate marketing strategies to communicate the
value, price positioning, and finally product distribution (Du Plessis, 1999).
5.1 Market segmentation
Market segmentation involves the segmentation of markets based on the identification of subgroups of
customers that are internally homogeneous in some relevant aspects e.g. their need and wants and
different from other market segments (Kotler, 2000; Van Trijp & Meulenberg, 1996). Factors that are
considered in segmentation include demographics, geographies and psychographies,
Demographic characteristics, such as age, gender, marital status, income, occupation and education,
are the most common bases for market segmentation and are important in locating a target market (Du
Plessis, 1999). This type of information provides the most accessible and cost-effective way to
identify target markets because it mostly involves 0 public-domain data (Du Plessis, 1999).
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Demographic measurements are therefore more or less indispensable to the market industry (Du
Plessis, 1999).
Age groups as defined by the census or in five-year increments are a useful way to understand and
segment a market. Analyzing age cohort groups or generations will often provide more meaningful
segments and marketing strategies than the other demographic segments (Hawkins et al., 2001). A
generation or age cohort is defined as a group who has experienced a common social, political,
historical and economic environment. Age cohorts function as subcultures because their shared
histories produce unique shared values and behaviors (Hawkins el 01.,2001). For these reasons age
has been found to affect the consumption of products ranging from beer to vacations. "Our age shapes
the media we use, where we shop, how we use products, and how we think and feel about marketing
activities" (Hawkins et al., 2001).
Gender segmentation has long been applied in marketing for example brands might be accompanied
by appropriate flavor, packaging and advertising cues to reinforce a gender image or certain features
are designed to appeal to a specific gender (Kotler, 2000). In this regard it is important to bear in mind
that many changes in gender related factors have occurred because of the continued impact of dual-
income households. One consequence for marketers is that women are not as readily accessible
through traditional media as they once were. Working women do not have so much lime available to
watch television or listen to the radio. For these reasons many advertisers now emphasize magazines
in their media schedules, especially those specifically aimed at working women (Schiffman & Kanuk,
1997).
As far as the influence of education and income are concerned, it is well recognised that education
influences what one can purchase by partially determining a person's income and occupation.
Education can also influence how a person thinks, makes decisions and relates to others and therefore
has a strong influence on a person's tastes and preferences (Hawkins et al., 2001; Ibid & Smith, 1996).
It must be borne in mind that a household's income level combined with its accumulated wealth
determines its purchasing power. As far as occupational status is concerned, the number of
professional workers such as engineers, scientists and lawyers has grown rapidly over the past fifteen
years. Likewise, managerial, marketing, sales, health care and social services jobs have also seen
rapid growth. In contrast, traditional blue-collar occupations have grown slowly if at all (Person,
1993). Occupation also has a direct influence on preferences for products, media and activities, and
the income generated provides the means to acquire them (Mulhern et al., 1998). Therefore services
targeted at professional, managerial or service worker have experienced greater growth in demand
than those targeted at the traditional blue-collar worker (Hawkins et al., 200 I). Hawkins et al. (200 I)
suggested that income is generally more effective as a segmentation variable when used in conjunction
with other demographic variables.
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The living Standards Measure (LSM) is used in South Africa to measure social class, or living
standard, regardless of race, income or education. The LSM quantifies the ownership of certain
durable goods and access to services to yield a composite measure of social class. There are eight
LSM groups ranging from group I with the lowest living standards to group 8 with the highest (Du
Plessis, 1999).
In geographic segmentation the market is divided by location. The theory behind this approach is
that people who live in the same region, suburb or neighbourhood, have broadly similar lifestyles,
needs and wants, and these differ from the needs of people living in other areas (Du Plessis, 1999).
Geographic segmentation is most often applied in conjunction with other types of measurement such
as demographics, and is then broadly referred to as "geodemographic". This approach is useful when
the differences in product consumption correspond closely with demographic or lifestyle "types" of
people who live in different areas or suburbs (Du Plessis, 1999).
Psychographic characteristics refer to the inner or intrinsic qualities of the individual consumer and
strategies for consumer segmentation are thus based on specific psychologic variables. Where
demographics help to locate a target market, psychographies help to describe how the members of that
market think and feel (Schiffman & Kanuk, 1997). Consumers may therefore be segmented in terms
of their needs and motivations, personality, perceptions, learning, level of involvement and attitudes
(Schiffman & Kanuk, 1997). Psychographic segmentation has become increasingly popular and most
published studies on segmentation are based on some form of lifestyle or psychograophic data (Du
Plessis, 1999).
5.2 Target positioning
Market segmentation is followed by target positioning which refers to an assessment of the market
potential of each segment. One or more target segments are subsequently selected for a specific brand
and promotional appeal. The brand is then positioned to satisfy the needs of target customers better
than competitive offerings (Rath, 1999). For example the target positioning of probiotic and prebiotic
containing products involve health conscious consumers, between the ages of 18 and 49 years and in a
high socio-economic group.
5.3 Market communication strategy
The target market profile and product characteristics determine the marketing communication strategy
(Du Plessis, 1999). For example the person selling the product, publicity, advertisements or sales
promotion techniques such as competitions, sponsorships, brochures, leaflets or special offers might
be used as marketing communication. Menrad et al. (2000) maintain that in the marketing of
functional foods a strong need for specific information and communication activities to consumers has
been identified because consumers' knowledge and awareness of the health elfects of newly
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developed functional ingredients is limited. A crucial success factor for the marketing of functional
foods is not only to target information at consumers, but also at opinion leaders, e.g. medical doctors
and nutrition advisors (Menrad et al., 2000). According to Menrad et al. (2000) the success of
information marketing of health products campaigns also depends on whether the message of the
health effect dissiminated to the consumer via advertisements, labels and other sales promotion
techniques is simple and easy to understand. Specialist terminology and medical details should
therefore be avoided.
5.4 Price positioning
"Price is the amount of money and/or other items with utility needed to acquire a product" (Cant et al.,
2002). The price of a product should cover manufacturing and marketing costs and generate sufficient
contribution to overheads and profits. Price positioning thus depends on the expected quantities that
can be sold at that price level (Cant et al., 2002). For the price positioning of for example probiotic
and/or prebiotic containing products, marketers should consider probiotic culture or prebiotic cost,
packaging, distribution, advertisements and profits (Sanders, 1998). Consumers also evaluate prices in
relation to the product's perceived quality and the prices of competitive substitute products (Cant et
al., 2002). Marketers should therefore know how much the consumers in the target market are willing
to pay for the product (Sanders, 1998).
5.5 Distribution
An additional requirement for good marketing is the availability and distribution of the products to the
target market at locations where it is convenient for procurement (Menrad, 2003). The marketer of the
product should establish effective distribution channels i.e. when and where to supply products and
physical distribution including transport and storage (Cant et al., 2002; Van Trijp & Meulenberg,
1996). Good channel decisions require a sound knowledge of where target customers shop for the
product in question (Cant et al., 2002). The market success of functional food products depend on the
use of high-volume distribution channels e.g. supermarkets, general retail stores or discount retailers
(Menrad, 2003). In Europe these are the most important distribution channels for functional foods.
Most consumers are not willing to go to specific shops just to buy functional food products and expect
these products in retail outlets (Menrad, 2003).
6. Future prospects
Diet is a major focus of public health strategies aimed at maintaining optimum health throughout life,
preventing the early onset of chronic diseases such as gastrointestinal disorders, cardiovascular
disease, cancer, osteoporosis, as well as promoting healthier ageing. Probiotics in combination with
prebiotics may be become important strategy in the prevention and treatment of these diseases
(Bezkorovainy, 200 I). The increasing consumer health consciousness and expenditure strengthens
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this possibility, as socio-economic factors are responsible for the expanding worldwide interest in
functional foods. Therefore the market for functional food products containing probiotics and
prebiotics can be developed and expanded (Mattilla-Sandholm et al., 2002).
Although the probiotic and prebiotic concept is currently widely accepted 111 the scientific and
industrial fields, further research input is required. Matllia-Sandholm et al. (2002) proposed that the
future scientific and technological research areas should involve the following:
• Investigations of the mechanisms of probiotic and prebiotic action in the GIT and development of
diagnostic tools and biomarkers for the assessment of probiotics and prebiotics
• Examination of the effects of probiotics on GIT diseases, GIT infections, and allergies
• Ensuring the stability and viability of probiotic products by developing feasible manufacturing and
storage technology
• Development of technology for non-diary, novel or artificial probiotic fortification
• Evaluation of the role of probiotics as functional food in healthy consumer groups and bearing in
mind consumer needs.
The possibility that the properties of prebiotics could be manipulated is also being investigated,
allowing molecules with desired functionality to be manufactured and implemented in the functional
food market (Rastall & Martin, 2002). Another important factor that should receive attention is the
continued growth of the market for probiotic and prebiotic containing products. Consumers should be
educated regarding the health benefits of probiotics and prebiotics to increase their awareness of these
products. Therefore marketers of probiotic and prebiotic containing products should ensure a good
marketing strategy.
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Abstract
Probiotic (live microbes) and prebiotics (non-digestible food-ingredients) that benefit the consumer's
health by improving their intestinal microbial balance are fast gaining interest as functional foods and
supplements. It is important that such products are correctly labelled to provide the consumer with
correct information. In this study probiotic and prebiotic containing products manufactured in South
Africa were identified. Probiotic and prebiotic health and content related claims stated on the labels of
products were evaluated according to available scientific evidence, the proposed South African
regulations within the Foodstuffs, Cosmetics and Disinfectants, Act, 1972 (Act 110. 54 of 1972;
http://www.doh.gov.za; 2003/05/02 accessed) and microbial assessment. A range of products was
identified wh ich included probiotic and/or prebiotic containing supplements (capsules), food items
fortified with probiotics and/or prebiotics and fermented foods containing probiotics e.g. dairy
products. Most of the health related claims on the labels of the identified products do not comply with
the proposed South African regulations. However, results also indicate that the proposed South
African regulations should be reconsidered to include another five claims, for which scientific sound
evidence is available. Probiotic strains and viable cell number claims stated on the labels of the
products mostly comply with the proposed South African regulations. The claims regarding prebiotic
type and concentration stated on labels of the products all comply with the proposed South African
regulations with the exception of three products. The actual viable cell content of three out of five
probiotic supplements readily available on the South African market, did not comply with the content
claim stated on the label. However, this problem did not seem to affect the inhibitory activity of the
probiotic strains against indicator strains isolated from faeces of patients diagnosed with AIDS.
Key words: market assessment, product assessment, probiotics, prebiotics
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Introduction
Consumers are becoming more aware of functional foods and supplements and the potential role of
these products in a balanced diet and ensuring health (Mattilla-Sandholm et al., 2002). Functional
foods can be defined as foods that contain physiologically active components, which provide health
benefits beyond basic nutrition (Clydesdale, 1999) by affecting one or more functions in the body in a
targeted way (Roberfroid, 1999). "The component that makes the food 'functional' can either be an
essential macronutrient with specific physiological effects such as resistant starch or omega-3 fatty
acids or an essential micronutrient" (Roberfoid, 1999). "It also includes food components that have
some nutritive value, but are not classified as 'essential', such as oligosaccharides or food components
with no nutritive value, such as live microorganisms (e.g. probiotics) or plant chemicals
(phytochemicals)" (Roberfoid, 1999). A food product can be naturally functional i.e. containing an
active component or can be made functional by increasing the concentration of a natural component,
by adding a component not naturally present in the product, by replacing or reducing a component
naturally present e.g. fat, or by improving the bioavailability of a component (Roberfroid, 1999).
"A dietary supplement is defined as a product intended for ingestion as a supplement to the diet"
(Smolin & Grosvenor, 2000). Supplements may contain one or more of the following ingredients:
vitamins, minerals, herbs, botanicals, or other plant-derived substances; amino acids, enzymes,
concentrates and extracts. Dietary supplements can be manufactured as pills, tablets, capsules,
gelcaps, liquids and powders (Smolin & Grosvenor, 2000).
At present the functional food market in many countries seems to be dominated by gut health
products, in particular probiotic and prebiotic containing products (Menrad, 2003). Some of the most
popular functional foods on the market include Nestlé LCI yoghurt, Danone Actimcl and Mueller's
Procult brand in Europe; Nestlé LC I yoghurt in the United States and a probiotic containing milk,
Yacult, in Japan (Kopp-Hoolihan, 200 I; Temmerman et al., 2002). No similar scientific information
regarding popular functional foods in South Africa could be traced.
Probiotics are defined by Fuller (1989) as "a live microbial food supplement that beneficially affects
the host animal by improving its intestinal microbial balance". Reported potential health benefits of
probiotics include alleviation of lactose intolerance, immune enhancement, inhibition of pathogen
colonization, reduction of colon cancer, reduction of serum cholesterol levels, improved digestion and
reduction of gastrointestinal disorders such as diarrhea and constipation (Crittenden, 1999; Fuller &
Gibson, 1995; Kopp-Hoolihan, 2001; Saavedra et al., 1994; Salminen et al., 1998). Probiotics are
available in various forms of pharmaceutical preparations e.g. (powders, liquid suspensions and
tablets), or are incorporated in for example fermented food products to produce functional foods
(Fuller, 1989; Svensson, 1999).
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The latest trend in the functional food market is to combine probiotics with prebiotics to enhance the
effect of probiotics (Menrad, 2003). Prebiotics are defined as 'non-digestible food ingredients that
beneficially affect the host by selectively stimulating the growth and/ or activity of probiotic bacteria
in the colon' (Gibson & Roberfroid, 1995). However, prebiotics also have health benefits that are not
related to the simultaneous intake of probiotics. These include increased mineral absorption and
improved bone health, a decrease in serum triglycerides and constipation relief (Roberfroid, 2000).
Inulin and fructo-oligosaccharides are amongst the most common prebiotics included in breakfast
cereals, nutritional drinks or used in combination with probiotics in nutritional supplements
(Roberfroid, 200 I). The prebiotic potential of inulin and fructo-oligosaccharides may be ascribed to
their molecular structure. The linear chains of these compounds mainly consist of f3(2~ I)-type
linked fructose molecules while the other types of prebiotics are branched and less readily accessible
for bacterial hydrolyses (Van Loo et al., 1999).
As the market of probiotic containing products, especially probiotic supplements, is still growing,
long-term experience with the use of particular strains is not available (Mattilla-Sandholm el al.,
2002). Possible dangers such as contamination and the presence of potentially pathogenic species
such as E feacium and E faecalis have been found in probiotic products (Alcid el al., 1994).
Furthermore, the appropriateness of Efeacium as a probiotic is still controversial (Hamilton-Miller &
Shah,2003). The production and marketing of probiotic functional foods should therefore be strictly
controlled and carefully monitored to ensure safe and correctly labelled products (Sanders & Huis in't
Veld, 1999; Saarela et al., 2000). Information on the label of the product, especially regarding the
composition and identity of the probiotic strains included, need to be correct to guarantee safety and
functionality (Temmerrnan el al., 2002). Recent studies conducted on probiotic supplements and
dairy products in Europe revealed gross irregulatories in this regard. In most of the cases the identity
and number of viable strains recovered did not correspond to the information on the label (Hamilton-
Miller et al., 1999; Holzapfel et al., 1998; Reuter, 1997; and Temmerman el al., 2002).
One solution to address the problem of an unacceptable product content is to improve the control of
the probiotic strain content of products via legislation. However, despite the large market segment
occupied by probiotic foods and supplements in Europe, no specific regulation regarding the labelling
of these products exists (Richardson, 1996). Although this particular market has not yet been that well
developed in the United States, where the United States Food and Drug Administration (FDA) strictly
regulates the labelling and marketing of conventional foods containing probiotic bacteria. As a result,
110 statements regarding health benefits for probiotics may be stated on the labels of products. In
South Africa permissible statements regarding health benefits of probiotic and prebiotic claims are
included in the proposed South African regulations governing the labelling and advertising of
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Foodstuffs, Cosmetics and Disinfectants, Act, 1972 (Act No. 54, 19723, http://www.doh.gov.za.
2003/05/02 accessed). However, despite the fact that this type of regulation is being finalised, limited
information is available regarding the probiotic and prebiotic containing product market in South
Africa.
In view of the above, the aims of this study were to complete a market and product assessment of
probiotic and prebiotic containing products manufactured in South Africa. This firstly involved
identifying the range of products available on the South African market. Secondly, the health and
probiotic/prebiotic content related claims that are made on the labels of the identified products were
evaluated based on available scientific evidence, proposed South African regulations and microbial
assessments.
Materials and Methods
Identification of probiotic and prebiotic products on the South African market
For the purposes of this study "probiotic and prebiotic containing products manufactured 111 South
Africa" is defined as all products manufactured in South Africa which contain either imported
probiotic strains and/ or prebiotics (most products) or probiotic strains and/ or prebiotics produced in
South Africa (minority of products). For the identification of such products available on the South
African market during the time period of 1 February to 1 September 2003, the following information
sources were scrutinized or visited: general outlets (e.g. Pick 'n Pay, Woolworths, Checkers, Spar),
health food stores, web-sites, published information including scientific literature, advertisements and
pamphlets obtained at conferences and shops. Every identified product that contained either probiotics
and/or prebiotics was listed and the following information was recorded: type of product (tablet, syrup,
food item, straw containing probiotics in powdered form), specific target group (if applicable),
probiotic strains [strain, number of viable cells (cfu/g)], prebiotic (type and concentration), and current
cost/ per lOOg. The information was collated in descriptive tables based on target group and/or
product type.
Evaluation of claims on probiotic and prebiotic containing products manufactured in South
Africa
For the purposes of this study "claims" are defined as health related claims e.g. treatment and
prevention of diarrhea, improvement of lactose intolerance, alleviation of food allergy and so forth as
well as probiotic and prebiotic content related claims i.e. strain and viable cell numbers of probiotic
and concentration of prebiotics included.
3 Referred to as proposed South African regulations from here onwards
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Evaluation of health related claims in proposed South African regulations
The health related claims regarding probiotics and prebiotics on the label of each identified product
were listed and similar claims were grouped together. The wording/content of each of the claims was
subsequently compared to the prescribed wording/content claim as is proposed by the South African
regulations (Tables 3.1 and 3.2) to determine whether it complied with the regulations.
TABLE 3.1: The wording/ content of the probiotic claim proposed in the South African regulations of
Foodstuffs, Cosmetics and Disinfectants, Act, 1972 (Act No. 54, 1972, http://www.doh.gov.za.
2003/05/02 accessed).
Permissible information to accompany a Conditions
probiotic claim
Probiotics such as Bifidobacteria and the For foods for persons older than I year
Lactobacilli improve the intestinal The probiotic microbial count should exceed I x 106 colony forming
microbial balance, and consequently the units per gram product for foodstuffs.
health and functioning of the digestive
tract. They manufacture B vitamins, Permitted species are, Lactobacillus spp., Bifidobacterium spp.,
inhibit the growth of harmful pathogens Lactococcus spp., Streptococcus salivarius subspecies thermophilus,
and may, when ingested on a regular basis Lactobacillus delbrueckii subspecies bulgaricus.
as part of a prudent, balanced diet, assist in
improving the immune status, the digestion For foods, formulae for infants younger than I year
of lactose and may help reduce the risk of The probiotic bacterial count should exceed 106 colony per gram
colon cancer. product for foodstuffs.
Permitted organism is Bifidobacterium infantis only.
Evaluation of health claims based on scientific soundness
The scientific soundness of each of the identified claims was assessed by searching the scientific
Iiterature for any published studies that seemed to provide data in support of the claim. However, in
this process it was assumed that publication of a paper relating to a claim in a scienti fie journal is not
necessarily final proof of scientific soundness of such a claim. To address this issue, the research
quality of each identified paper was assessed based on the study design that was applied. According to
Farnworth (2000), it is generally accepted that health claims concerning specific nutrients/ foods/
functional components need to be assessed using a random controlled trial (RCT). The following
criteria of RCT's in humans were therefore used to assess the quality of the identified papers (Smolin
& Grosvenor, 2000).
1. The measurements used must be objective. Subjective claims, referred to as anecdotal evidence,
which include individual testimonials or opinions, are not acceptable objective measurements.
2. The experimental population must be appropriate, i.e. human and the subjects used must be in line
with conclusions drawn and recommendations formulated. It is for example not acceptable to use
adult subjects and formulate health claims for children.
3. The study must include a control group.
4. The study must include an experimental group.
5. Subjects must be randomly assigned to an experimental and control group.
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6. Control subjects must receive a placebo.
7. The study must be at least single-blind, but preferably double-blind.
8. The journal in which the study was published must be peer reviewed.
Although sample size is a very important factor to consider in a study design, it was not possible to
specify a minimum sample size for a scientifically sound study for the assessment of probiotic and
prebiotic related health claims.
A study was classified as scientifically sound if at least seven out of eight of the mentioned criteria
were met. If any two or more of the criteria were not met, the study was classified as lacking in
scientific soundness, although not necessarily completely worthless. Although in vitro studies supply
important evidence regarding microbial activity and potential health benefits, the final proof lies in the
execution of well-planned RCT's. In vitro studies were therefore not accepted as a scientific basis for
the formulation of a health claim.
Evaluation of content claims regarding strains included, viable cell numbers and prebiotic type and
concentration
The probiotic strains and viable cell numbers, type of prebiotic and concentration thereof were listed
for each identified product and compared to the proposed South African regulations in this regard
(Table 3.2). This information was included in the mentioned descriptive tables.
TABLE 3.2: The wording/content of the prebiotic claim proposed in the South African regulations of
Foodstuffs, Cosmetics and Disinfectants, Act, 1972 (Act No. 54, 1972, htpp://www.doh.gov.za.
2003/05/02 accessed).
Permissible information to Conditions Food stuff
accompany claim
Prebiotics are food components that At least 3 g "prebiotic" per daily serving. Fructo-o Iigosaccharides
escape digestion by normal human The amount and source of 'prebiotics' such mainly from chicory,
digestive enzymes and reach the as fructo-oligosaccharides, galactosylsucrose onion, garlic, asparagus,
large intestine where they may or galacto-oligosaccharides from whey shall Jerusalem artichoke and
create conditions that will promote be declared on the label. soya beans, Galacto-
the growth of indigenous, colonic oligosaccharides from
bacteria, also referred to as whey and
probiotics and are considered to be Galaetos ylsucrose.
beneficial.
Microbial assessment of viable cel! numbers included in jive selected probiotic supplements
Five probiotic supplements readily available in pharmacies were selected to determine the viability
(growth and inhibitory activity) of the probiotic strains and to compare the actual viable cell numbers
with the "label" claim in this regard.
For determination of viable cell numbers, the samples were taken at time of production and the content
of the capsule was resuspended in 10ml sterile distilled water and a 1O-fold dilution was prepared. A
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total of 100111of each dilution were plated in duplicate onto De Man Rogosa Sharpe (MRS) agar
(Biolab, Diagnostics, Midrand, S.A). Plates from each dilution were incubated aerobically and
anaerobically at 37°C. After 24h of incubation, the viable cell numbers were determined by counting
the number of white colony forming units (cfu) grown on the plate and compared to the cell numbers
indicated on the label.
10 further assess the viability of the probiotics included in the products, probiotic strains isolated from
each of the five products were screened for inhibitory activity against the following ten indicator
strains isolated from the faeces of patients diagnosed with AIDS; Salmonella typhi, Salmonella
typhimurium, Salmonella Gr.B., Shigella jlexnerii I, Shigella jlexnerii 3, Shigella sonnei, Shigella
boydii, Shigella spp., Yersina spp., Vibrio parahemolyticus. The strains were cultured in MRS broth
(Biolab) for 18h at 37°C and 10 J..LIspotted on MRS agar (Biolab). The plates were incubated for 24h
at 37°C and then lawned with active growing strains from the indicator strains, imbedded in soft agar
(0.8%, miv), as described by Van Reenen et al. (1998). The plates were incubated at 37°C for 24h and
the colonies examined for the formation of zones, which indicate level of inhibitory activity and thus
viability. The examination of inhibitory activity was done in triplicate and the means derived.
Results
Probiotic and prebiotic containing products on the South African market
The identified range of probiotic- and prebiotic containing products manufactured in South Africa is
listed in Tables 3.3 to 3.8. The products include three fortified infant foods (Table 3.3), seven yoghurt
products selected from a variety of dairy products containing live cultures targeted at children and
adults (Table 3.4) and sixteen probiotic supplements of which three are targeted at infants/children and
thirteen at adults (Table 3.5). A combination of probiotics and prebiotics was found in six
supplements of which only one is targeted at children (Table 3.6), two energy drinks and one dairy
product targeted at children and adults (Table 3.7). Sixteen food items naturally containing or fortified
with prebiotics, including two supplements, two breakfast cereals, eleven nutritional drinks and one
muesl i bar, were identified. Four of these are targeted at infants/children, four at children and adults
and eight at adults only (Table 3.8).
The cost of probiotic products in September 2003 varies between R7.78 and R8.80 per 100g of infant
food; between R 1.16 and R2.63 per 1OOmlof dairy product and between R 1.30 and R8.81 per capsule.
The cost of supplements containing probiotics and prebiotics varies between R 1.92 and R3.56. The
dairy product containing probiotics and prebiotics cost R 1.40 per 100mi. The products containing
prebiotics cost R5.78 for lOOg of infant food, between R2.76 and R2.95 for lOOg of breakfast cereal
and between R9.80 and R 15.60 for lOOg of nutritional drink. The costs of some products were not
available and these were the products from web-sites and brochures.
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TABLE 3.3: South African manufactured infant food fortified with probiotics
Manufacturer Product Probiotic Number of viable Cost per lOOg
strains cells (cfu/g) in Rand
(Sept. 2003)
Nestlé NAN 2 probiotic Bifidobacterium *
follow-up formula with Lactobacillus" Not available 8.80
iron (from 6 months)
Nestlé NAN3 probiotic Bifidobacterium *
enriched with BL- a Lactobacillus" Not available 7.78
probiotic (from Iyear)
Nestlé Growing up milk Bifidobacterium *
enriched with BL- a Lactobacillus * Not available Not available
probiotic
* Species comply with the proposed South African regulations
TABLE 3.4: South African manufactured dairy products containing probiotics*
Manufacturer Product Probiotic strains Number of Cost per 100m!
viable cells in Rand
(cfu/g)
Parmalat Low fat Bulgarian Lb. acidophilust
yoghurt Streptococcus Not available 1.16
thermophilust, Lb.
bulgaricust
Dairybelle Low fat yoghurt Original live Aê-cultures] Not available 1.16
Dairybelle Drinking yoghurt Live AB-cultures! Not available 1.20
Fair Cape Low fat Bulgarian Live probiotic Aê-culturesr
yoghurt Not available 1.80
Fair Cape Drinking yoghurt Live probiotic cultures! Not available 1.66
Woolworths Low fat yoghurt HOWARU Bifido probiotic I x 106t 2.26
cultures+
Woolworths Ayrshire fat free S. thermophilust; L. I x 10"t 2.63
yoghurt acidophilust,
Bifidobacteriumt I x 106t
* Only a selection of dairy products claiming live AB-culture content were included
+ Species and viable cell numbers comply with the proposed South African regulations
:j: Do not comply with the proposed South African regulations
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TABLE 3.5: South African manufactured probiotic containing supplements
Manufacturer Product and Probiotic strains Number of Delivery form Cost per unit in
target group viable cells Rand (Sept.
(cfu/g) 2003)
Bioflora Acidoflora L. acidophilust Not capsules Not available
(adults) available
Bioflora Bifidoflora B. bifidumt, B. Not capsules Not available
(adults) longums available
Bioflora Intesti flora L. acidophilust, B. Not capsules Not available
(adults) bifidums, B. longumt available
Bioflora Infanti flora B. infantist I X 10~-r capsules 3.16/caps
(infants)
Bioflora Kiddie-forte L. acidophilust, B. capsules 3.16/caps
(children) bifidumv, B. Iongumt I X 109t
African B- immune: Lactobacillus sp. t
dynamics probiotics Bifidobacterium sp. t I x 109'j' capsules Not available
(adults)
African B- immune: Lactobacillus sp. t
dynani ics little Bifidobacterium sp. t I X 109-;- chewable Not available
(children,3-10 tablets
years)
SA Scientific Vagi forte Lactobacillus sp. t Not capsules and
pharma- (women) Bifidobacterium sp. t available tablets Not available
eeuticals
Zoë Care Zoë AB-Lactics Acidophilust,
Probiotia (adults) Bifidobacteriumt 1.8 x 10lOt capsules 2.90/caps
Health
Biopro Reuteri L. reuterit I x 10~t Chewable
(adults) tablets or in 3.42/caps
straws
Laetologie Lactobacillus
(adults) acidophilust, Not syrup 120/200ml
Bifidobacterium available
bifidumt
Cipla Medro Lactovita Lactobacillus 6 x 10 t capsules 1.30/caps
(adults) sporogenest
NATURA Acidoflora Not specified Not capsules Not available
available
SOLGAR Advanced L. acidophilust capsules
Acidophilus Bifidobacterium tactist 5 x 108'j' I.75/caps
Plus
SOLGAR Advanced 40+ L. acidophilust, L. capsules
Acidophilus bulgaricust, L. 2.10/caps
paracaseit, B. lactist , 1.5 x 109"j"
S. thermophilust
Adcock Ingram Inteflora 250 Saccharomyces 0,15g capsules 8.81/caps
Ltd. (adults) boulardii"
* Yeast species do not comply with the proposed South African regulations
t Species and viable cell numbers comply with the proposed South African regulations
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TABLE 3.6. South African manufactured supplements containing probiotics In combination with
prebiotics
Manufac- Product Probiotic Number of Prebiotic and Delivery Cost per
turer and target strains viable cells concentration form unit in
group (cfu/g) Rand (Sept.
2003)
Pharrna Culturelle: L.rhamnosus. t Fructo-ol igosac- capsules/
Dynamics Probiotic B. Iongumt 1X 108-j- charide+r chewable 1.92/caps
supple-ment tablets
(adults)
Pharma Culturelle: L. acidophilust
Dynamics Paediatric Bilongumi, 1 X 108 Fructo-oligosac- capsules Not
sachet Sthermo- charide+t available
(infants; philust
toddlers)
Pharma Culturelle: L. acidophilust
Dynamics Vaginal L. paracaseit 1 X 108 Fructo- capsules Not
capsules oligosaccharide+t available
(women)
Biotlora Combi-forte B. bifidum+,
(adults) B.longum!", I X 109 Not specified capsules 3.16/caps
L. acidophilut
Viridian Acidophilus L. ac idophilust 5 X 10" Fructo-oligosac-
complex B. bifidumi, 5 X 108 charide+ capsules 2.30/caps
with F.O.S L. bulgaricust 5 X 108 (40mg/capsule)
AIM Probiotic L. salivariust, 1.3 X 10~ Fructo-o Iigosac-
Flora Food L. plantarumt 1.3 X 108 charide+ capsules 3.56/caps
(adults) (210 mg/capsule)
* No content claim regarding concentration
"i" Species, viable cell numbers and prebiotic and concentration comply with the proposed South African
regulations
TABLE 3.7: South African manufactured energy drinks and diary products fortified with probiotics
d biotian pre rotres
Manufac- Product Probiotic Number of Prebiotic and Cost per unit
turer and target group strains viable cells concentration in Rand
(cfu/g) (Sept. 2003)
B-immune: energy Lactobacillus!", Fructo-oligosac-
African drink (adults and Bifidobacteriumt 2.5 x 109i" charidet Not available
Dynamics childten ) (7.5g1100g)
B- immune: Lactobocillust, Fructo-
African Probiotic maize Bifidobacteriumt I x 109t oligosaccharide+ Not available
Dynamics drink (adults and (3gll OOg)
children)
Woolworths 4 plus fat free HOWARU
Bulgarian yoghurt Bifido probiotic I x 106t Inulin+r lAO
cultures"!"
* No content claim regarding eoncentranon
tSpecies, viable cell numbers and prebiotic type and concentration comply with the proposed South African
regulations
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TABLE 3.8: South African manufactured prebiotic supplements and food items with claimed
prebiotic content*
Manufacturer Product and target group Prebiotics Concentration Current cost per
unit (Rand)
African Dynamics B-immune preBiotics Fructo- 1200 mg per
(Adults and children) oligosaccharides capsulet Not available
(FOS) t,
Raftiloset
Nestlé Lactogen 2 Nestlé Fructo-
(infants) ol igosaccharidest 1.7g1100g"!" 5.78
Nestlé Nespray fortified Prebio ' Fructo-
(children) oligosaccharidest Not available Not available
Nestlé Build-up (Vanilla) Prebio Fructo- Not available Not available
(school children; adults) oligosaccharides]
Nestlé Growing-up milk Prebio' (+ Fructo-
I year/+ 3 years oligosaccharidest Not available Not available
Nestlé Cerevita Prebio' Fructo- 6g/l OOg'i' 2.76
(general) ol igosaccharidesr
Nestlé Muesli Bar Prebio ' Fructo- Not available Not available
oligosaccharidest
Bokomo Pronutro Chicory (source of Not available 2.95
(general) FOS) t
Biotlora Colon Food Fructo- Not available Not available
(adults) oligosaccharides]
African Dynamics B - immune: imrnuno-rneal Fructo- 6.4g/100gt
(adults) olgisaccharidest Not available
Zoë Care Nutrivive Shake 3000 Lactilol+, Fructo-
(children, adults, elderly) olgisaccharidesr Not available Not available
Slimmer's ideal by choice Prebiotic fibre] Not available 15.60
Target Candida Prebiotic fibre:~ Not available 17
(women)
C strategy Fructo- 5g/l OOg"!" Not available
oligosaccharidest
Extreme Care with prebiotic
fibre Prebiotic fibre] 12g/100gt 9.80
(adults)
OPTI-MX Supa Form Fructo-
Nutrition Nutritional drink oligosaccharides] 5g/l00g'i' Not available
(adults)
* None include content claims regarding concentration
t Prebiotic type and concentration comply with the proposed South African regulations
:t: Prebiotic type and concentration do not comply with the proposed South African regulations
Evaluation of claims on South African manufactured probiotic and prebiotic containing
products
Health related claims on products based on proposed South African regulation and scientific evidence
The comparison of the health claims stated on the label of probiotic and prebiotic containing products
manufactured in South Africa with the South African regulations is presented in Table 3.9. Scientific
evidence that seems to support each claim is also included in this table. The studies that complied
with a 111 in irnum of seven out of eight of the stated criteria for a ReT (Table 3. 10) are printed in bold
in Table 3.9.
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TABLE 3.9: Claims stated on the labels of probiotic and or prebiotic containing products, references
supporting claims and compliance with the proposed South African regulations
Claims Products on which Scientific evidence Comply with
the claim is made SA
regulations
Prevention of diarrhoea in NAN 2, Infantiflora, * Isolauri et al., 1991; Kaila et al., 1992;
infants B-immune little Saavedra et al., 1994; Shornikova et al.,
1997; *Vanderhoofetal., 1999; No
Guandalini et al., 2000; Haschke et al.,
2001; Hatakka et al., 2001; Szajewska
and Mrukowicz, 2001
Assists in prevention and NAN 2, Infantiflora, No references No
treatment of nappy rash B-immune little
Assists in prevention and NAN 2, Infantiflora, Benno et al., 1996 No
treatment of constipation B-immune little
Assists in protection of NAN 2, Infantiflora,
infants in hygienically B-immune little No references No
compromised situations
Decrease lactose intolerance NAN 2, Infantiflora, Montes et aI., 1995;
symptoms B-immune little Shermak et al., 1995; Yes
Vesa et al., 1996
Treatment of disorders of the Bifidoflora Grill et al., 1995; Goldin, 1996 No
colon
Replenish intestinal flora of Combiforte, Sittonen et al., 1990; Orrhage et al.,
adults (after antibiotic Intestiflora, Reuteri 1992; Bennet et al., 1996; Pochapin, Yes
treatment) 100 2000; Cremonini et al., 2002;
Helps the body to naturally B-immune, Lactologic, Sittonen et al., 1990, Orrhage et al.,
alleviate diarrhoea in adults. lnteflora, Culture lie 1992; Bennet et al., 1996; Pochapin. No
Probiotic supplement 2000; Cremonini et (II., 2002
and Paediatric sachet
Improves digestive health, B-immune, Gibson and Wang, 1994b; McBain and
improves stool quality, BifidofloraLactologic Macfarlane, 1997; Saavedra et al., 1999; No
prevents constipation , Inteflora, Culturelle Haschke et (11.,2001
Probiotic supplement,
and Paediatric sachet,
Lactogen Prebio 1
Helps the body to naturally B-immune, Lactologic,
alleviate flatulence Inteflora, Culturelle No references No
Probiotic supplement
and Paediatric sachet
Reverses the negative effects B-immune, Kiddie-
of antibiotics on the digestive forte No references No
tract
Reverses the negative effects B-immune, Kiddie-
of alcohol on the digestive forte No references
tract No
Reverses the negative effects B-immune, Kiddie-
of stress on the digestive tract forte No references
No
Reverses the negative effects B-immune, Kiddie-
of poor diet on the digestive forte No references No
tract.
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Table 3 9 (continued)
Claims Products on which Scientific evidence Comply with
the claim is made SA
regulations
Inhibits intestinal and food B-immune, Probiotic Holzhapfel et al., 1995; Cocconier et ai.,
poisoning pathogens Flora Food, Pronutro/ 1997; Fooks and Gibson, 2002
including E.coli, Streptococci Extreme Care with
and Salmonella and feeds prebiotic fibre, No
friendly bacteria, balances Slimmers ideal by
intestinal pH. choice, Supa Form
Nutritional drink, B-
immune prebioties
Assist in promotion of Acidoflora
healthy bowel flora for (NATURA) No references No
treatment of acidity,
heartburn, indigestion and
digestive upsets
Very effective in treating B-immune, Lactologie, Pelto, et ai., 1998; Gionchetti et ai.,
Irritable Bowel Syndrome/ Inteflora 2000, Nobaek et al., 2000; Niedzielin et No
Colitis/ radiation-caused al.,2001
enterocolitis
Very effective in treating B-immune, Lactologie, Malin et al., 1997; Pelto et al., 1998;
Crohri's Disease Inteflora Campieri, et al., 2000; Guslandi, et al., No
2000
Very effective in preventing B-immune,
of dyspepsia Lactologie, Inteflora No references No
Restore and maintain the Vagi forte, Hilton et al., 1992; Hilton and Isenberg,
normal vaginal flora (mainly Acidoforte, 1995 No
lactic acid bacteria) Culturelle Probiotic
frequently destroyed by the supplement and
administration of broad- Paediatric sachet
spectrum antibiotics and the
use of disinfectants, soaps
and deodorants
Treatment of food allergies Kiddie-forte Heyman et al., 1995; Majamaa and;
Isolauri et al., 2000 No
Treatment of acne Kiddie-forte No references No
Boost immune system Kiddie- forte, Link-Amster et al., 1994; Schiffrin et
B-immune ai., 1997; MattilIa-SandhoIm and
energy/ Kauppila, 1998; Alander and MattilIa- Yes
maize drink, Sandholm, 2000; Fisberg et al., 2000;
B-immune Haschke et ai., 2001
prebioties
Treatment during steriod Kiddie-forte No references No
therapy
Treatment during Kiddie-forte No references No
chemotherapy
Treatment during Kiddie-forte Salminen et al., 1988; Hendriksson et No
radiotherapy al., 1995; Salminen et al., 1995
* References stated on website of product.
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TABLE 3.10: Evaluation of the study design of scientific papers on the health benefits of probiotics
and prebiotics
Objec- Appro- Experi- Control Ran- Placebo Blinded Peer
tive mea- priate mental dom review
Study surement population group
Alander and Mattilla- -.J -.J -v -v -.J -v Single -v
Sandholm, 2000
Bennet el al., 1996 x -v -v x -v x x ..J
Campieri el 01., 2000 -.J -v -.J -.J -.J -.J Single -v
Coconnier el 01., 1997 x x x x x x x -v
Cremonini el al., 2002 -.J -v ..J. -.J -.J -v Double -v
Fooks and Gibson, 2002 ~ In vitro -v -v -.J x x -v
Gibson and Wang, 1994 -.J In vitro -.J -.J -.J x x -v
Gionchetti et 01.,2000 ~ -v -v -v -.J -.J Double -v
Goldin, 1996 -.J -.J -v x x x x -v
Grill el aI., 1995 -.J -v -v x x x x ..J
Guandalini el al., 2000 --::j -.J -v -v -v -.J Double -v
Guslandi, et al., 2000 -.J -v -v -v -.J -.J Single -v
Haschke et al., 200 I -.J -.J -.J -.J -.J -v Double -v
Haschke el al., 200 I --::j -.J -v -v -v -.J Double -.J
Hatakka el al., 200 I -.J -v -v -v -.J -.J Double -v
Hendriksson el 01., 1995 -.J -.J -.J -v -.J x x ..J
Hilton and Isenberg, -.J -v -v -v -.J x x -v
1995
Hilton el al., 1992 --::j -.J -v -v x x x ..J
Holzhapfel, el al., 1995 -v In vitro ..J -.J x x x ..J
Isolauri el al., 1991 -.J -v -v -v -v -.J Single -v
Isolauri el al., 2000 -.J -.J -.J -v -.J -.J Double -v
Kaila el 01., 1992 ..J -v -v -v -v x Single -v
Link-Amster et al., 1994 -.J -v -v -.J -.J x Single -v
Majamaa and lsolauri, ~ -v -v -v -.J -v Double -.J
1997
Majamaa el al., 1995 -v -.J -.J -.J -.J -.J Single -v
Malin et al., 1997 -.J x -v x x x x -v
Mattilla-Sandholm and -:;r -.J -v -.J -.J -v Single -.J
Kauppila, 1998
McBain and McFarlane, ---;r In vitro -v -.J -.J x x -v
1997
Montes el 01., 1995 x x -v -v -.J x x -v
Niedzielin el al., 2001 -.J ..J ..J -v -.J -.J Double -.J
Nobaek el al., 2000 x -v -v x -.J -.J x -.J
Orthage el al., 1992 -.J ..J ..J -v -v -v Double ..J
Pelto el al., 1998 -.J -v -v -.J -.J -.J Single -.J
Poehapin, 2000 x -v ..J x -v x Single -.J
Roberfroid, 2000 -.J x -v -v -.J x x -v
Saavedra el al., 1994 ---;r -.J -.J -.J -.J -.J Double -.J
Saavedra el al., 1999 -.J -v -v -v -.J -v Double -v
Salminen et al., 1988 -:;r -.J -v -.J -.J x x -v
Salminen et al., 1995 ."f -.J -v -.J -.J x x -.J
Shermak el al., 1995 x x -v -v -.J x x -.J
Shornikova et al., 1997 -:;r ..J ..J -v -.J -.J Double -v
Sittonen el al., 1990 -.J -.J -v -.J -.J -.J Single ..J
Szajewska and -.J -v -v -v -v -v Double -.J
Mrukowicz, 200 I
Vanderhoof el 01., 1999 -.J -.J -v -.J -.J -.J Double -.J
Vesa el al., 1996 -v ..J -v -v -v -v Single i
..J~ com lied with stated criteriap
x = did not comply with stated criteria
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These data indicate that only three out of twenty-six claims comply with the proposed South African
regulations. Sound scientific evidence seems to be available for all claims permissible according to
the proposed South African regulations. However, sound scientific evidence is also available for at
least five additional claims, including diarrhea prevention in infants; diarrhea prevention in adults;
improvement of digestive health, stool quality, and constipation; prevention of Crohn's disease and
treatment of food allergies which are not permissible according to the proposed South African
regulations. Furthermore, eighteen claims were identified on the products for which no sound
scientific evidence could be traced.
Claims regarding probiotic strains, viable cel! numbers and prebiotic type and concentration included
in the products
Probiotic strain claims made on the labels of identified products (Tables 3.3 - 3.8) all comply with the
proposed South African regulations (Table 3.1) with the exception of four dairy products and one
supplement. The dairy products produced by Dairybelle and Fair Cape do not specify the species
included and only claim live AB-cultures/probiotic cultures. Inteflora 250 marketed by Addock
Ingram Ltd. contains a yeast specie, Saccharomyces boulardii which is not permissible. The claims
concerning the included viable cell numbers vary between I xl08 cfu/g and 6 xl09 cfu/g (Tables 3.3-
3.7), which comply with the proposed South African regulations. The prebiotic type claims made on
the identified products (Tables 3.6 - 3.8) include fructo-oligosaccharides, Raftilose and chicory, which
all comply with the proposed South African regulations. Three products including Slimmer's ideal by
choice, Target Candida and Extreme Care do not specify the type of prebiotic but only claim prebiotic
fibre content, which does not comply with the proposed South African regulations. The prebiotic
concentration claims varies between 3g and lSg per 100g, which comply with the proposed South
African regulations. Only one product, namely Lactogen 2 manufactured by Nestlé, contains
I. 7g11 OOgfructo-oligosaccharides and does not comply with the proposed South African regulations.
Microbial assessment of viable cell numbers included injive selected probiotic supplements
The comparison of viable cell numbers stated on the labels of the supplements with the actual viable
cell numbers is listed in Table 3.11.
TABLE 3.11: Comparison of the actual viable cell numbers with the claims on the labels of five
probiotic supplements manufactured in South Africa
Supplement Viable cell numbers stated on Actual viable cell numbers
the label of the supplement identified
(cfu/g) (aerobic/anaerobic) (cfu/g)
I I x 108 1 x 108/ 1.7x 108
2 I X 108 2.8 x 106/3 x 106
3 1 X 108 2 X 107 (aerobic)
4 I x 108 4 x 105/ lA x 107
5 1 X 107 1.5 X 107
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The viable cell numbers in Supplements 1 and 5 are in line with the viable cell numbers stated on the
labels of the supplements. The viable cell numbers in Supplement 2 were two log-cycles lower and in
Supplements 3 and 4 one log-cycle lower than the claimed number of viable cells. The viable cell
numbers in Supplement 4 were only 4 x 105 cfu/g when grown in aerobic conditions, which does not
comply with the proposed South African regulations.
The results of the screening of the probiotic strains isolated from the five selected supplements against
a panel of ten indicator strains are present in Table 3.12.
TABLE 3.12: Inhibitory activity of probiotic strains from five probiotic supplements manufactured
in South Africa against a panel of indicator strains
Human pathogens Supplement 1 Supplement 2 Supplement 3 Supplement 4 Supplement 5
Salmonella typhi ++ ++ ++ ++ ++
Yersina sp. ++ + ++ + +
Shigella jlexnerii I +++ ++ ++ ++ ++
Salmonella +++ +++ + +++ +
typhimurium
Shigella jlexnerii 3 +++ +++ ++ ++ +++
Shigella sonnei ++ ++++ ++ ++ ++++
Shigella boydii ++++ ++++ ++ +++ ++++
Salmonella Gr. B ++ +++ +++ ++ +++
Shigella sp. ++++ +++ +++ ++ ++++
Vibrio parahemo- +++ ++ ++ ++ +++
lyticus
+ indicates20-25mm zone size
++ indicates26-30mm zone size
+++ indicates31-35mm zone size
++++ indicates36+mm zone size
All the strains showed good inhibitory activity against the panel of indicator strains isolated from
faeces from patients diagnosed with AIDS, as is indicated by the zone sizes.
Discussion
The probiotic and prebiotic containing product market is a fast growing industry worldwide and the
list of available products seems to be increasing on a daily basis (Hilliam, 1996). Probiotic and
prebiotic products accounted for 65% of the European functional foods market in 1997 (Hilliam,
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1998). In the United States food probiotic products are almost exclusively diary products such as fluid
milk, yoghurt and kefir, although marketing of probiotics at this point of time is extremely limited
(Hartman Group, 2002; Stanton et al., 200 I). The original functional food market in Japan was
dominated by soft drinks with probiotics the significant, functional ingredient in many of these
products (Young, 1996). In these countries the probiotic and prebiotic market seems to be dominated
by dairy products including yoghurt and fermented drinks (Hilliam, 1998; Young, 1996). Although
not seen as an exhaustive list, a large variety of probiotic and prebiotic containing products
manufactured in South Africa were identified in this study. This range of products on the South
African market includes probiotic and prebiotic supplements (capsules) and fortified food items,
fermented foods containing probiotics e.g. dairy products and probiotics used in combination with
prebiotics in supplements and food fortification. Dairy products also seem to be prominent in the
market although fortified cereals, especially baby cereals, and supplements also seem to be growing
markets.
As far as South African prices for probiotic and/or prebiotic containing products are concerned, it is
interesting to note that the price range is much larger for the probiotic and/or prebiotic containing
supplements than for the functional foods containing these substances. The consumer needs to be
educated about the potential value of different types of products to empower them to make informed
decisions in this regard. Factors that need to be considered in deciding on a product include levels of
viable probiotic cell numbers, prebiotic concentration and convenience of use. Lee and Salminen
(1995) suggested that a daily intake of 106 to 109 cfu/g probiotic bacteria is necessary to achieve
therapeutic effects. It would be difficult to eonsurne such large numbers of organisms in the form of
for example dairy products and supplements may therefore be more convenient to attain therapeutic
dosages in those suffering from disease (Sanders, 1999). However, it must be borne in mind that in
addition to probiotics, fermented dairy products provide a nutrient-dense food source, which includes
high quality protein, highly absorbable calcium, conjugated linoleic acids, butyric acid and bioactive
peptides. Other functional foods like energy drinks are often also fortified with a range of nutrients
that could benefit health, which might not be present in a probiotic and prebiotic capsule and/or tablet
(Sanders, 1998).
It is important that the health claims stated on the labels of products supply the consumer with reliable
information because such claims influence consumer behaviour and potentially affect public health
(Clydesdale, 1997). From this research it was evident that quite a number of claims stated on the
labels of products cannot be substantiated by scientific evidence and are therefore misleading. Beside
the fact that the consumer is being manipulated in to buying a product under false pretences, it could
potentially be dangerous if such products are used to treat a condition instead of seeking medical help
(Herbert & Kasdan, 1994). Manufacturers and marketers of these products should therefore be held
accountable for health related claims on products via appropriate legislation.
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Unlike the European situation (Hilliam, 1998), South African legislators have formulated proposed
regulations for the labeling of probiotic and/or prebiotic containing products within the Foodstuffs,
Cosmetics and Disinfectants, Act, 1972 (Act No. 54, 1972, http://www.doh.gov.za. 2003/05/02
accessed). When these regulations were applied to assess the acceptability of claims stated on the
labels of products identified in this study, it was found that only three out of 26 claims complied with
the regulations. However, sound scientific evidence was found for five additional claims not included
in the proposed South African regulations. Therefore, if South African manufacturers follow the
regulations, the consumer will also be misinformed because a number of proven health benefits will
not be mentioned on the labels of products. To rectify this situation, it is thus suggested that the
proposed South African regulations be revised to include the following five claims: diarrhea
prevention in infants; diarrhea prevention in adults; improvement of digestive health, stool quality and
constipation; prevention ofCrohn's disease and treatment of food allergies.
The content related claims on the labels of the identified products were mostly in line with the
proposed South African regulations. Probiotic cultures most commonly claimed on the labels of
supplements and functional foods in South Africa include L. acidophilus, B. bifidum and B. Iongum.
which complies with the proposed South African regulations. The same species are generally claimed
to be included in European probiotic supplements (Temmerman, et al., 2002). However, two infant
foods in South Africa are fortified with Bifidobacterium sp. and Lactobacillus acidophilus instead of
B. infantis, which is specified in the proposed South African regulations for use in infant foods aimed
at infants younger than one year. All the probiotic containing products on which information
concerning strains is mentioned, comply with the proposed South African regulations concerning
strain content, with the exceptions of NAN2 and Intetlora 250. The viable cell number claims on the
labels of all the products on which this aspect was mentioned, varies between I x 108 cfu/g and 1.8 x
1010cfu/g, which complies with the proposed South African regulations.
The viable cell numbers of three of the five probiotic supplements tested for actual viable cell numbers
were not in line with the numbers stated on the labels of the supplements. This phenomenon is not
uncommon as Hamilton-Miller et al. (1999), Hoa et al. (2000) and Temmerman et al. (2002), also
reported that the identity and number of viable strains recovered from probiotic supplements and dairy
products in the United Kingdom and Europe did not correspond to the information on the label.
Hamilton-Miller and Shah (2002) suggested that manufacturers should ensure careful manufacturing
practices and proper storage of probiotic containing products to ensure cell survival. Despite the fact
that the actual viable cell numbers in these supplements were lower than the viable cell numbers stated
on the labels, all the probiotic strains showed good inhibitory activity against the indicator strains
isolated from faeces from patients diagnosed with AIDS.
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The prebiotic types used in the prebiotic containing products manufactured in South Africa include
fructo-oligosaccharides, Raftilose and chicory, which comply with the proposed South African
regulations. However, three products did not specify the type of prebiotic but only claimed prebiotic
fibre content, which does not comply with the proposed South African regulations. The prebiotic
concentration claimed on the labels varies between 3g and lSg per lOOg, which complies with the
proposed South African regulations. However, one product contained 1.7g11OOg fructo-
oligosaccharides which does not comply with the proposed South African regulations. However, if the
daily portion size consumed is 200g or more, it will comply with the proposed South African
regulations.
[t is of concern that quite a number of products on the South African market only claim AB-culture
content or prebiotic fibre content without specifying probiotic species, viable cell numbers, prebiotic
type and concentration. This situation indicates that the proposed South African regulations are not
being enforced and that it is not possible for the consumer to make a well-informed decision about the
use ofthese products. It is of vital importance that this situation should be rectified.
Conclusions and recommendations
It can be concluded that a large variety of probiotic and prebiotic containing products are found on the
South African market. It seems that manufacturers of these products are misleading consumers with a
number of health claims that are not scientifically sound. Marketing claims should be based on sound
scientific evidence and should comply with legislation in this regard. However, the proposed South
African regulations clearly do not include all the scientifically sound health claims and should be
revised to ensure that the consumer is provided with correct information. The content related claims
on the labels of products mostly comply with the proposed South African regulations although a
number of products do not provide this information. Finally, it is evident that viable cell number
claims on the labels of products are not always true. However, this problem does not seem to affect
the inhibitory activity of the probiotic strains included in the product.
[t is recommended that the proposed South African regulations regarding probiotic and prebiotic
containing products should be revised and that the manufacturers of these products should
subsequently be held responsible to provide the consumer with scientific sound, true and legally
correct information.
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CHAPTER4
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Abstract
The awareness of South African consumers of probiotics and prebiotics was investigated by
conducting a survey among a select group of 100 consumers. An interview schedule containing
questions on general awareness of probiotics, AB-cultures and prebiotics, products containing these
compounds, consumption of such products, possible health benefits thereof and sources of
information, was developed and used to interview respondents. It was found that the general
awareness of probiotics (18%), AB-cultures (36%) and prebiotics (4%) is low. Those who are aware
of probiotics (including AB-cultures) and prebiotics seem to be students, females and younger
consumers although their knowledge of the health benefits thereof is limited. It is recommended that
manufacturers of probiotic and prebiotic containing products should improve their market strategy in
order to increase the general awareness of consumers of probiotics and prebiotics and the associated
health effects thereof.
Keywords': market survey, consumer awareness, probiotics, AB-cultures, prebiotics
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Introd uction
Several steps are involved in the development of a new food product. According to Baker el al.
e 1988) these steps or stages include the idea development, sensory profiling, consumer sampling, shelf
life studies, packaging, production, market testing and marketing. Marketing, the final step in the
developing process, may determine the success or failure of a new product. A new product must not
only be of good quality but the awareness of consumers should also be raised to persuade him/her to
consume the product regularly. Low consumer awareness and knowledge of a product might therefore
restrain the growth of the market of the product (Menrad, 2003). Manufacturers should therefore
ensure high consumer awareness of products to improve growth of a market.
In general, the market for probiotic and prebiotic containing products and the awareness of these
products in improving health is increasing (Mattilla-Sandholm el al., 2002). Probiotics and prebioties
are used in the fortification of food items and in supplements (Roberfroid, 2000). Fuller (1989)
defined probiotics as "a live microbial food supplement that beneficially affects the host animal by
improving its intestinal microbial balance", whereas prebiotics are defined as 'non-digestible food
ingredients that beneficially affect the host by selectively stimulating the growth and/ or activity of
probiotic bacteria in the colon" (Gibson & Roberfroid, 1995).
In Europe consumers have a strong interest in gut-health foods and are aware of the health benefits of
probiotics, with the French being the most aware, followed by the Germans and the British (Hilliam,
1996). France manufactured the first yoghurt containing bifidobacterium in the 111 id-I980s, which
subsequently took about 9% of the yoghurt market (Hilliam, 1996). The marketing strategy involved
emphasized the role of probiotics in gut health, lowering blood cholesterol, and improving the body's
natural defences (Young, 1997). The German market for probiotic yoghurt is growing rapidly as it
increased by 150% during 1996 - 1997, whereas the market in the United Kingdom grew by 26%
during the same time period and is estimated at $2 billion (Young, 1997). In contrast with probiotics,
European consumer awareness of prebiotics is very low (Cathro & Hilliam, 1993). Prebiotic
containing products on the European market are mostly found in the dairy sector. The first prebiotic
containing product available on the European market was Nutricia, a fermented milk drink containing
L. caseii and inulin, which was launched in Belgium in 1994 (Hilliam, 1996). In Japan the awareness
of probiotics and prebiotics is high and the functional food market is dominated by soft drinks with
probiotics the significant, functional ingredient. In 1993 a functional drink containing probiotics and
prebiotics was launched in Japan and achieved sales of 11 billion yen in the first year (Young, 1996).
In the United States consumer awareness of probiotics and prebiotics is still growing as the health
benefits of these products are not yet recognized in the country's legislation (Stanton el al., 200 I).
The probiotic portion of the functional food market in the United States has been estimated to be
between $50-$200 million during the late 1990's (New Hope Natural Media, Boulder, CO; Arts,
1996). Although a range of probiotic and prebiotic containing products seem to be available on the
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South African market (see Chapter 3), no information regarding the awareness of the South African
consumers of these products is available.
lt is evident that the market for probiotic and prebiotic containing products is growing world wide
possibly also in South Africa. The determination of consumer awareness of these products provides
important information for marketers and health providers to estimate the growth of the market and
create awareness among consumers about the potential health benefits of these products. It was
therefore deemed necessary to conduct an exploratory survey to determine the awareness of a select
group of consumers in South Africa of probiotics and prebiotics as such, products containing
probiotics and prebiotics, potential health benefits as well as sources of information regarding these
products.
Methods
Study design
The study design involved a cross sectional survey. Surveys involve the collection of primary data
that may include depth and extent of knowledge; attitudes; interest and opinions; past, present or
intended behaviour as well as classification of data according to variables such as demographic and
socio-economic measures of age, income, occupation and place of residence (Rousseau, 1999).
Sample
The geographic area chosen for the survey was the town of Stellenbosch, situated in the Western Cape
Province of South Africa. It was argued that as far as market awareness of functional foods is
concerned, there is no reasonable indication that consumers in Stellenbosch would show different
attitudes and/or behavior to those in similar areas of South Africa. Stellenbosch is a town with 83 000
inhabitants in a high socio-economic group (Living Standards Measurement Group 8) (Stellenbosch,
Tourism, 200 I).
The target population included individuals who exhibited awareness of the link between health and
nutrition by either buying yoghurt (potential probiotic containing product) or any dietary supplement.
A convenience sample of one hundred subjects was recruited over a period of two weeks in September
2003. Three main grocery supermarkets, one health store and two pharmacies in Stellenbosch were
identified. A subject was approached and willingness to participate determined once he/she made a
purchase of yoghurt or one or more dietary supplements. To ensure the inclusion of a wide range of
consumers representing different age, gender, occupation and ethnic groups, each targeted outlet was
visited at least twice a day, at least twice a week for two weeks (Addendum I).
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Survey instrument
The survey instrument which consisted of an interviewing schedule containing closed and open ended
questions, was developed using the dendogram technique (Schutte, 2003). A dendogram is a visual
presentation that conceptualizes links and illustrates the different issues pertaining to a specific
subject. The consumer market segments suggested by Kotler (2000) (Addendum 2) were used as
starting point for the development of the dendogram. These segments include two broad groups of
variables. First, consumer characteristics that include geographic, demographic and psychographic
segments and second, consumer responses to benefits sought or brands used. This study involved
mainly the demographic segment and consumer response to brands used. The final questionnaire
(Addendum 3) consisted of nineteen questions regarding knowledge of probiotic/AB-
cultured/prebiotic containing products and four questions regarding demographics including gender,
age, occupation and ethnicity. Consumer awareness of probiotics, Lactobacillus acidophilus and
Bifidobacterium (AB)-cultures and prebiotics was assessed by asking whether the respondent had ever
heard of the product(s). If yes, the respondent was asked to name examples, whether he/she had ever
consumed it for health purposes, whether he/she believed the product is necessary for a person as well
as the respondent's main source of information regarding the product(s). The survey instrument was
pilot tested on ten students at the University of Stellenbosch to assess comprehension. No changes to
the survey instrument were necessary.
Data collection and analysis
All the interviews were conducted by the primary researcher. An appointment with the manager of
each targeted outlet was made to obtain permission to conduct the survey in the shop. The primary
researcher was stationed at the dairy product or supplement sections during the survey.
Data coding and analyses were performed by the primary researcher. All the data were entered into
Excef9 worksheets. The SPS~ 11.0 version and a syntax file were used for data analysis purposes.
Frequencies were tallied for close ended and open-ended questions with preset options (categories).
Where necessary categories (options) were collapsed. For open-ended questions for which options
were not predetermined, similar answers were grouped together and assigned a code. Frequencies
were subsequently tallied. The frequency data are presented in the text or were included in frequency
tables. To assess the relationship between demographic variables and awareness of probiotics, AB-
cultures and prebiotics, cross tabulations were constructed with age, gender, ethnicity, and
employment status as classification variables. The Pearsons Chi-square test was used to determine
whether there were any significant differences in the profiles of awareness of probiotics, AB-cultures
and prebiotics between the age, gender, ethnicity, and occupation status groups. A p-value of < 0.05
was accepted as significant.
Stellenbosch University http://scholar.sun.ac.za
97
Results
The sample of 100 subjects included 38% males and 62% females. Forty one percent were between
the age of 10 and 29, 32% between the age of 30 and 49 and 27% between the age of 50 and 69. As
far as ethnicity is concerned, 82% were white and 18% of mixed ancestry. Sixty one percent were
working, 20% were not working and 19% were students.
Less than a fifth (18%, n= 18) of the subjects indicated that they had heard of probiotics. The groups
most aware of probiotics include students (significant), subjects aged between 10 and 49 (strong
tendency) and females (strong tendency) (Tables 4.1,4.2 and 4.4). No ethnic differences were evident
(Table 4.3). The probiotic products most commonly mentioned by the subjects who had heard of
probiotics included yoghurt (94.4%, n=17) and to a lesser extent supplements (5.6%, n=l) and other
items wh ich included cheese and animal feed (11.1 %, n=2). Of those subjects who had heard of
probiotics, 72.2% (n=13) specifically consumed such products, especially yoghurt, to increase their
probiotic intake. Reasons cited by these subjects why probiotics are necessary, include improved
health, increased beneficial microflora, improved immune system and the inhibition of the growth of
Candida (Table 4.5). Their main source of information in this regard was magazines and the labels of
products (Table 4.6).
More than a third (36%, n=36) of the subjects indicated that they had heard of AB-cultures. The
groups most aware of AB-cultures include females (significant) and working people (strong tendency)
(Tables 4.1 and 4.4). No ethnic or age differences were evident (Tables 4.2 and 4.3). Of those
subjects who were aware of AB-cultured products, 16.7% (n=6) specifically consumed such products,
especially yoghurt, to increase their AB-culture intake. Only a few subjects cited reasons why AB-
cultures are necessary. These reasons include improved health and improved beneficial miereflora
(Table 4.5). Their main source of information in this regard was labels, magazines, word of mouth
and their doctor (Table 4.6).
Only a very small number of subjects (4%, n=4) indicated that they had heard of prebiotics. The
groups who tended to be aware of prebiotics were females, students, those of mixed ancestry and
younger people (Tables 4.1-4.4). Of those subjects who were aware of prebiotics, only one subject
specifically consumed Nestle's muesli bars to increase his/her prebiotic intake. The only reason cited
by subjects why prebiotics are necessary is improved health (Table 4.5). Most of the subjects were not
able to cite any reasons. Their main source of information in this regard was labels of products and
their doctor (Table 4.6).
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TABLE 4.1: Column % ofknowledge ofprobiotics lAB cultures/ prebiotics by gender
Male Female Pearsons Degrees of
Question Chi-square freedom
n=38 n =62 p-value
Have you ever heard of probiotics:
Yes 10.5 22.6 0.128 I
No 89.5 77.4
Have you ever heard of AB cultures:
Yes 23.7 43.5 0.008 2
No 65.8 33.9
Not applicable 10.5 22.6
Have you ever heard of prebiotics:
Yes 2.6 4.8 0.585 I
No 97.4 95.2
TABLE 4.2: Column % of knowledge of probiotics IAB cultures/ prebiotics by age
Question 18-29 yrs 30-49 yrs 50-69 yrs Pearsons Degrees of
Chi- freedom
n = 41 n =32 n = 27 square
l!_-value
Have you ever heard of probiotics:
Yes 22.0 25.0 3.7 5.235 2
No 78.0 75.0 96.3
Have you ever heard of AB
cultures: 36.6 34.4 37.0 0.219 4
Yes 41.5 40.6 59.3
No 22.0 25.0 3.7
NA
Have you ever heard of prebiotics:
Yes 7.3 3.1 0 0.307 2
No 92.3 96.9 100
TABLE 4.3: Column % of knowledge of probiotics lAB culturesl prebiotics by ethnicity
Question White Mixed Pearsons Degrees of
ancestry Chi-square freedom
n=82 n = 18 p-value
Have you ever heard of probiotics:
Yes 18.2 16.7 0.898 I
No 81.8 83.3
Have you ever heard of AB cultures:
Yes 36.4 33.3 0.957 2
No 45.5 50.0
Not applicable 18.2 16.7
Have you ever heard of prebiotics:
Yes 3.4 8.3 0.414 I
No 96.6 91.7
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TABLE 4.4: Column % of knowledge of probiotics /AB cultures/ prebiotics by occupational status
Question Working Non- Students Pearsons Degrees of
working Chi-square freedom
n = 61 n = 20 n = 19 p-value
Have you ever heard about
probiotics:
Yes 9.8 20.0 42.1 0.006 2
No 90.2 80.0 57.9
Have you ever heard about AB
cultures:
Yes 42.6 30.0 21.1 0.26 4
No 48.0 50.0 36.8
Not applicable 9.8 20.0 18.0
Have you ever heard about
prebiotics:
Yes 1.6 0 15.8 0.14 2
No 98.4 100 84.2
TABLE 4.5: Frequency % of knowledge of health benefits of probiotics/ AB cultures/ prebiotics
(multiple answers)
Question Probiotics AB-cultures Prebiotics
n = 18 n =36 n=4
Why do you think it is necessary for
probiotics/ AB-cultures/ prebiotics intake
Improve health 38.9 25.0 25.0
Increase beneficial microflora 33.3 13.9 0
Improve immune system 11.1 0 0
Inhibit growth of Candida 5.6 0 0
Don't know 11.1 5.6 75.0
Other 0 55.6 0
TABLE 4.6: Frequency % of main sources of information of probiotics/ AB cu Itures/ prebiotics
(multiple answers)
Main source of Probiotics AB-cultures Prebiotics
information n = 18 n =36 n=4
Doctor 11.1 5.6 25.0
Magazines 16.7 11.1 0
Labels 22.2 44.4 50.0
Other 38.9 8.3 0
Don't know 11.1 30.6 25.0
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Discussion
The results point to the possibility that consumer awareness of probiotics in South Africa is very low.
However, the awareness of AB-cultures seems to be higher than probiotics, which might be explained
by the fact that most probiotic containing yoghurt product labels claim to contain AB-cultures, while
no reference is made to probiotic cultures as such. Hilliam (1996) found that 80% of French
respondents were aware of probiotics and 46% claimed that they had bought products containing
probiotics. Only 7% of German respondents and 15% of respondents in the United Kingdom claimed
to have heard of probiotics. The South African consumers who were aware of probiotics, mostly
seerned to have knowledge about the health benefits thereof and their main sources of information
were the labels on products, magazines and their doctor. Hilliam (1996) also found that in France,
Germany and the United Kingdom doctors and health professionals are important sources of
information concerning functional foods. Other sources of information reported by Hilliam (1996)
include television, the national press, women's magazines and brochures.
Prebiotics seem to be an even less known term in South Africa. This could be linked to the fact that
prebiotic products mostly state the fructo-oligosaccharides or inulin content but do not refer to the
generic term, prebiotics. The few respondents in this study who were aware of prebiotics, did not
seem to have any knowledge about the health benefits thereof. According to Cathro and Hilliam
(1993) only 16% of French respondents, 9% of German respondents and 3% of British respondents
claimed that they had heard of prebiotics. No information regarding their knowledge of the health
benefits of prebiotics was reported.
According to Childs (1997) consumer research has identified several common characteristics of
functional food purchasers, namely that they are predominantly female, well-educated, high earners,
aged between 35 and 55 years and are actively interested in health. Similar trends were identified in
this research. In this study it was found that women were significantly more likely to have heard of
AB-cultures and tended to have been more likely to have heard of probiotics and prebiotics. Two
possible explanations can be put forward for this situation. First, women buy many of the products for
household consumption (Engel et al., 1993). Cant et al. (2002) report that women buy 80% of
consumer goods and make 80% of health care decisions. It can therefore be speculated that women
are more exposed to products on the market, including supplements and functional foods, and would
therefore have a better chance to have been exposed to probiotic and prebiotic containing products.
Second, despite the fact that women are not as readily accessible through the traditional media
(television and radio) because many of them work (Schiffman & Kanuk, 1997), they are now more
readily reached through magazines (Wellner, 2002). Consequently many advertisers now emphasize
magazines in their media schedules, especially those specifically aimed at working women (Schiffman
& Kanuk, 1997). It can therefore be speculated that the higher awareness of females could be
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explained by the fact that women might be more inclined to read magazines than men, especially
health related magazines.
The higher awareness of the working people in this study regarding AB-cultures could possibly be
Iinked to a higher income and higher level of education than that of the non-working group (Schiffman
& Kanuk, 1997). Educated consumers are expected to be more informed about health and nutrition
and therefore to purchase health foods and' supplements (Fotopoulos & Chryssochoidis, 2000).
However, the higher awareness of students regarding probiotic and prebiotic containing products is not
in line with what was expected, as they are not included in the working group. This finding can
possibly be linked to the fact that students might be exposed to relevant information as a result of their
studies or through close interaction with other students on campus.
Consumer research indicates that age affects the consumption of products ranging from beer to
vacations. Age also shapes the media people use, where they shop, how they use products, and how
they think and feel about marketing activities (Goode & Moutinho, 1996). In this study it was found
that the younger age groups were more aware of probiotics and prebiotics with the exception of AB-
cultures. These results are also contradictory to expectations as it has been reported that consumers
older than 50 years are more focused on their health and thus more inclined to buy healthy and
functional foods (Sanders, 1998). It can therefore be speculated that South African consumers in this
age group are not yet that well informed about the health benefits of probiotics and prebiotics.
The respondents who were of mixed ancestry seemed to be as aware of probiotics and prebiotics as
their white counterparts. However, it must be borne in mind that only a small number of these
respondents were included in the study. It can only be speculated that the awareness levels of Black
and Indian respondents will not be higher than was found for the white respondents and the
respondents from mixed ancestry who participated in this study.
It is evident from the results in this study that the existing markets for probiotic (including AB-
cultures) and prebiotic containing products in South Africa are mainly students, females and younger
people. To expand the market for these products, manufactures should focus on men, working people
and older people. Furthermore, to ensure continued growth of the probiotic and prebiotic market in
South Africa, it is recommended that manufacturers of these products should raise consumer
awareness by employing effective marketing strategies (Menrad, 2003). The latter involves the
identification of the target market; determining the communication strategy, for example
advertisements or brochures; price positioning and distributing the products to the target market (Du
Plessis, 1999). The market strategy for probiotic and prebiotic containing products should amongst
others include communicating the health benefits thereof to the target market. This could be done by
making reliable scientific studies available to journalists, by developing newsletters aimed at the
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public, by promoting the publication of articles in scientific journals and health magazines and by
developing informative websites. Another important avenue for communication with the consumer is
the product label that could provide important information about the content and nutritional value of
the product (Deliza et al., 2003). Marketers must therefore ensure that the labels of probiotic and
prebiotic containing products contain legally correct information regarding probiotic strains and/or
prebiotic type used as well as permissible health claims. Furthermore, to ensure correct price
positioning marketers should know how much the consumers in the target market are willing to pay
for the product, which should determine considerations concerning probiotic culture or prebiotic cost,
packaging, distribution, advertisements and profit margins (Sanders, 1998). Finally, the market
success of probiotic and prebiotic containing products also depends on the availability of high-volume
distribution channels such as supermarkets and general retail stores (Menrad, 2003). Although no
information in this regard was obtained in this study, Cathro and Hilliam (1993) maintain that
consumers expect to buy functional foods in supermarkets and pharmacies and not only in specialized
shops such as health food stores.
Conclusions and recommendations
It can be concluded that the results of this study indicate that consumer awareness of probiotics and/or
AB-cultures and prebiotics in South Africa is very low. Those who are aware of probiotics and
prebiotics seem to be students, females and younger consumers. Knowledge of health benefits of
especially prebiotics is limited and products, labels, magazines and doctors seem to be the most
important sources of information in this regard. Although this study was of an exploratory nature and
only a hundred subjects were included, these subjects were selected specifically because they
purchased either yoghurt or a health food product/supplement. It is therefore proposed that the general
population will be even less aware of the products.
It is recommended that manufacturers of probiotic and prebiotic containing products should improve
their market strategy in order to increase the general awareness of consumers of probiotics and
prebiotics and the associated health effects. This could be done by providing legally correct health
and content claims on the labels of products as well as the publication of scientific sound literature in
for example magazines, brochures and newsletters.
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Abstract
Probiotic lactic acid bacteria and prebiotics are effective in the treatment and prevention of clinical
disorders in humans. Twelve strains of a potential probiotic panel were screened for inhibitory
activity against indicator strains, Escherichia coli and Salmonella sp., lactic acid bacteria,
Stapylecoccus aureus, Listeria innocua, Bacillus cereus, Clostridium spp. and Propionibacterium spp.
from the LMG-panel. Five lactic acid bacteria (LAB), Lactobacillus plantarum. Lactobacillus casei
LHS, Lactobacillus salivarius 241, Lactobacillus curvatus DF 38 and Pediococcus pentosaceus 34
were selected for further study on the basis of their inhibitory activity. The strains inhibited the
growth of all the pathogenic bacteria isolated from the faeces of patients diagnosed with AIDS. All
five strains were grown effectively in soyrnilk-base, which has been proposed as a growth medium for
probiotic strains for commercial production of probiotic concentrates. Lyophilization of the strains
grown in soyrnilk-base revealed a 2 log-cycle decrease in cell numbers, but without reduction of the
inhibitory activity against pathogens isolated from faeces from patients diagnosed with AIDS. Growth
of these strains in the presence of the prebiotics Raftiline®GR (inulin), Raftilose®L95 (oligofructose)
and Raftilose'[Synergy l (inulin and oligofructose) (SA YANNAH Fine Chemicals) revealed that 1%
(rn/v) Raftilose'[Synergy l acted as the best substrate. The inhibitory activity of the LAB against
indicator strains isolated from the faeces of patients diagnosed with AIDS was also enhanced when
combined with the selected prebiotic.
Keywords: lactic acid bacteria, probiotic strains, prebiotics, soyrnilk
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lntrod uction
Various factors such as diet, stress and medication factors may disturb the balance of the normal flora
in the gastro-intestinal tract (Fuller & Gibson, 1997). Should this occur, the numbers of health-
promoting bacteria such as lactobacilli and bifidobacteria decrease, leading to domination by
pathogenic bacteria. Overgrowth of these pathogens may lead to clinical disorders, including cancer,
inflammatory disease, ulcerative col itis or other gastrointestinal disorders (Fooks et al., 1999).
Probiotic lactic acid bacteria, i.e. "viable cells that beneficially affect the host by improving its
intestinal microbial balance" (Fuller, 1989), have the ability to colonize the gastrointestinal tract and
compete with pathogen ic bacteria (Crittenden, 1999; Fuj iwara et al., 1997; Kai lasapathy & Ch in,
2000). Probiotic strains compete with pathogens for available nutrients and other growth factors
(Rolfe, 2000), antagonize pathogens through production of antimicrobial and antibacterial compounds,
such as bacteriocins and butyric acid (De Vuyst & Vandamme, 1994; Dodd & Gassen; 1994;
Kailasapathy & Chin, 2000), and reduce the intestinal pl-l, which in turn stimulates the growth of other
lactic acid bacteria (Langhendries, et al., 1995). Probiotic bacteria may also stimulate the immune
system (lsolauri et al., 1991; Isolauri et al., 1995; Rolfe, 2000), and lead to the production of lactase
(Rolfe,2000).
For commercial production of probiotic concentrates, the probiotic strains need to be prepared
according to specific methods and the cells stabilised in growth-supporting media to ensure metabolic
activity. A few studies have been conducted on non-dairy stabilising substrates such as soymilk
(Kamaly, 1997; Mattilla-Sandholm et al., 2002). Soymilk contains fermentable sugars and several
microbial growth-stimulating compounds and is relatively inexpensive (Kamaly, 1997).
Probiotic strains are freeze-dried or spray-dried when used in special formulations such as capsules or
tablets, food fortification or when used as starters in the production of fermented foods (Saarela et aI.,
2000). Freeze-drying is the most popular method since many strains cannot tolerate the relatively high
temperatures that are used in spray-drying (Mattilla-Sandholm et al., 2002). However, many probiotic
strains loose their viability after prolonged storage at room temperature (Myllarinen, et al., 1998).
Probiotic strains are available in various forms of pharmaceutical preparations, mostly as encapsulated
cells, or are incorporated in functional foods. The latest trend is to include probiotic cells with
prebiotics (Fooks et al., 1999). Prebiotics are generally defined as 'non-digestible food ingredients
that beneficially affects the host by selectively stimulating the growth and/or the activity of one or a
limited number of bacteria in the colon, especially Lactobacillus and Bifidobacterium spp.' (Gibson, &
Roberfroid, 1995). Prebiotics may thus render probiotic cells a competitive advantage over other
bacteria normally present in the gastrointestinal tract (Collins & Gibson, 1999; Crittenden, 1999) and
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may help to maintain a balance of gut flora in healthy individuals or restore the equilibrium 111
individuals with an altered microflora due to disease, age, or variation in diet (Fooks el al., 1999).
This paper reports on the identification of viable probiotic strains, soymilk-base as an appropriate
growth medium and determination of the effect of lyophilization (freeze-drying) for potential
commercial use. The growth and inhibitory activity of the five LAB in the presence of prebiotics was
also determined.
Materials and Methods
Bacterial strains and growth conditions
The lactic acid bacteria (LAB) strains from the culture collection of the Department of Microbiology,
University of Stellenbosch, that were screened against indicator strains from the species of Bacil/us,
Clostridium, Enterococcus, Lactobacillus, Leuconostoc, Listeria, Pediococcus, Propionibacterium,
Salmonella, Shigella, Staphylococcus, Streptococcus, Vibrio and Yersinia are listed in Table 5.1.
TABLE 5.1: Lactic acid bacteria screened for inhibitory activity
LAB strains Origin
Lactobacillus plantarum 423; 411 R; 81 Sorghum beer
Lactobacillus salivarius 241 Pig intestine (ileum)
Lactobacillus curvatus DF38 Italian salami
Lactobacillus casei LHS Sherry
Enterococcus fecalis 92 Pig faeces
Enterococcus sp. B3 Pig faeces
Pediococcuspentosaceus ATCC 43200 Cucumber brine
Pediococcus pentosaceus 34 Unknown
Pediococcus sp. Department culture collection
Probiotic x Commercial product
The indicator strains, Escherichia coli and Salmonella sp. (Department of Microbiology, University of
Stellenbosch, Stellenbosch, South Africa) and strains from the LMG- panel (Lab voor Microbiologie,
University of Ghent, Ghent, Belgium) and a panel of indicator strains isolated from patients diagnosed
with AIDS (Tygerberg Hospital, Cape Town, South Africa) used in this process are listed in Table 5.2.
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Indicator strains Origin
Baci/1us cereus LMG 6910 Pasteurised milk
Clostridium sporogenes LMG 8421 Soil
Clostridium tyrobutyricum LMG 13571 Cheese
Enterococcusfaecalis LMG 8222 Urine
Escherichia coli Pig faeces
Lactobacillus acidophilus LMG 8151 Acidophilus milk
Lactobacillus bulgaricus LMG 6901 Bulgarian yoghurt
Lactobaci/1us casei LMG 6904 Cheese
Lactobaci/1us curvatus LMG 9198 Milk
Lactobacillusfermentum LMG 18026 Milk
Lactobacillus helveticus LMG 6413 Swiss Emmental cheese
Lactobacillus plantarum LMG 6907 Pickled cabbage
Lactobacillus reuteri LMG 9213 Adult intestine
Lactobacillus sakei LMG 9844 Sauerkraut
Leuconostoc cremoris LMG 6909 Hansen's dried cheese starter
powder
Listeria innocua LMG 11387 Bovine, brain
Pediococcus pentosaceus LMG 9445 Cheese curd
Propionibacterium acidipropionici LMG Sheep milk
16446
Propionibacterium sp, LMG 13573 Unknown
Salmonella sp, Pig_faeces
Staphylococcus carnosus LMG 13567 Unknown
Streptococcus thermophilus LMG 6986 Pasteurised milk
Salmonella Gr.B. 003 Faeces of patient with AIDS
Salmonella typhi 00 I Faeces of patient with AIDS
Salmonella typhimurium 002 Faeces of patient with AIDS
Shigella boydii 007 Faeces of patient with AIDS
Shigella flexnerii I Faeces of patient with AIDS
Shigellajlexnerii 3 Faeces of patient with AIDS
Shigella so/mei 006 Faeces of patient with AIDS
Shigella spp. 008 Faeces of patient with AIDS
Vibrio P!lrahemolyticus 0 I0 Faeces of patient with AIDS
Yersina spp. 009 Faeces of patient with AIDS
All lactic acid bacteria were cultured in MRS broth (Biolab, Biolab Diagnostics, Midrand, S.A.). The
Clostridium spp. was cultured in Reinforced Clostridium Medium (Biolab), the Propionibacterium
spp. in GYP broth (Van der Merwe et al., 2003) and all other species in Brain heart Infusion (BHI)
broth (Biolab). Incubation conditions were as indicated by the respective culture collection
catalogues.
Screeningfor inhibitory activity of lactic acid bacteria
The twelve LAB were cultured in MRS broth (Biolab) for 18h at 37°C and 10 ~tIspotted on MRS agar
(Biolab ). The plates were incubated for 24h at37°C and then lawned with active growing cells of the
indicator strains E. coli and Salmonella sp. as well as the LMG-panel listed in Table 5.2. The cells
were imbedded in soft agar (0.8%, miv), as described by Van Reenen et al. (1998). The plates were
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incubated at 37°C for 24h and the colonies examined for the formation of inhibition zones. All tests
were conducted in triplicate. Strains with the broadest spectrum of inhibitory activity were selected
for further studies and were tested for inhibition against each other. Inhibitory activity was confirmed
by testing the cell-free supernatant of 18h-old cultures from MRS broth (Biolab). Ten ~d of the
supernatant was spotted onto MRS agar (Biolab), lawned with each selected LAB strain as described
before and examined for the formation of inhibition zones after 24h. The inhibitory activity of the
selected strains was also tested against indicator strains isolated from faeces of patients diagnosed with
AIDS (Table 5.2).
Growth in soymilk-base and growth and inhibitory activity after lyophilization
The five selected LAB were cultured in MRS broth (Biolab) at 37°C for 24h and then inoculated into
10% (m/v) of a commercially available soymilk-base that was sterilized by autoclaving. Viable cell
numbers were counted on MRS agar plates. After 24h growth at 37°C, the cultures were harvested by
centrifugation (9000 x g; 30min, 4°C), the pellet resuspended in soymilk-base and freeze dried. Viable
cell numbers and inhibitory activity against the pathogens isolated from the faeces of patients
diagnosed with AIDS (Table 5.2) were determined as before.
Effect of prebiotics on the inhibitory activity of lactic acid bacteria
The five selected LAB from the screening for inhibitory activity were grown In 10mi MRS broth
(Biolab ), without dextrose, and supplemented with 2% (w/v) of a 5% (w/v) suspension of filter-
sterilised Raftiline®GR (92%, w/v, inulin; 8%, w/v, glucose/fructose/sucrose), Raftilose®L95 (95%,
w/v, ol igofructose, 5%, w/v, glucose, fructose, sucrose) and Rafti 10se®Synergy I (combination of 92%,
w/v, inulin and oligofructose, 8%, w/v, glucose, fructose, sucrose) respectively prebiotics were from
SA VANNAH Fine Chemicals (ORAFTI, Tienen, Belgium). The tubes were inoculated with 15 ul of a
12h-old lactic acid bacterial culture and incubated for 24h. The control was MRS broth (Biolab),
without dextrose and prebiotics. Growth was recorded by optical density readings (00600). Changes in
culture pH were recorded after 24h of incubation at 37°C. The prebiotic which stimulated the growth
of the five selected strains the best was selected for further studies. The effect of 0 ..5% - 3.0% (w/v,
with 0.5% intervals) of the selected prebiotic on inhibitory activity of the selected strains was tested
against E. coli and Salmonella sp. were tested as described before (Van Reenen et al., 1998). The
prebiotic concentration that yielded the best inhibitory activity was included in MRS broth (Biolab)
and the strains tested against the indicator strains isolated from the faeces of patients diagnosed with
AIDS (Table 5.2).
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Results
Screening for inhibitory activity of lactic acid bacteria
The screening of twelve LAB strains for inhibitory activity against the indicator strains indicated that
the spectrum of inhibitory activity differed for each strain (Table 5.3, p.114). The indicator strains not
effected by the LAB strains included L. casei, L. curvatus, L. planrarum, L. reuteri, P pentosaceus, S.
thermophilus, P. acidipropionici. The following five strains with the best inhibitory activity were
selected for further studies: Lactobacillus plantarum 423, Lactobacillus casei LHS, Lactobacillus
salivarius 241, Lactobacillus curvatus OF38 and Pediococcus pentosaceus 34.
These strains had no inhibitory effect on each other (results not shown) but did show inhibitory activity
against all the indicator strains isolated from AIDS patients (Table 5.4, p.115).
Growth in a soymilk-base and growth and inhibitory activity after lyophilization
Soyrnilk-base as growth medium supported the growth of the five selected LAB strains, as is indicated
by a two log-cycle increase over 24h (Table 5.5).
TABLE 5.5: Cell counts of selected LAB grown in soymilk-base before and after lyophilization
Five selected LAB Soymilk (control) After lyophilization
o hrs (cfu/g) 24 hrs (cfu/g) 48 hrs (cfu/g)
L. plan/arum 423 4.1 x 105 2.5x 107 3.6 X 105
L. casei 1.1 x 105 4x 107 2 x 105
L. curvatus OF 38 8x 104 4.7x 107 3.2 X 105
L. salivarius 1.5x 105 3.1 X 108 2.1 x 106
P. pentosaceus 34 2.1 x 105 3 x 107 2.4x 105
The cell numbers of the LAB strains were reduced by two log-cycles when lyophilized (Table 5.5).
Lyophilized cells grown in MRS broth (Biolab) yielded a spectrum and level of inhibitory activity
against pathogens isolated from patients diagnosed with AIDS in the same order as cells that have not
been lyophilized (Table 5.4).
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TABLE 5.3: lnhibi flAB E. coli. Sal n. d-
Indicator strains
~ ~
._
Inhibitory ei.. '" '" 1:: l:::Cf) ;:s ~ ;:s I..J '" Cl.._ ::2 t:: '" I..J .... - ~ ::l .~strains (:; ~ .... ;:s I..J .~ Cl '" § ~ t:: I..J.._ .~ ..... .::;-- ~ l::: (:; .... g '" I..J .~ "t'" t:i CS .._ ~ ~ .8,l::: ~ il Cl (:; .._ ;:s (:; (:; ~ ~c.._ ~ .!?f:l i: .._ - I..J -E'cs '_ ;:: ._ b(I-- Cl t:: -- :..... ;::s .~Cl 1:: I..J (:; l::: '" '" .... I..J -- .::. Cl ...... -ClI..J (:; ;:s ~ '" b (:; §-i: ~ Cl .(3 '" .... '" Cl I..J-- -Cl '" t:l., < Cl Cl (:;~ '" <- (:; Cl ....ltj .....j .....j .....j .....j ~ .....j ltj ...... (:; ~ .§ ëJ ~ tic. ~ .(3C/) I..J cq
Lplamarum 423 + + + + + + - - + + + + + + +
Liplaruarum - - - - - - - - - - - - - - -
411R
Lplantarum 81 R + - + + + + - - + + + + + + -
L.curvatus OF 38 + + - + - + - + - - + - - - -
P.pentosaceus - + - + + + + + + + + - - - -
ATCC 43200
Probiotic x - - - + - + - - - + + + - + -
P. pentosaceus + + - + - + + + + + + + - - -
34
P. pentosaceus + + - - + + + + - - + + - - -
sp. PBC
Enterococcus sp. - - - - - + + + - - + + - + -
B3
E.feacium - - - - - + - - - + + + - + -
L.salivarius 241 + + - - - + + + + + + + + + -
L. casei LHS + + - + + + + + + + + + + + -
+ = growth inhibition; - = no growth inhibition
1 Only the indicator strains against which inhibitory activity was found, are included in the table.
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TABLE 5.4: lnhibi- - -- -- -~- - - -- ----- -.I -- -- -- --0------- ------~--- -.------ ---------- ------ ------- _- .......'--------- ---t-l------ _._- - -----
Inhibitory strains Salmonella Yersina Shigella Salmonella Shigella Shigella Shigella Salmonella Shigella Vibrio
typhi sp. flexnerii 1 typhimurium flexneri 3 sonnei boydii Gr.B sp. parahemolyt icus
When cultured in MRS broth
L. plan/arum 423 + ++ +++ ++++ ++++ ++ ++ ++ ++ ++
L. salivarius 241 ++ ++ ++ + ++++ + ++ ++++ ++ +
L curvatus 0F 38 +++ ++++ ++++ +++ ++++ ++ +++ +++ ++ +
P. pentosaceus 34 +++ +++ ++++ ++ +++ ++ ++++ +++ + ++
L casei LHS +++ ++ +++ ++++ +++ ++ +++ ++ + ++
When grown in the presence of 1% (w/v) Raftilose®Synergyl
L plan/arum 423 ++++ ++++ ++++ +++ ++++ +++ +++ ++++ +++ ++
L salivarius 241 ++++ ++++ ++++ +++ ++++ +++ +++ ++++ ++ ++
L curvatus OF 38 ++++ ++++ ++++ +++ ++++ +++ ++++ +++ ++ ++
Piperuosaceus 34 +++ +++ ++++ +++ ++++ +++ +++ +++ +++ ++
L casei LHS ++++ +++ ++++ +++ ++++ +++ ++++ ++++ ++ ++
After lyophilization
L plan/arum 423 + ++ ++ +++ +++ ++ ++ ++ ++ ++
L salivarius 241 ++ ++ ++ + +++ + + +++ ++ +
L curvatus 0F 38 +++ +++ ++++ ++ +++ ++ ++ ++ ++ +
P. pentosaceus 34 ++ +++ ++ ++ +++ ++ +++ ++ + +
L casei LHS +++ ++ ++ ++++ ++ + +++ ++ + ++
-- -----
fLAB . di d f f, f
Inhibition zone sizes: + 20-25mm zone size; ++ 26-30mm zone size; +++ 31-35mm zone size; ++++ larger than 36mm
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Effect of prebiotics on the inhibitory activity of lactic acid bacteria
The growth of LAB strains in MRS medium supplemented with prebiotics was much more vigorous
than in the control medium (without dextrose) as reflected by a rapid decrease in pH and an increase in
cell density (Table 5.6). This effect was recorded for all three prebiotics with the best results recorded
for Raftilose'[Synergy l .
TABLE 5.6: Changes in pH and cell density (ÓD600) after 24h growth of LAB in MRS broth, in the
presence and absence of prebiotics
The selected MRS without MRS with MRS with MRS with
LAB dextrose Raftiline®GR Raftilose®L95 Raftilose®
Synergy!
Lb. plan/arum 423 pH 6.42 6.30 6.31 5.36
00 0.046 0.058 0.048 1.355
Lb. salivarius 241 pH 6.40 4.96 5.16 4.96
00 0.025 1.287 1.033 1.289
Lb. casei LHS pH 6.43 5.22 5.40 5.07
00 0.068 0.918 0.922 1.205
Lb. curvatus OF 38 pH 6.43 5.22 5.53 5.22
OD 0.077 1.077 0.942 1.216
P. pentosaceus 34 pH 6.44 5.78 5.50 5.59
OD 0.032 1.029 1.170 1.180
A concentration of 1% (w/v) Raftilose'[Synergyl had a greater effect on the inhibitory activity of the
LAB than 0.5% (w/v). However, further enhancement of activity was not found for any of the five
strains with further increases in Raftilose'[Synergy l concentration (Figure 5.1).
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Fig. 5.1: The inhibitory effect of five selected LAB in combination with different concentrations of
Raftilose'fSynergyl on E coli and Salmonella sp. growth
The inclusion of 1% (w/v) Raftilose'[Synergyl in the MRS medium (Biolab) increased the inhibitory
activity of the five selected LAB strains against the indicator strains isolated from the faeces of
patients diagnosed with AIDS. The inhibition zone sizes were increased to 31-3 Smm and greater than
361ll1ll (Table 5.4).
Discussion
In the development of an effective probiotic concentrate for commercial purposes, it is essential to
identify viable LAB and ensure optimal cell counts and inhibitory activity after production. In this
research five LAB were identified from a panel of twelve LAB that showed effective inhibitory
activity against indicator strains under normal conditions. Of these five, L curvatus OF 38 and P.
pentosaceus 34 tended to inhibit the indicator strains isolated from the faeces of patients diagnosed
with AIDS to a greater extend than observed for L plan/arum 423, L casei LHS and L salivarius 241,
as reflected by larger inhibition zone sizes. The inhibitory spectrum of these five was similar to that
reported for other similar LAB such as L plantarum 0407, L. pentosus 905, L. reuteri SD2112, and L.
acidophilus LaS against E coli, C. jejuni and S. enteritidis (Fooks & Gibson, 2002). The effective
competitive exclusion of pathogens by LAB strains may involve a number of mechanisms, such as the
production of organic acids and a range of antimicrobial compounds or variations of the same type
antimicrobial compound. Organic acids such as lactic acid and acetic acid in undissociated form
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penetrate the cell membrane and dissociate intracellularly to its anionic form and protons (H+) (Silva el
aI., 1987 Russell & Diez-Gonzlaez, 1998). Accumulation of anions in the cytoplasm interferes with
essential cell functions and reduces the intracellular pH. This antagonism by probiotic bacteria against
pathogenic bacteria is important to maintain a normal intestinal microbial balance (Roberfroid, 2000).
Apart from lactic acid and acetic acid, probiotics produce antimicrobial peptides, such as bacteriocins
and/or low-molecular-mass antimicrobial compounds (Saarela et al., 2000). Four distinct classes of
bacteriocins have been identified in four distinct classes on the basis of biochern ical and genetic
characterization including (I) antibiotics, (II) small heat-stable, non-Ianthionine peptides, (IIa)
Listeria-active peptides, (lIb) poration complexes consisting of two pepeides for activity, (IIc) thiol-
activated peptides, (III) large heat-labile proteins, and (IV) complex bacteriocins (Klaenhammer,
1993). L. plantarum 423 produces plantaricin 423 which belongs to the group IIa (anti-Listeria)
bacteriocins with a broad spectrum of inhibitory activity (Van Reenen et al., 1998). The other selected
LAB strains included in this study may produce bacteriocins and/or organic acids with similar
inhibitory activity, as indicated by the respective inhibitory zone sizes.
Soymilk has gained interest as a medium for growth and biochemical activities of lactic acid bacteria
for commercial production of probiotic concentrates (Kamaly, 1997). Studies done by Wang el al.
(2002) and Beasley el al. (2003) showed that soymilk supports the growth of lactic acid bacteria. In
this study the five selected LAB also showed good growth in soyrnilk-base. It can therefore be
deducted that the soybean-oligosaccharides, raffinose and stachyose, present in the soymilk-base,
supplied sufficient nutrients for LAB growth and fermentation. This notion is supported by the work
of Wang el al. (2003), who studied LAB fermentation in soymilk and found that raffinose and
stachyose are metabolized by these strains. Soyrnilk-base can therefore be used as an efficient growth
medium for LAB for the commercial production of probiotic concentrates.
Lyophilization (freeze-drying) is the most popular method to dry LAB for storage purposes, although
more expensive than spray-drying. With both these drying methods, cell damage may occur
(Porubcan & Sellars, 1979). Freeze drying of LAB grown in soymilk-base resulted in a two log-cycle
decrease in cell numbers, which could indicate cell damage. However, the fact that no reduction in
inhibitory activity agains the indicator strains was found indicates that the reduction in cell numbers
did not affect the functional properties of the LAB negatively. It would however be prudent to include
protectants such as lactose or sucrose, monosodium glutamate (MSG) and ascorbate, which are usually
added to cultures to prevent cell destruction and prolong storage (Champagne et al., 1991; Mayra-
Makinen & Bigret, 1998; Souzu, 1992).
Il is clear from the Iiterature that probiotic growth and inhibitory activity can be improved by
combination with prebiotics in vivo. According to Roberfroid and Delzenne (1998) and Roberfroid
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(1999), the inulin/ oligofructose-type products are the prebiotics that have been investigated most
extensively for their prebiotic properties. The consistently observed prebiotic potential of inulin and
oligofructose may be ascribed to the molecular structure thereof, namely linear chains composed of
mainly 13(2~ I )-type linked fructose molecules. The other types of prebiotics are branched and less
readily accessible to bacterial hydrolyses (Van Loo et al., 1999). In this research the greatest increase
in LAB cell numbers and inhibitory activity was observed in MRS broth supplemented with 1%
Raftilose'[Synergy l , a combination of inulin and fructo-oligosaccharides. Raftilosef'Synergy l contains
a carefully selected OP distribution (OP = Degree of Polymerization=chain length of the molecules).
It can therefore be speculated that the polisaccharides and oligosaccharides of Raftilosef'Synergyl are
Illore easily hydrolysed by LAB than the prebiotics Raftiline®GR and Raftilose®L95. The inclusion of
1.0% (w/v) Raftilose'[Synergyl enhanced the growth of the five selected LAB (in vitro) and increased
inhibitory activity against indicator strains isolated from faeces of patients diagnosed with AIDS. The
increased inhibitory activity when LAB are grown in the presence of Raftilosefxynergyl can be
explained by the fact that inulin and oligofructose are fermented by the LAB and that the production
of antimicrobial substances such as short-chain fatty acids including acetate, propionate and butyrate is
increased (Schley & Field, 2002). This increase in short-chain fatty acids and lactic acid leads to a
decrease in the pH of the large intestine and benefits the organism as it constitutes an ideal medium for
the growth of the LAB. The resulting increase in populations of LAB can also compete with
pathogens for nutrients and receptors on the gut wall and, therefore, limit the growth of pathogens
(Schley & Field 2002). The inhibitory effect of probiotic strains combined with prebiotics is also
illustrated by the work of Grneiner et al. (2000) who studied the influence of a synbiotic mixture
consisting of Lactobacillus acidophilus 74-2 and 1% (w/v) powered fructo-oligosaccharide
preparation on the microbial ecology sustained in a simulation of the human intestinal microbial
ecosystem (SHIME reactor). The results indicate that the growth of L. acidophilus 74-2 increased by
I log-cycle and that the growth of E. coli and enterobacteria was inhibited. A substantial increase in
shalt-chain fatty acid production was found which resulted in decreased pH values. Although this
study and those reported in the literature were conducted in vitro, it is proposed that a similar effect
will occur in vivo (Roberfroid & Deizenne, 1998).
Conclusions and recommendations
It can be concluded that probiotic strains with good inhibitory activity in vitro are available in South
Africa. For the commercial production of probiotic concentrates the identified LAB can be grown
successfully in soyrnilk-base and be lyophilized for storage. It can also be concluded that the presence
of 1.0 % (w/v) Raftilosef'Synergyl increases LAB cell numbers and inhibitory activity in vi/ra. and
that a similar effect will occur in vivo.
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Based on the results of this study, it is recommended that for the purposes of the development of
effective probiotic and prebiotic containing products, at least three of the five identified probiotic
strains should be included. Furthermore, probiotics should be combined with 1.0% (w/v)
Raftilose'[Synergy l to optimalize the inhibitory activity of the probiotics in vivo.
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1. General discussion
Research has shown that a balanced gastrointestinal ecosystem is resistant to colonization by invading
species when in balance within its host and therefore improves immune functions and health (Buddington
el aI., 2002). Certain factors could cause disturbances of this balanced ecosystem leading to greater
sensitivity to pathogens and clinical disorders (Fuller & Gibson, 1997). These disorders can be treated or
prevented by dietary supplementation of specific compounds known as probiotics (Fooks el aI., 1999;
Collins & Gibson, 1999). The survival of probiotic strains in the gastrointestinal tract can be improved
by available fermentable subtrates such as oligosaccharides and polisaccharides, known as prebiotics
(Gibson & Roberfroid, 1995).
Consumers are becoming more aware of nutrition and health and therefore an expansion of the market in
probiotic and prebiotic products in Europe has been witnessed (Temrnerrnan el ai., 2002). However, very
little information in this regard for the South African market could be traced. Therefore, the first
objective of this study was to identify probiotic and prebiotic containing products available on the South
African market. A large variety of products were subsequently identified, which included probiotic
and/or prebiotic containing supplements (capsules), food items fortified with probiotics and/or prebiotics
and fermented foods containing probiotics e.g. dairy products.
As part of the marketing of probiotic and prebiotic containing products, content and health related claims
are often made on the labels of the products. For the protection of consumers, manufacturers and
marketers of these products should be held accountable for health related claims on products via
appropriate legislation. South African legislators have formulated proposed South African regulations
within the Foodstuffs, Cosmetics and Disinfectants, Act, 1972 (Act no. 54 of 1972;
htpp://www.doh.gov.za. 2003/05/02 accessed) for the labeling of probiotic and/or prebiotic containing
products. A further objective of this study therefore was to determine to what extent the content and
health claims on the identified products comply with the proposed South African regulations. It was
found that only three out of 26 health claims made on the labels complied with the proposed South
African regulations indicating that manufacturers might be misinforming the public. However, sound
scientific evidence was found for five additional claims not currently included in the proposed South
African regulations. Therefore, if South African manufacturers follow the current proposed South
African regulations, the consumer will be misinformed because a number of proven health benefits will
not be mentioned on the labels of products. To rectify this situation, our research suggests that the
proposed South African regulations should be revised to include the following five claims: diarrhea
prevention in infants; diarrhea prevention in adults; improvement of digestive health, stool quality and
constipation; prevention of Crohn's disease and treatment of food allergies. Assessment of the content
related claims showed that probiotic cultures most commonly claimed to be included in supplements and
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functional foods in South Africa include L. acidophilus, B. bifidum and B. longum, which complies with
the proposed South African regulations. However, two infant foods were found to be fortified with
Bifidobacterium sp. and Lactobacillus acidophilus instead of B. infantis, which is specified in the
proposed South African regulations for use in infant food aimed at infants younger than one year. The
content claims regarding viable cell numbers on the labels of the products varies between I x 108 cfu/g
and 1.8 x 1010 cfu/g, which comply with the proposed South African regulations. The prebiotic
containing products identified in this study claimed to include fructo-oligosaccharides, Raftilose and
chicory, which comply with the proposed South African regulations. However, three products were
identified on which the type of prebiotic was not specified, although prebiotic fibre content was claimed,
wh ich does not comply with the proposed South African regulations. The prebiotic concentration claimed
on tile labels varies between 3 g and 15 g per 100 g, which complies with the proposed South African
regulations. Only one product that contains 1.7 gil 00 g fructo-oligosaccharides does not comply with the
proposed South African regulations. However, if the daily portion size consumed from the latter product
is increased, it might comply with the proposed South African regulations.
Stability and viability of probiotics strains are often problematic when commercialised. Studies done by
Hamilton-Miller el al., 1999; Holzapfel el al., 1998; Reuter, 1997; and Temmerman el al., 2002 on the
microbial analyses of probiotic dairy products and supplements, demonstrated that the identity and the
number of recovered species do not always correspond to the information stated on the product label. A
further objective of this study therefore was to test the claims concerning viable cell numbers on the
labels of the products emperically. The viable cell numbers of three out of the five probiotic supplements
that were tested were not in line with the viable cell numbers stated on the labels of the products. Despite
the fact that the actual viable cell numbers in these supplements were lower than the viable cell numbers
stated on the labels, all the probiotic strains showed good inhibitory activity against the indicator strains
isolated from faeces of patients diagnosed with AIDS.
It is of concern that quite a number of products on the South African market only claim AB-culture
content or prebiotic fibre content without specifying probiotic species, viable cell numbers, prebiotic type
and concentration. This situation indicates that the proposed South African regulations are not yet being
enforced and that it is not possible for the consumer to make a well-informed decision about the use of
these products. It is of vital importance that this situation be rectified.
Low consumer awareness and knowledge of probiotics and prebiotics might restrain the growth of the
probiotic and prebiotic market (Menrad, 2003). No information regarding the awareness of the South
African consumer of these products in South Africa could be traced. Therefore, a further objective of this
study was to conduct an exploratory market survey to determine the awareness of the South African
consumer regarding probiotics and prebiotics. The results indicate that the awareness of these consumers
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of such products is probably low. However, the awareness of AB-cultures seems to be higher than the
awareness of probiotics, which might be explained by the fact that most probiotic containing yoghurt
product labels claim to contain AB-cultures, but no reference is made to probiotic cultures. Prebiotics
also does not seem to be a well-known term in South Africa. This could be linked to the fact that
prebiotic products mostly state fructo-ol igosaccharide or inul in content but do not refer to the generic
term, prebiotics. The consumers who were aware of probiotics, mostly seemed to have knowledge about
the health benefits thereof and their main sources of information were the labels on the products,
magazines and their doctor. The few respondents who were aware of prebiotics, did not seem to have any
knowledge about the health benefits thereof. In this study it was found that females, students and younger
people are more aware of probiotics (including AB-cultures) and prebiotics. It is speculated that the
higher awareness of females is because women are usually responsible for food shopping and are
therefore more exposed to health food products (Wellner, 2002). They are also more inclined to read
health magazines than men (Cant et al., 2002). According to Schiffman and Kanuk (1997) working
people have a higher income and higher level of education than the non-working group and might be
more informed about health and nutrition. Therefore, the higher awareness of students regarding
probiotic and prebiotic containing products is not in line with what was expected, as they are not included
in the working group. This finding can possibly be linked to the fact that students might be exposed to
relevant information as a result of their studies or through close interaction with other students on
campus. It was also found that the younger age groups were more aware of probiotics and prebiotics,
with the exception of AB-cultures. These results are also contradictory to expectations as it has been
reported that consumers older than 50 years are more focused on their health and thus more inclined to
buy healthy and functional foods (Sanders, 1998). It can therefore be speculated that South African
consumers in this age group are not yet that well informed about the health benefits of probiotics and
prebiotics.
Not many viable probiotic starter cultures are produced in South Africa (Personal communication, 2002,
Prot. L.M.T. Dicks, Department of Microbiology, University of Stellenbosch). Therefore, the next three
objectives of this study were formulated to identify viable probiotic strains, an appropriate growth
medium and determine the ·effect of lyophilization for future commercialisation. For these purposes a
panel of twelve potential probiotic strains was screened for potential inhibitory activity against porcine
pathogens and strains from the LMG-panel. Based on the results five lactic acid bacteria (LAB) with the
best inhibitory activity were selected and screened against a panel of ten indicator strains isolated from
faeces of patients diagnosed with AIDS. The five strains showed inhibitory activity against all the
indicator strains. Inhibitory activity involves the lactic acid bacterial production of a range of
antimicrobial compounds or variations of the same type antimicrobial compound including lactic acid
and acetic acid, antimicrobial peptides, such as bacteriocins and/or low-molecular-mass antimicrobial
compounds (Saarela et al., 2000).
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For commercial production of probiotic concentrates the probiotic strains need to be stabilised in growth-
supporting media to ensure metabolic activity. Soymilk has been suggested as a growth-medium because
it contains fennentabie sugars and several microbial growth-stimulating compounds and is relatively
inexpensive (Kamaly, 1997; Mattilla-Sandholm et al., 2002). Soyrnilk-base was therefore tested as a
potential growth medium for the five LAB and it was found that the LAB showed good growth in this
medium. This indicates that the soybean-oligosaccharides, raffinose and stachyose present in the
soymilk-base, could act as sufficient nutrition for LAB growth and fermentation. These results show that
soyrnilk-base could be used successfully as growth medium for LAB without supplementation with
prebiotics.
Probiotic strains are either freeze-dried or spray dried when commercially produced (Saarela et al., 2000).
Lyophilization (freeze-drying) is the most popular method and therefore the effect of lyophilization on the
inhibitory activity of LAB was also determined. The five LAB were lyophilized after growth in soymilk-
base and it was found that this procedure decreased the LAB cell numbers by two log-cycles. However,
lyophilized cells grown in MRS broth (Biolab) yielded a spectrum and level of inhibitory activity against
indicator strains isolated from patients diagnosed with AIDS in the same order as cells that have not been
lyophilized.
Finally, it has been shown that the viability of probiotic strains in vivo is enhanced by the presence of
prebiotics. Therefore a further objective of this study was to test the growth of the five LAB in the
presence of prebiotics (in vitro). The effect of three prebiotics namely Raftiline®GR (inulin),
Raftilose®L95 (oligofructose) and Raftilose'ÏSynergy l (a combination of inulin and oligofructose) was
investigated. The greatest increase in LAB cell numbers and inhibitory activity was observed with 1.0 %
(w/v) Raftilosef'Synergyl , which contains a carefully selected OP distribution (OP = Degree of
Polymerization=chain length of the molecules). It is speculated that the polisaccharides and
oligosaccharides of Raftilosef'Synergyl are more easily hydrolysed by probiotic strains than the
compounds in the prebiotics, Raftiline®GR and Raftilose®L95. Further tests showed that the combination
of the five LAB and 1.0% (w/v) Raftilose'[Synergy l enhances the inhibitory activity of these strains
against the panel of indicator strains isolated from the faeces of patients diagnosed with AIDS. These
results can be explained by the increased production of antimicrobial compounds such as short-chain fatty
acids including acetate, propionate and butyrate due to the LAB fermentation of inulin and oligofructose
(Schley & Field, 2002).
Based on the results of the last four objectives, it can be recommended that for the purposes of the
development of effective probiotic and prebiotic containing products, at least three of the five identified
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probiotic strains should be included and that the probiotics should be combined with 1.0% (w/v)
Raftilose't'Synergy l to optimalize the inhibitory activity of the probiotics in vivo.
2. General conclusions and recommendations
From the results of this research it can be concluded that a variety of probiotic and prebiotic containing
products are available on the South African market. However, it seems that manufacturers of these
products are misleading consumers with a number of health claims that appear on the labels of some
products that are not scientifically sound. On the other hand, the proposed South African regulations
clearly do not include all the scientifically sound health claims. Content claims regarding probiotic strain,
viable cell numbers and prebiotic type and concentration were mostly in line with the proposed South
African regulations. It can also be concluded that the awareness of South African consumers regarding
probiotics and prebiotics is low. The existing market of these products include females, students and
younger people whereas the potential target market includes men, working people and older people. A
further conclusion is that viable probiotic strains for commercialization in South Africa are available.
Five viable probiotic strains that show good inhibitory activity, can be grown in soymilk-base to produce
probiotic concentrates and are not negatively influenced by lyophilization, were identified. Finally, it is
suggested that the addition of the prebiotic, Raftilosef'Synergyl , to products containing these probiotics
wi II enhance the viabi Iity thereof in vivo.
It is therefore recommended that:
• The proposed South African regulations should be revised in order to ensure that the consumer is
provided with correct information on the labels of the products containing probiotics and prebiotics.
• Manufacturers of probiotic and prebiotic containing products should be held responsible to provide
the consumer with scientifically sound and legally correct information.
• Consumer awareness of probiotics and prebiotics should be increased using effective, focussed
marketing strategies to ensure continued growth of the probiotic and prebiotic market.
• South African manufacturers of probiotic and prebiotic containing products should consider using
probiotic strains isolated in South Africa, such as the identified five LAB.
• South African manufacturers of probiotic containing products should also consider the addition of
prebiotics to these products to enhance the effectiveness thereof in vivo.
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ADDENDUM 1
Dendogram: Major segmentation variables for consumer markets
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Addendum 1
Fig.1: Dendogram : Major segmentation variables for consumer markets
Consumer market
I
Geographic Demographic
I
Psychograph ic Behavioral
1 I I I I I I I I I I II Region II City I Density II Climate II Age I I Gender I I Occupation II Race II Lifestyle I Personality J I Benefits I I Occasions I Brand I
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ADDENDUM2
Market survey of pro biotic and prebiotic supplemented food-items/ supplements
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Addendum 2
Market survey of probiotic-and prebiotic supplemented food-items/ supplements
I. Have you ever heard about probiotics?
lNoIIJ
~
1.1 Can you think of any foods/products in which we find probiotics?
Foods/Products No Yes
AB cultures in yogurt I 2
Interflora I 2
Other: I 2.....................................................................
1.2 Have you ever consumed any of these products specifically to increase
your intake of probiotics?
~
~
1.3 If yes, which foods/products?
lA In your opinion, why do you think are probiotics necessary for you?
1.5 What is/was your main source of information about probiotics?
2. Have you ever heard about live AB-cultures?
2.1 Can you think of any foods/products where we find live AB-cultures?
2.2 Have you ever consumed foods/products containing AB-cultures specifically to increase
your intake of these cultures?
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2.3 If yes, which foods/products?
.......................................................................
+
2.4 In your opinion, why do you think are AB-cultures necessary for you?
2.5 What is/was your main source of information about AB-cultures?
3. Have you ever heard about prebiotics?
3. I Can you think of any foods/products where we find prebiotics?
3.2 Have you ever consumed any of these products specifically to increase
your intake of prebiotics?
FoTll
~
~
~
3.4 In your opinion, why are prebiotics necessary for you?
3.3 Which product(s)? : .
3.5 What is/was your main source of information about prebiotics?
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4. In which of the following age categories do you fall?
10-19 20-29 30-39 40-49 50-59 60-69 70+
I 2 3 4 5 6 7
5. With which population group d If I ?o you associate yourse t le most.
Coloured African White Indian Other
I 2 3 4 5
6. What is your current occupation?
Professional I
Non-professional/Administrative 2
Labourer
..,
,)
Unemployed 4
Retired/Pensioner 5
Housewife 6
Student 7
Other: ............................................. 8
Thank youfor your cooperation
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ADDENDUM 3
Time table for market survey
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Addendum 3
TABLE 1: Time table for market survey in week one
Outlet MOD Tue Wed Thur Fri Sat
Neelsie 9:00- 12:00 -
Pharmacy 9:30 12:30
Boord 9:00 - 10:30 -
Pharmacy 9:30 II :00
Clicks 10:00- 12:00 -
10:30 12:30
Spar 12:00 - 9:00 -
12:30 9:30
Pick 'n Pay 9:00 - 13:00 -
9:30 13:30
Checkers 12:00 - 10:00 -
12:30 10:30
TABLE 2: Time table for market survey in week two
Outlet MOD Tue Wed Thur Fri Sat
Neelsie 12:00- 9:00-
Pharmacy 12:30 9:30
Boord 12:00 - 9:00 -
Pharmacy 12:30 9:30
Clicks 13:00 - 10:00 -
13:30 10:30
Spar 9:00- 12:30 -
9:30 13:00
Pick "n Pay 9:00- 12:30 -
9:30 13:00
Checkers 12:30 - 9:00 -
13:00 9:30
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